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The cytochromes P450 (P450s) are a remarkable class of heme enzymes that catalyze 
the metabolism of xenobiotics and the biosynthesis of signaling molecules. 
Controlled electron flow into the thiolate-ligated heme active site allows P450s to 
activate molecular oxygen and hydroxylate aliphatic C–H bonds via the formation 
of high-valent metal-oxo intermediates (compounds I and II). Due to the reactive 
nature and short lifetimes of these intermediates, many of the fundamental steps in 
catalysis have not been observed directly. The Gray group and others have 
developed photochemical methods, known as “flash-quench,” for triggering electron 
transfer (ET) and generating redox intermediates in proteins in the absence of 
native ET partners. Photo-triggering affords a high degree of temporal precision for 
the gating of an ET event; the initial ET and subsequent reactions can be monitored 
on the nanosecond-to-second timescale using transient absorption (TA) 
spectroscopies. Chapter 1 catalogues critical aspects of P450 structure and 
mechanism, including the native pathway for formation of compound I, and 
outlines the development of photochemical processes that can be used to artificially 
trigger ET in proteins. Chapters 2 and 3 describe the development of these 
photochemical methods to establish electronic communication between a 
photosensitizer and the buried P450 heme. Chapter 2 describes the design and 
characterization of a Ru-P450-BM3 conjugate containing a ruthenium 
photosensitizer covalently tethered to the P450 surface, and nanosecond-to-second 
kinetics of the photo-triggered ET event are presented. By analyzing data at multiple 
wavelengths, we have identified the formation of multiple ET intermediates, 
including the catalytically relevant compound II; this intermediate is generated by 
oxidation of a bound water molecule in the ferric resting state enzyme. The work in 
Chapter 3 probes the role of a tryptophan residue situated between the 
 xi 
photosensitizer and heme in the aforementioned Ru-P450 BM3 conjugate. 
Replacement of this tryptophan with histidine does not perturb the P450 structure, 
yet it completely eliminates the ET reactivity described in Chapter 2. The presence 
of an analogous tryptophan in Ru-P450 CYP119 conjugates also is necessary for 
observing oxidative ET, but the yield of heme oxidation is lower. Chapter 4 offers a 
basic description of the theoretical underpinnings required to analyze ET. Single-
step ET theory is first presented, followed by extensions to multistep ET: electron 
“hopping.” The generation of “hopping maps” and use of a hopping map program 
to analyze the rate advantage of hopping over single-step ET is described, beginning 
with an established rhenium-tryptophan-azurin hopping system. This ET analysis is 
then applied to the Ru-tryptophan-P450 systems described in Chapter 2; this 
strongly supports the presence of hopping in Ru-P450 conjugates. Chapter 5 
explores the implementation of flash-quench and other phototriggered methods to 
examine the native reductive ET and gas binding events that activate molecular 
oxygen. In particular, TA kinetics that demonstrate heme reduction on the 
microsecond timescale for four Ru-P450 conjugates are presented. In addition, we 
implement laser flash-photolysis of P450 ferrous–CO to study the rates of CO 
rebinding in the thermophilic P450 CYP119 at variable temperature. Chapter 6 
describes the development and implementation of air-sensitive potentiometric 
redox titrations to determine the solution reduction potentials of a series of P450 
BM3 mutants, which were designed for non-native cyclopropanation of styrene in 
vivo. An important conclusion from this work is that substitution of the axial 
cysteine for serine shifts the wild type reduction potential positive by 130 mV, 
facilitating reduction by biological redox cofactors in the presence of poorly-bound 
substrates. While this mutation abolishes oxygenation activity, these mutants are 
capable of catalyzing the cyclopropanation of styrene, even within the confines of an 
E. coli cell. Four appendices are also provided, including photochemical heme 
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oxidation in ruthenium-modified nitric oxide synthase (Appendix A), general 
protocols (Appendix B), Chapter-specific notes (Appendix C) and Matlab scripts 
used for data analysis (Appendix D). 
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1.1. Cytochrome P450: a remarkable metabolic enzyme 
Every living organism is composed of cells that are alive with chemical reactions, 
the processes that allow them to grow, reproduce, and respond to the 
environment. Beneficial nutrients are broken down to provide energy and 
synthetic building blocks, new molecules are built from scratch or modified for 
specific purposes, and unwanted or harmful chemicals are detoxified and excreted. 
Each of these metabolic processes must be accomplished in a very precise, 
controlled fashion; this often requires surmounting a significant reaction barrier. 
Thus, cells employ enzymatic machinery to catalyze these reactions. 
Metabolic enzymes face a number of significant challenges. Splitting up large 
molecules into smaller or more useful components requires activating, breaking, 
and functionalizing some of the strongest and most inert chemical bonds found in 
organic molecules. Additionally, a series of reduction and oxidation reactions 
(redox) is often required, in which electrons are specifically transferred out of one 
chemical bond and into a new one. All of these transformations must occur in a 
tightly controlled fashion in order to synthesize complex molecules with specific 
information encoded in the molecular structure. Furthermore, they must be 
accomplished on a wide variety of substrates; exposure to toxins and xenobiotics in 
the environment provides a constant variety of sizes, geometries, and 
functionalities. 
A remarkable class of enzymes called cytochrome P450 (often abbreviated as just 
“P450”), plays a critical role in these metabolic processes. These enzymes possess 
three characteristics that make them indispensible. First, the P450 center houses a 
thiolate-ligated heme active site capable of generating extremely reactive iron-oxo 
species. These reactive species can react with alkane C–H bonds – the most 
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common and inert bonds found in organic molecules. Secondly, the amino acids 
that directly surround the active site orient substrates in proximity to the reactive 
center, allowing the enzyme to form new bonds in a controlled fashion with high 
levels of regio- and stereoselectivity. Finally, flexible protein architecture around 
the active site allows P450s to envelop substrates with a wide variety of sizes, 
geometries, and functionalities, and thus, metabolize myriad small molecules.  
Because of these three features, P450s are found in every living organism, from 
bacteria and archaea, to plants, fungi, and animals; there are even a number of 
viruses that carry the P450 genetic code. Since their initial discovery in rat liver 
microsomes in the 1940s, advances in genomics have led to the discovery of over 
20,000 versions of P450,1 and this number keeps rising. The remarkable reactivity 
displayed by P450s has made them a highly active field of research, involving many 
disciplines from medicine and toxicology to molecular biology, biochemistry, and 
biophysics. In addition, they are inspiration for the development of inorganic 
catalysts and synthetic methodologies. A fundamental question continues to 
fascinate scientists: how do these enzymes catalyze such difficult transformations? 
Specifically, what is the nature of the catalytically active species? How does the 
enzyme control the fundamental electron transfer (ET) events that are required to 
form the active species, and for it to then react with substrates? Furthermore, can 
we harness and modify P450s to drive catalysis in an entirely new way?  
This Chapter begins by discussing the key features of P450s that contribute to their 
remarkable reactivity, including the nature of reactive intermediates along the 
catalytic pathway. Two soluble, bacterial enzymes are highlighted in particular: 
P450 BM3 from the soil bacterium Bacillus megaterium, and CYP119 from the 
thermophilic hot-springs archaeum Sulfolobus acidocaldarius. These two variants 
are the focus of the experimental work that will be presented and analyzed in 
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Chapters 2-6. This first Chapter next addresses a rapid, photochemical method for 
triggering ET within enzyme systems in order to generate and investigate reactive 
species. Implementation of this method is discussed in Chapters 2-5. Finally, this 
Chapter discusses a recent report of engineered P450-catalyzed cyclopropanations. 
By manipulating electron flow, these artificial P450s can be reprogrammed to 
catalyze cyclopropanation of styrene within the context of an E. coli cell. 
Electrochemical measurements that quantify this electronic manipulation are 
presented in Chapter 6. 
1.2. P450: structural features that direct function 
The first X-ray crystallographic characterization of a P450 was achieved in 1987 
for the soluble, bacterial P450CAM from Pseudomonas putida.2 Bacterial variants 
such as P450CAM often are stable, soluble, and easier to study. In contrast, 
mammalian variants are delicate and frequently are membrane bound. Due in 
large part to improvements to crystallization techniques, there are almost 600 P450 
structures in the protein data base (PDB) to date, including 107 structures of 
human variants. This increasing wealth of data allows identification of common 
features and individual peculiarities. Entire volumes have been written on the 
relationship between P450 structure and function,3 so this Chapter only briefly 
highlights the features that are pertinent to Chapters 2-6 of this Thesis. 
Cytochrome P450s are largely α-helical proteins, with a tertiary structure that is 
highly conserved and unique to the superfamily; no non-P450 proteins share this 
fold.4 The structures of P450 BM3 and CYP119 are shown in Figure 1.1. It is 
perhaps unsurprising that the most highly conserved regions are those adjacent to 
the active site, while those associated with substrate specificity may differ 
significantly among P450 variants. 
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Figure 1.1. Structures of P450 BM3 heme domain from Bacillus megaterium and 
CYP119 from Sulfolobus acidocaldarius. BM3: top, green, PDB: 2IJ2. CYP119: 
bottom, cyan, PDB: 1IO7. Heme active sites are highlighted in orange. All figures 
in this Chapter were made using PyMol graphics software for Mac. 
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At the heart of cytochrome P450 lies the heme, iron protoporphyrin IX, that drives 
P450 chemistry. The iron center is ligated on the proximal face by an absolutely 
conserved cysteine (Figure 1.2, green); this ligation is absolutely critical for P450 
function. This cysteine is part of a signature β-bulge containing the conserved 
sequence FxxGx(H/R)xCxG; this lies at the end of helix L, which runs beneath the 
heme (Figure 1.2, blue). This region of the protein fold is critical for holding the 
cysteine in place. Three hydrogen bonds from nearby backbone amide N-H 
donors also stabilize the thiolate ligand. This ligation and hydrogen bonding 
arrangement is shared with two other heme monooxygenases: chloroperoxidase 
and nitric oxide synthase. 
 
Figure 1.2. P450 BM3 active site. The heme is colored pale pink. The L helix 
(blue), and contains cysteine400 (green) which ligates the heme. In bright pink: 
arginine398 and tryptophan96 form hydrogen bonds with one of the heme 
propionates. The long I helix (purple) above the heme contains threonine268 
(orange). The axial water molecule, and an additional, structured water molecule 
above the heme are shown as a black dot. 
The P450 heme is not covalently bound to the protein structure, but rather is held 
in place by cysteine ligation, hydrophobic contacts, and hydrogen bonding 
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between the heme propionates and amino acid side chains. The precise nature of 
the hydrogen bonding partners differs among P450 variants. For P450 BM3, this 
includes a tryptophan96 and arginine398; site directed mutagenesis studies that 
replaced tryptophan96 with non-hydrogen bonding residues (e.g., alanine) saw 
greatly diminished heme incorporation in the expressed mutants. CYP119 
contains a more extensive hydrogen bond network between the protein and the 
heme propionates (Figure 1.3). Histidine76, histidine315, and arginine80 form 
hydrogen bonds with one of the heme propionates, and arginine259 forms a 
hydrogen bond with the other. 
 
Figure 1.3. CYP119 active site. The heme is colored pale pink. The L helix 
(blue), and contains cysteine317 (green) which ligates the heme. In bright pink: 
histidine315, histidine76, and arginine80 form hydrogen bonds with one of the 
heme propionates, and arginine259 forms a hydrogen bond with the other. The 
long I helix (purple) above the heme contains threonine213 (orange). The axial 
water molecule is black. 
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Figure 1.4. Overlay of substrate-free (open, gold) and substrate-bound (closed, 
blue) forms of P450 BM3. Top: view from the front. Bottom: views from distal 
(left) and proximal (right) faces. 
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The distal face of the P450 heme is in contact with the substrate binding pocket. In 
the absence of substrate, a water molecule acts as the distal axial ligand, making the 
iron center six coordinate and low spin. The long I helix (Figure 1.2 and Figure 
1.3, purple) runs along this distal face, and contains a conserved threonine side 
chain that is involved in oxygen activation, as discussed in Section 1.3. The 
substrate binding pocket of cytochrome P450 is largely hydrophobic, with key 
residues positioned to align substrate. While the heme active site is deeply buried, 
a long substrate-access channel provides a pathway for molecules to enter. Upon 
substrate binding, large conformation changes can be seen for many P450 variants. 
For example, in the presence of long chain fatty acids such as palmitic acid, the 
P450 BM3 G, H, and B´ helices tighten down on the pocket (Figure 1.4). 
1.3. P450 activity: reactions and mechanisms  
Broadly, P450s catalyze the metabolism of xenobiotics and the biosynthesis of 
signaling molecules. The most common and well-studied transformations are 
monooxygenase reactions, such as hydroxylation of aliphatic and aromatic 
carbons or heteroatoms, and epoxidations.5 Dehydrations, ring formations and 
expansions, and reductive halogenations among many others have also been 
observed. As will be discussed in Section 1.6, the heme active site can also be 
engineered for non-native reactions including carbene transfer. 
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Figure 1.5. Various reactions catalyzed by cytochrome P450s. 
Oxygen Activation 
P450 monooxygenase activity requires binding and activation of molecular oxygen 
(O2) with the input of high-energy electrons. Once the O–O bond is broken, a 
single oxygen atom is incorporated into an organic substrate molecule; the other is 
released as water. A canonical P450 catalytic cycle is shown in Figure 1.6; black 
rhombs represent the active site heme. Each step in this catalytic process relies on 
critical features in the P450 architecture.  
The stepwise, reductive activation of dioxygen involves transient generation of 
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oxos. In order to prevent deleterious generation and release of these species, many 
P450s have an important gating mechanism prevents the flow of electrons, and 
thus, the activation of dioxygen, in the absence of substrate; both P450 BM3 and 
CYP119 fall into this class. In these enzymes, the resting state contains a six-
coordinate, ferric (FeIII) heme, which is ligated by the axial thiolate on the 
proximal face, and a loosely bound water molecule on the distal face (species 1 of 
Figure 1.6). Strong interactions of the iron 3d orbitals with these ligands cause the 
resting state to be low-spin. 
 
Figure 1.6. Canonical P450 catalytic cycle. 
Due in large part to the strongly donating character of the axial thiolate, the resting 
state FeIII/II reduction potential is too negative to be reduced by native redox 
cofactors such as reduced nicotinamide adenine dinucleotide phosphate 
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Substrate binding causes displacement of the axial water molecule,6 forming a five-
coordinate, ferric heme in which the iron center is displaced below the ring of the 
porphyrin (species 2).7 The weaker ligand field in this geometry favors the high 
spin iron state, and shifts the FeIII/II reduction potential 50-150 mV positive,8 
facilitating one-electron reduction of the heme (species 3).  
Table 1.1. Relevant reduction potentials of wild type P450s and redox cofactors8–10  
 
a: ref 9. b: ref 10. c: ref 8. d: Chapter 6 of this Thesis 
The requisite electrons from NAD(P)H, and are transferred to the heme by various 
electron relays. For the subset of P450s known as “Class I” enzymes, a flavoprotein 
reductase acquires the two electrons from NADPH and dispatches them 
individually to an iron-sulfur protein, which in turn reduces the P450 oxygenase. 
Mammalian P450s associated with steroid synthesis and the majority of bacterial 
enzymes fall into this category. In Class II enzymes, a single flavoprotein reductase 
transfers the electrons from NADPH to the P450 oxygenase via the associated 
flavin mononucleotide cofactor (FMN).11 The mammalian P450s involved in drug 
metabolism are an example of this class.11 P450 BM3 belongs to a unique, “self-
sufficient” class, in which the reductase and oxygenase domains are fused. This 
facilitates ET, and allows P450 BM3 to turnover product with some of the highest 
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rates: 930 min-1 for lauric acid, and 1470 min-1 for arachidonic acid.12 For 
comparison, CYP119 oxidizes lauric acid at a rate of 11 min-1.13 
 
Figure 1.7. Structure of P450 BM3 oxygenase and reductase domains (PDB: 
1BVY). The oxygenase domain is colored green (heme: red), and the reductase 
domain is colored blue (flavin: purple).  
The ferrous heme readily binds oxygen, forming a ferric superoxide (species 4). 
Further reduction by one electron and protonated forms a hydroperoxy species 
(species 5). Two main factors affect heterolysis of the O–O bond at the heme active 
site. First, the “thiolate-push” from the strongly-donating thiolate ligand assists in 
heterolytic bond cleavage.14 Second, a well-organized proton relay facilitates 
selective protonation of the distal oxygen. This relay includes the conserved 
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threonine side chain on helix I, as well as organized water molecules within the 
active site (Figure 1.2). The doubly-protonated distal oxygen departs as a water 
molecule, generating a ferryl, ligand-radical-cation species known as Compound I 
(CI, Figure 1.6, species 6). 
P450 active hydroxylation agents: ferryl compounds I and II 
CI is an extremely reactive oxidant, which allows P450 to functionalize strong and 
unactivated C–H bonds. CI abstracts a hydrogen atom from substrate to form 
Compound II (CII, Figure 1.6 7), which then undergoes radical recombination 
with substrate to produce hydroxylated product. Release of product from the 
active site and re-ligation by a water molecule returns the enzyme to its resting 
state. 
The native steps of substrate binding, ET, and O–O bond cleavage are slower than 
the reaction of CI with substrate. However, CI can be generated from the resting 
state by reaction with chemical oxygen-atom donors, including meta-
chloroperoxybenzoic acid (mCPBA). This chemical oxidation was accomplished 
cleanly for highly purified samples of CYP119, and CI was spectroscopically 
characterized by UV-visible absorption, Mössbauer, and electron paramagnetic 
resonance (EPR) spectroscopies.15,16 The apparent second order rate constant for 
reaction of CI with lauric acid (dodecanoic acid) is  1.1 x 107 M-1s-1.15 
It is remarkable that a wide range of specific chemical transformations can be 
achieved by very similar reactive heme-oxygen intermediates. It is equally 
remarkable that an enzyme can house a reactive species capable of activating 
aliphatic C–H bonds, and emerge unscathed. How does the enzyme house such a 
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reactive species without reacting with the much weaker bonds that make up the 
protein itself?  
One factor is the gating mechanism described earlier; many P450s cannot be 
reduced (and therefore cannot activate dioxygen to form CI) in the absence of 
substrate. Another factor is the thiolate ligation; this causes CII to be more basic 
than other heme enzymes which are ligated by histidine. Characterization of 
chloroperoxidase and P450 CII by Mössbauer spectroscopy indicates a protonated, 
FeIV-OH species.17,18 CII in CYP158 from Streptomyces coelicolor has a reported 
pKa of almost 12,18 much higher than the pKa of ~3.5 for histidine-ligated proteins 
such as horseradish peroxidase and myoglobin.19 Abstraction of the hydrogen 
atom from substrate requires transfer of both the electron and the proton. By 
facilitating proton transfer through basicity of CII, a less-oxidizing CI is required. 
Much progress has been made to understand the native P450 catalytic cycle. 
Chemical generation, trapping, and spectroscopic characterization of the CI and 
CII active species have been huge steps in the understanding of cytochrome P450 
reactivity. However, the fundamental nuclear reorganization that drives O–O 
bond scission to form CI, and the events of hydrogen atom abstraction and radical 
rebound to form hydroxylated substrate, have yet to be observed directly. 
Formation of these intermediates requires rapid and precisely controlled ET. 
1.4. Photo-triggered electron transfer in proteins 
Photo-triggered processes provide a high degree of temporal precision for the 
gating of reactions. Absorption of a photon occurs nearly instantaneously, and 
light energy can be delivered in discrete packets using pulsed lasers. In these cases, 
the precision of temporal gating is limited by the length of a laser pulse; this can be 
a few nanoseconds (as in the case of experimental instrumentation for this Thesis) 
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or as little as a few femtoseconds. In order to translate the energy from photons 
into a desired reaction, such as ET, an additional component is needed: a 
photosensitizer.  
When photosensitizers absorb a photon of the appropriate wavelength, a reactive 
electronic excited state is generated. Ruthenium tris(2,2´-bipyridine) 
([Ru(bpy)3]2+) is a classic example.20,21 The metal-to-ligand charge transfer 
(MLCT) absorption band (λmax = 453 nm) is responsible for the orange-red color of 
this complex (Figure 1.8). Excitation into the MLCT band generates a reactive 
excited state that is both oxidizing at the metal center and reducing at the ligand 
(Figure 1.9, left). The excited state can relax by emission of a photon (λmax = 626 
nm), or can be “quenched” by ET to or from a redox partner.  
 
Figure 1.8. [Ru(bpy)3]2+ absorption (blue, solid) and emission (red, dashed) 
spectra in water, at room temperature. The emission spectrum was generated 
using 480 nm excitation. 
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Figure 1.9. [Ru(bpy)3]2+ photochemistry. Left: MLCT excited state of 
[Ru(bpy)3]2+. Right: Modified Latimer diagram for [Ru(bpy)3]2+; potentials are vs. 
the normal hydrogen electrode (NHE), in water.20,21 
In some cases, the photosensitizer’s excited state reduction potential is sufficient to 
accomplish a desired ET reaction within the lifetime of the excited state (e.g., 600 
ns for [Ru(bpy)3]2+ in deoxygenated water). However, in cases where additional 
driving force is required, or where the ET reaction is slower than luminescent 
relaxation of the photosensitizer, a method called “flash-quench” can be employed. 
In our example of [Ru(bpy)3]2+, a “flash” of light, such as a laser pulse, generates 
the photosensitizer excited state; this in turn is “quenched” by ET with exogenous 
small molecules. By selection of an appropriate quencher, either the more 
oxidizing [Ru]3+ or more reducing [Ru]1+ can be generated; this new species can be 
used to achieve ET with a system of interest. Flash-quench generates a 
photosensitizer state with additional driving force, and the separation of charges 
extends the lifetime of the reactive species. 
By partnering photosensitizers with redox-active proteins, flash quench can be 
used to trigger biologically-relevant ET. In particular, the Gray lab has focused on 
systems in which the electron acceptor (or donor) is a metal center, such as copper 
in azurin, or heme iron in cytochromes, including cytochrome P450 (Figure 1.10). 
An advantage of these systems is that the metal center has strong absorbance in the 
	   18	  
visible region. Furthermore, the absorption bands are sensitive to oxidation state 
of the metal center; ET reactions can be monitored using transient absorption 
spectroscopies. By varying the nature of the photosensitizer and the protein 
structure, the Gray lab and others have probed the mechanistic aspects of 
biological ET. Curious readers are directed toward a number of excellent reviews 
for further details.22–24 An extension of this analysis, multistep ET (“hopping”) is 
discussed in Chapter 4. 
 
Figure 1.10. Redox active model proteins. Left to right: P. aeruginosa azurin 
(PDB: 1JZG, Cu in blue), horse heart cytochrome c (PDB: 1HRC, heme Fe in red), 
cytochrome b562 (PDB: 256B, heme Fe in red). 
The bulk of this Thesis (Chapters 2-5) focus on the extension of these photo-
triggered methods to generate redox intermediates and investigate ET mechanisms 
in cytochrome P450. To set the stage for the design of photosensitizer-P450 
systems, we outline strategies for the selection of appropriate photochemical 
elements. 
Photosensitizers 
A wide variety of photosensitizers have be used for initiating ET within proteins. 
The Gray lab and others have employed ruthenium, rhenium, and osmium 
photosensitizers with a variety of ligand frameworks to study ET processes within 
metalloproteins, including heme proteins.22,25 Selection of an appropriate 
	   19	  
photosensitizer for each specific application requires assessment of several 
photochemical and photophysical aspects. 
Electronic communication between the protein and photosensitizer is critically 
important. For systems in which the protein redox cofactor is solvent exposed, 
simple photosensitizers such as [Ru(bpy)3]2+ can be implemented. However, when 
the redox cofactor is buried inside the protein framework, more elaborate methods 
must be employed. Photosensitizer “wires” that bind noncovalently to the protein 
surface, or within the substrate channel, can be used (Figure 1.11).  
 
Figure 1.11. An example of a perfluorinated ruthenium wire. 
A potential disadvantage of these wires is that noncovalent binding results in a 
distribution of free and bound photosensitizers. For enhanced control over 
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Figure 1.12. Photosensitizers for site-specific surface labeling at amino acids 
(blue). Left: [Re(dimethyl-bpy)(CO)3(imidazole)]1+ is ligated by hisitidine. Center: 
[Ru(bpy)2(imidazole)]2+ is ligated by histidine. Right: 
[Ru(bpy)2(iodoacetamidophenanthroline)]2+ is tethered to cysteine. 
This can be achieved by direct coordination of the photosensitizer metal center by 
histidine amino acids (Figure 1.12 left and center). Alternatively, nucleophilic 
residues such as cysteine can be modified with an iodoacetamido linker attached to 
the photosensitizer ligand, in order to generate a covalent thioether bond between 
protein and photosensitizer (Figure 1.12, right). Selective photosensitizer 
conjugation to a specific site on the protein surface is accomplished by removal of 
native histidine/cysteine residues, and installation of a single labeling site, using 
site directed mutagenesis. 
Selection of the photosensitizer/protein conjugation method is also important. The 
cysteine tethering reaction is more rapid, and can be accomplished at low 
temperature (4 °C) within the span of a few hours.26 By comparison, histidine 
labeling often takes days or weeks, and may require room- or elevated temperature 
(37 °C).27,28 However, the more flexible iodoacetamido linker (cysteine-labeling) 
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direct metal ligation by histidine. For experiments in which knowledge of discrete 
photosensitizer-protein distance is important, histidine labeling may be 
advantageous. Additionally, it is important to consider the native amino acid 
composition of the protein. For example, for large proteins that contain a high 
number of exposed histidine residues, cysteine labeling is more practical. 
The photosensitizer must also provide sufficient driving force to accomplish the 
desired ET. Varying the metal center and the ligand framework provides a range of 
driving forces that span over 1 V.29  
Absorption (of both photosensitizer and protein) is another key factor. It is 
desirable to excite the photosensitizer at a wavelength that is not also absorbed by 
the protein or its cofactors. Protein absorption reduces the number of photons 
available to excite the photosensitizer; it could cause undesired sample heating as 
excited protein molecules relax by thermal processes; or (particularly in the case of 
heme enzymes) it could cause protein photochemistry or luminescence that 
interfere with observation of the desired ET processes.  
Small molecule quenchers  
Flash-quench methods require an exogenous small molecule ET quencher (Q). For 
protein experiments, Q must be water soluble up to millimolar concentrations at 
mild pH (6-8), and must have an appropriate reduction potential to rapidly 
(ideally, diffusion limited) oxidize or reduce the photosensitizer.  
In addition, the quencher must not have significant absorbance at wavelengths of 
interest for the photosensitizer-protein system; this is analogous to what was 
described for protein absorbance. Laser-triggered flash-quench ET process can be 
probed by transient absorption spectroscopies, therefore it is also desirable that the 
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quencher not absorb at the probe wavelengths (e.g., the Soret region for heme 
proteins: 390 – 440 nm). 
A final consideration for quencher selection is redox reversibility. In a reversible 
cycle (such as depicted in Figure 1.13), the stable, reduced quencher serves as an 
electron source to complete the ET cycle and return the system back to its resting 
state. In an ideal reversible system, the flash-quench cycle can be repeated ad 
infinitum, with no degradation or persistent accumulation of intermediates. 
Reversibility is most desirable for rapid transient absorption laser studies, in which 
the averaging of many shots is required to achieve a sufficient signal-to-noise ratio. 
Alternatively, irreversible quenchers serve as a sacrificial oxidant; this supplies 
more time for slow reaction events, and allows for accumulation (and detection) of 
oxidized species. Irreversible quenchers are usually desirable for steady-state flash-
quench processes, such as light-driven catalysis. Parameters for three water-soluble 
ET quenchers are given in Table 1.2. 
 
Figure 1.13. Flash-quench ET cycles. Oxidized species are highlighted in red, 
reduced species in blue. Left: Reversible flash-quench ET. Right: irreversible flash-
quench. 
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Table 1.2. Parameters for a selection of oxidative quenchers.30–33 Potentials are 
reported vs. NHE.  
 
1.5. Photo-triggered ET in P450: two pathways toward reactive heme species 
Photosensitizers and flash-quench can be used in place of native ET partners to 
generate and investigate the active species CI and CII. Reductive flash-quench 
supplies the electrons necessary to activate dioxygen (Figure 1.14, blue arrows), 
much more rapidly than the ET with native redox partners. Alternatively, 
assuming microscopic reversibility of reaction in the catalytic cycle, one could 
envision a novel pathway in which direct oxidation of the ferric aquo heme (loss of 
one electron and one proton) generates CII, followed by a second one-electron 
one-proton oxidation to generate CI (Figure 1.14, red arrows). An attractive 
aspect of this “reverse,” oxidative route is that the oxygen atom in CI, which would 
be incorporated into substrate, is derived not from dioxygen or reactive oxygen 
species, but from water. This method was previously implemented to generate CII 
and CI in histidine-ligated heme enzymes and model systems (vide infra). Inspired 
by these successes, we began the pursuit of P450 CI using the oxidative route; these 
experiments are discussed in Chapters 2-4. Reductive ET and associated reactions 
are discussed in Chapter 5. 
	   24	  
 
Figure 1.14. Pathways for formation of high valent CI and CII. Blue arrows: 
reductive activation of dioxygen (native catalytic cycle). Red arrows: oxidative 
activation of water. Purple arrows: hydroxylation of substrate (RH). 
Precedence for photochemical heme oxidation 
Photochemical heme oxidation was first achieved for the model system 
microperoxidase-8 (MP8), the heme-containing 8-amino acid fragment of 
horseheart cytochrome c (Figure 1.16, right). Laser flash-photolysis of a sample 
composed of [Ru(bpy)3]2+, an excess of [Ru(NH3)6]3+ as an oxidative quencher, and 
MP8 resulted in one-electron oxidation of the exposed heme. The position, shape, 
and intensity of the heme Soret and Q-bands are sensitive to oxidation state and 
heme environment. CII formation was observed by a shift to higher energy of the 
Soret band at pH values above 7. In more acidic solutions, CII was not produced, 
but rather an FeIII porphyrin radical cation species was characterized by loss of the 
Soret absorbance (a “bleach”) (Figure 1.15). Analogous flash-quench oxidation 
was also achieved for the histidine-ligated enzyme horseradish peroxidase (HRP) 
(Figure 1.16, left).  
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Figure 1.15. Flash-quench oxidation of a heme protein active site. Blue arrow 
indicates excitation with blue light (e.g., 480 nm), the red arrow indicates emission 
of red light (e.g., 630 nm). 
 
Figure 1.16. Histidine-ligated hemes. Left: Horseradish Peroxidase (HRP, PDB: 
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P450 considerations: the buried heme 
The analogous use of [Ru(bpy)3]2+ was unsuccessful for oxidation of the P450 
heme, likely due to deep burial of the active site within the protein scaffold. 
Ruthenium “wires” were synthesized as substrate mimics; rapid flash-quench 
heme reduction was accomplished using an imidazole-terminated perfluorinated 
ruthenium wire (Figure 1.11).34 However, this method both blocks the substrate 
channel and displaces the axial water molecule that is necessary for oxidative 
formation of CII. Covalent tethering of the photosensitizer to the P450 surface has 
finally enabled the desired oxidative ET (Chapter 2). 
1.6. New Frontiers: Novel P450 Active Species for Non-Native Catalysis 
Cytochrome P450s offer a seemingly boundless platform in which to design and 
examine redox catalysis. As described earlier, the catalytic scope of native P450 
catalysis is already vast (Figure 1.5). With small adjustments from directed 
evolution and rational design, P450 catalysis can be extended further to include the 
biodegradation of halocarbons,35 and oxidation of gaseous hydrocarbons.36–38 By 
modifying the surface with photosensitizers, P450 catalysis can even be driven with 
light.39,40 As described in the previous section, the development of photochemical 
methods may be used to accomplish P450 catalysis by activating water, instead of 
oxygen or other reactive oxygen species. 
However, the extent of catalysis is restricted by the nature of the active species; 
atom-transfer reactions catalyzed by CI are limited to oxygenation reactions. 
Development of alternative atom transfer methods would greatly expand utility of 
P450 catalysts for industrial transformations. 
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One particularly attractive new reaction target is enzymatic cyclopropanation. The 
controlled formation of new carbon-carbon bonds is one of the most fundamental 
challenges in synthetic chemistry. Specifically, generation of the strained 
cyclopropane motif often requires the formation of two new C–C bonds in a 
regioselective fashion, as well as control of the stereochemistry at all three carbon 
centers. Cyclopropanes are found in myriad organic compounds including natural 
products, pyrethroid insecticides, fragrances, and therapeutics,41 and the 
development of cheap, efficient, selective, and sustainable cyclopropanation 
methods is an active area of research.42 The development of enzymatic 
cyclopropanation routes can take advantage of selectivity imparted by the protein 
scaffold under mild temperatures and pressures. However, this reactivity requires 
formation of a novel active species. 
Inspiration for P450-catalyzed carbene transfer came from small molecule late 
transition metal porphyrins (primarily Rh, Fe, Ru, Os), which catalyze the 
cyclopropanation of alkenes in the presence of diazo carbene precursors.43–47 The 
reaction is thought to proceed via initial formation of a metallo-carbenoid, 
followed by carbene transfer to the alkene. 
Early in 2013, Coelho et al. reported carbene transfer from ethyldiazoacetate 
(EDA) to styrene to form cyclopropanated products catalyzed by cytochrome P450 
BM3.48 Both wild-type and engineered P450 mutants were capable of catalyzing 
the reaction, but specific mutants achieved high turnover numbers. In particular, 
the single T268A mutation was sufficient to raise the turnover number from 5 
(wild-type) to 323, with high selectivity for trans 1:99 cis:trans ratio and 96% 
enantioselectivity for the trans S,S diastereomer. Additional mutations to the active 
site and periphery were used to reverse this cis:trans selectivity; the highest 
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selectivity was reported as 92:8 cis:trans, with 97% S,S enantioselectivity for the cis 
form. 
 
Figure 1.17. P450-catalyzed cyclopropanation of styrene. 
In analogy to small molecule metalloporphyrin studies,47 the authors proposed a 
mechanistic scheme that employs a high-valent carbenoid active species (Figure 
1.18, right).  
 
Figure 1.18. Native and engineered P450 catalytic schemes. Left: Consensus P450 
catalytic cycle for oxygenations, showing hydroxylation of a fatty acid. Right: 
Proposed catalytic scheme for the cyclopropanation of styrene.  
Many details of the proposed mechanism have yet to be experimentally verified, 
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significant evidence that ferrous (not ferric) P450 is required to activate 
ethyldiazoacetate (EDA). Cyclopropanation activity required the presence of 
strong reductant, such as dithionite, and the net reaction is inhibited by carbon 
monoxide, which readily binds to ferrous hemes.49  
 While this in method offers an exquisite proof-of-concept for the development of 
enzymatic cyclopropanations, the extension of this reactivity to in vivo systems 
would avoid time consuming isolation and purification steps. P450 BM3 is an ideal 
candidate for such development, as this “self-sufficient” enzyme contains both 
heme oxygenase and flavin reductase domains fused in a single polypeptide chain. 
No additional redox partner proteins are required. However, the biological 
electron source for heme reduction (a critical step for activation of EDA) is 
NADH. The aforementioned mutants show little to no cyclopropanation activity 
in the presence of this cofactor. 
This observed inactivity is due to a substrate gating mechanism described 
previously (Section 1.3); styrene binds with low affinity (KM ~ 5 mM)48 and is 
inefficient at effecting the low-to-high spin state change. Enzyme engineering to 
increase the binding affinity might facilitate gating; however, this would need to be 
achieved for every individual substrate. Incorporation of inert perfluorinated 
substrate mimics has been implemented to artificially prop the gate open and 
facilitate oxidation of tiny, ill-binding substrates such as ethane and methane.38 
However, use of these decoy molecules in vitro is expensive, and implementation 
for in vivo systems has not been established.  
Alternatively, the enzyme could be reprogrammed to bypass this substrate gating 
mechanism by altering the resting state reduction potential. In Chapter 6, we 
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describe a series of electrochemical experiments that probe electron flow in a new 
generation of P450 mutants engineered for cyclopropanation. 
1.7. Conclusions 
Rapid and efficient ET is critical for the formation of the reactive P450 
intermediates responsible for catalysis, as well as for their selective 
functionalization of organic substrates and biological molecules. The remaining 
Chapters in this Thesis explore the details of photochemical generation of high-
valent heme intermediates in ruthenium-P450 conjugates, photochemical heme 
reduction and gas binding as ways to monitor the native P450 cycle, and 
electrochemical characterization of P450 axial mutants in relation to 
cyclopropanation activity. 
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2.1. Background: Toward high-valent P450 intermediates 
Cytochromes P450 (P450s) catalyze a dazzling array of regio- and stereospecific 
oxidation reactions, including the hydroxylation of aliphatic and aromatic 
hydrocarbons and the epoxidation of alkenes.1,2 This activity requires the 
controlled formation of extremely reactive species within the protein framework. 
In the native catalytic cycle, P450s activate dioxygen with the aid of two electrons 
from reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H); one 
oxygen atom is delivered to the organic substrate, and the other is released as 
water.  
 
Figure 2.1. Catalytic cycle for P450-catalyzed hydroxylation reactions. 
The consensus P450 catalytic cycle (Figure 2.1) implicates a ferryl porphyrin 
radical cation (compound I, CI, intermediate 7) as the active oxygenating agent.3 























































substrate molecule to form a transient FeIV-hydroxide complex (compound II, CII, 
intermediate 6), and radical recombination (or rebound) with the substrate 
produces oxygenated product.4,5 Substrate release from the active site and re-
binding of a water molecule regenerates the ferric resting state of the enzyme.  
As described in Chapter 1, the elusive high-valent species, CI and CII, have been 
the target of decades of time-resolved spectroscopic studies. One intrinsic 
challenge in their pursuit is that the native electron transfer (ET) events that 
activate dioxygen are slow,6,7 and require the expensive redox cofactor, NADH. 
One method to circumvent these rate limiting reactions involves direct heme 
oxidation by oxygen atom donors such as peroxyacids (e.g., meta-
chloroperoxybenzoic acid, mCPBA) or hydrogen peroxide. In 2010, rapid mixing 
with mCPBA was used to generate and trap CI in highly purified samples of the 
thermophilic P450 CYP119 from Sulfolobus acidocaldarius.10 This reactive species 
was characterized by UV-visible absorption, electron paramagnetic resonance 
(EPR), and Mössbauer spectroscopies, and was found to be active for 
hydroxylation of model substrates such as lauric acid. Single-turnover 
hydroxylation studies yielded an observed second order rate constant of kobs = 
1.1x107 M-1s-1.10 
The events of H abstraction to form CII, and subsequent radical-rebound to 
produce hydroxylated product, have yet to be directly observed. Mechanistic 
studies of P450 catalysis in cryogenic matrices suggest that the barrier to formation 
of compound I (Figure 2.1, 5→6) is higher than that for its reaction with substrate 
(6→7→1).11 In order to gain insights into these rapid, reactive processes, new 
methods must be developed to generate high-valent P450 species on a timescale 
that is comparable to the rate of reaction with substrate. Experiments in which 
enzyme oxidation is initiated by rapid mixing of enzyme with a chemical oxidant 
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or substrate have a dead time of 0.25 ms - 10 ms (e.g., for a Bio-Logic® SFM-400 
stopped-flow). This timescale may be too slow to observe the fundamental bond-
breaking and bond-making events of interest. 
Photo-triggered methods provide a faster way to initiate reactions, with extremely 
high temporal resolution. Electronic transitions (including photo-induced 
excitation) are essentially instantaneous on the timescale of molecular motions. 
The dead time for monitoring a laser-triggered photochemical event is only 
limited by the temporal length of a laser pulse or the instrument response (~20 ns 
for the setup described herein, see Appendix B). The Gray laboratory has a long 
history of photo-initiating ET in proteins using inorganic photosensitizers, 
including ruthenium diimines and rhenium tricarbonyl complexes. Curious 
readers are directed toward a number of excellent reviews for further details.12–14 
A flash-quench cycle elicits ET with protein redox cofactors. In this method, a 
laser pulse generates a reactive, electronic excited state (Figure 2.2). Interaction of 
excited state with exogenous small molecule quenchers results in electron transfer 
quenching to generate a more oxidized photosensitizer species. The charge 
separation accomplished by the bimolecular ET increases the lifetime of the 
reactive photosensitizer, and provides additional driving force. For example, ~500 
mV of potential is gained by reversible, oxidative quenching of [Ru(bpy)3]2+ (E° vs. 
NHE in water: RuIII/II = 1.3 V; Ru*II/I = 0.8 V), and the lifetime is increased from ~ 
600 ns to nearly 100 μs.17,18  
In earlier work, [Ru(bpy)3]2+ (bpy = 2,2ʹ′-bipyridine) was employed in a 
bimolecular flash-quench photochemical oxidation procedure to generate CII and 
CI in the heme enzyme horseradish peroxidase (HRP) and in the “minienzyme” 
microperoxidase-8 (MP8), a heme-containing, 8-amino acid fragment from 
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cytochrome c.15,16 By oxidizing the active site directly, this route avoids the use of 
dioxygen or reactive oxygen species entirely. Instead, the high-valent ferryl species, 
which can incorporate an oxygen atom into substrate, is generated by oxidation of 
a water molecule that ligates the heme in the FeIII resting state. 
 
Figure 2.2. [RuII(bpy)3]2+ flash-quench and oxidation of the a heme protein 
active site. 
The approach of employing [Ru(bpy)3]2+ in solution was unsuccessful with P450, 
however, owing to the deep burial of the heme active site inside the polypeptide 
matrix of the enzyme. We circumvented this problem by covalently attaching the 
photosensitizer to the P450 surface. This has allowed us to successfully laser-
trigger photochemical heme oxidation in a Ru-P450 system, monitor the kinetics 
of electron transfer using transient absorption (TA) spectroscopy, and extract 
kinetics parameters for the rate of heme oxidation. The details of photosensitizer-
attachment, crystallographic characterization, laser-triggered heme oxidation, and 




2.2. Motivation and selection of the photochemical system 
Photosensitizer 
As described in Chapter 1, the Gray laboratory has used a variety of 
photosensitizers for triggering ET in proteins, and selective tethering at histidine 
or cysteine can be achieved. The heme domain of P450 BM3 contains 13 native 
histidines, but only three native cysteines, one of which provides proximal ligation 
for the heme. We have selected cysteine-labeling, using a ruthenium(II) bis-
bipyridine iodoacetamidophenanthroline [Ru(bpy)2(IAphen)]2+ complex (Figure 
2.3) that can be readily synthesized by published procedures.19 This 
photosensitizer is excited in the blue-green region of the visible spectrum, has a 
long excited state lifetime in deoxygenated water (900 ns),19 and, when oxidized to 
RuIII by flash-quench, has a sufficiently high reduction potential to oxidize the 
enzymatic active site (~ 1.3 V vs. NHE).17 
 




























Exogenous Oxidative Quencher  
We have selected ruthenium(III) hexaamine trichloride as a reversible, exogenous 
oxidative quencher. This complex is water soluble (> 50 mM, pH ≤ 8), has little or 
no absorbance in the regions of interest (390-500 nm), and undergoes rapid 
electron transfer with ruthenium diimine photosensitizers (vide infra). Some care 
must be taken to avoid decomposition: at high pH (> 8) and/or temperature (> 50 
°C) , [Ru(NH3)6]3+ decomposes and turns deep purple/black. In solutions of low 
ionic strength, this complex may also cause protein precipitation (observed for 
P450 and Nitric Oxide Synthase); this can be avoided by using protein solutions 
that contain 100-200 mM NaCl.  
We also attempted use of methyl viologen (dichloride salt) and 
chlorocobalt(III)pentaamine (dichloride salt). Upon irradiation (e.g., laser flash-
quench transient absorption studies), both of these quenchers caused Ru-P450 
sample degradation as observed by permanent bleaching of the P450 Soret (see 
Appendix C). Therefore, all of the studies described in this Chapter use 
[Ru(NH3)6]Cl3 as the oxidative quencher. 
P450 Mutants 
To achieve selective surface modification with the photosensitizer, we used site 
directed mutagenesis to remove two native cysteine residues (C62A, C156S) from 
the P450 BM3 heme domain. These two mutations had been made previously in 
order to achieve specific attachment at a non-native cysteine for photochemical 
and electrochemical methods.20,21 The resulting double-mutants are stable and 
active toward oxidation of fatty acids (e.g., palmitate and laurate) in the presence 
of oxygen donors (e.g., hydrogen peroxide or mCPBA). For our purposes, a single 
cysteine was introduced at residue 97 (K97C). This position was chosen by former 
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Gray group postdoctoral fellow, Lionel Cheruzel, for surface-exposure and 
proximity to the heme. The cysteine Cα to heme iron distance is 16.8 Å (Figure 
2.4). Additionally, residue 97 is directly adjacent to Trp96, which lies within 
hydrogen-bonding contact of one of the heme propionates. The role of this 
intervening residue will be further explored in Chapters 3 and 4. 
 
Figure 2.4. K97 labeling site. Left: Structure of the P450 BM3 heme domain 
from the proximal face (pdb 2IJ2) highlighting the heme (red), axial ligand C400 
(yellow), W96 (purple), and K97 (orange). Right: Space-filling model illustrating 






The RuII(bpy)2(Aphen)–P450(BM3)C62A/C156S/K97C conjugate (abbreviated 
RuIIK97C-P450BM3) has been characterized by ultraviolet-visible absorbance (UV-
vis), X-ray diffraction, and steady state and time-resolved fluorometry. The mass 
of the conjugate (54,200 Da) corresponds to that of the apo (heme-free) unlabeled 
protein (53,520 Da) plus the ruthenium photosensitizer (777 Da), minus the mass 
of iodide. 
UV-visible absorbance 
The triple-mutant P450 BM3 C62A/C156S/K97C has characteristic absorption 
features that are almost identical to wild-type: a Soret band at 418 nm, a near UV 
band at 360 nm, and Q-bands at 536 and 569 nm. The RuK97C-P450BM3 conjugate 
has an additional shoulder at 450 nm, due to the characteristic ruthenium diimine 
MLCT absorbance (Figure 2.5).  
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Figure 2.5. Absorption spectra of [Ru(bpy)2(IAphen)]+2 (yellow), P450-BM3 
C62A/C156S/K97C (blue), RuK97C-P450BM3 (green), at approximately equal 
concentrations. 
Steady-state Luminescence 
The free photosensitizer [Ru(bpy)2(Aphen)]2+ and RuIIK97C-FeIIIP450 conjugate have 
been examined by steady-state luminescence spectroscopy. When excited with 
blue light (e.g., 480 nm), both samples show a broad luminescence band in the red 
region of the visible spectrum, with λmax = 620 nm. The steady-state spectra of 
[Ru(bpy)2(Aphen)]2+ and RuIIK97C-FeIIIP450 are nearly superimposable, and very 
closely resemble that of [Ru(bpy)3]2+ (λmax = 626 nm) (Figure 2.6). Un-labeled 
P450 is not luminescent in the visible region. 
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Figure 2.6. Steady-state luminescence spectra of Ru photosensitizers in 
deoxygenated water. [RuII(bpy)3]2+ (red), free photosensitizer 
[RuII(bpy)2(Aphen)]2+ (dark blue), and conjugate RuIIK97C-FeIIIP450 (light blue).  
X-ray Crystal Structure Analysis 
We have determined the X-ray crystal structure of RuIIK97C-FeIIIP450 to 2.4-Å 
resolution (Figure 2.7). Two monomers were found in the asymmetric unit; the 
root-mean-squared deviation (rmsd) between the Cα atom positions in the two 
monomers is 0.34 Å, confirming that the two polypeptides have nearly identical 
conformations. Interestingly, the substrate channel is occupied by two unidentified 
electron density peaks. Additionally, the structure of RuIIK97C-FeIIIP450 more closely 
resembles that of the substrate-bound (closed) P450-BM3 enzyme (rmsd of 0.44 Å 
for Cα with the structure 2UWH22), in which the F and G helices (known as the 
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“lid domain”) contract inward toward the heme.23 In contrast, the substrate-free 
(open) form overlays with an rmsd of 0.66 Å (for the structure 2IJ224) (Figure 2.7). 





Figure 2.7. The RuK97C-P450BM3 structure. (PDB: 3NPL) RuII(bpy)2(Aphen) 
photosensitizer is colored blue, the heme is colored red and tryptophan96 is 
colored purple. 
 
Figure 2.8. Overlay of RuK97C-P450BM3 with wild type substrate-free and 
substrate-bound forms. Left: Substrate-free (open) form (pink, PDB: 2IJ2), RMS 
0.662. Right: Substrate-bound (closed) form (orange, PDB: 2UWH) RMS 0.440. 
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The Ru-photosensitizer is well defined in only one monomer of the crystal 
structure, owing to π-stacking of the bipyridine ligands with aromatic residues on 
adjacent crystal units (Figure 2.9). The distance between the Fe-heme and Ru-
photosensitizer is 24 Å.  
 
Figure 2.9. Stacking of RuK97C-P450BM3 with an adjacent crystal unit. P450: 
green, photosensitizer: blue. Adjacent crystal unit: pink. Trp90 and Tyr344 edge-
to-edge distances of 3.5-4.5 Å with the two bipyridine ligands. Glu 244 stacks 
beneath one of the bipyridine ligands, within 3.5 Å of the plane of the 
phenanthroline ligand. 
The Ru-photosensitizer in the second monomer, which lacks the π-stacking 
interactions with neighboring protein molecules, is highly disordered. This is 
probably due to flexibility of the cysteine-acetamide linkage. These observations 
suggest conformational freedom for the Ru-photosensitizer. The 24-Å Ru-Fe 
distance is likely near the maximum separation in the distribution of 
conformations sampled by the Ru complex in dilute RuIIK97C-FeIIIP450 solutions 
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since the ligands of the photosensitizer may form favorable hydrophobic with 
amino acid residues on the protein surface, decreasing the Fe-Ru separation.  
2.3.2. Laser flash-quench experiments 
In order to examine photo-triggered ET in a time-resolved manner, laser samples 
were prepared under inert atmosphere with either the RuIIK97C-FeIIIP450 conjugate or 
the free photosensitizer ([Ru(bpy)2(Aphen)]2+) in the presence or absence of 
exogenous quencher. Formation of the ferryl species from the ferric aquo resting 
state requires loss of protons, and we anticipated that the photo-triggered ET 
reaction would be pH dependent. Samples were prepared in buffers: 20 mM 
sodium acetate (pH 6, 7), 50 mM tris or 50 mM sodium borate (pH 8). 
Time-resolved luminescence 
The excited state luminescence decays of both [Ru(bpy)3]2+ and the free 
photosensitizer [Ru(bpy)2(IAphen)]2+ are monoexponential; 
τ(*[Ru(bpy)2(IAphen)]2+) is 720 ns. Somewhat unexpectedly, the time-resolved 
luminescence decay of RuIIK97C-FeIIIP450 (λobsd = 630 nm) is biexponential, with 
components of  (τ1 (*RuIIK97C-FeIIIP450) = 670 ns, τ2 (*RuIIK97C-FeIIIP450) = 140 ns	  (Figure 2.10).	   This biexponential nature of the RuIIK97C-FeIIIP450 decay does not 
appear to be affected by protein concentration over a range of 1-20 μM (see 
Appendix C). This suggests that a monomer-dimer equilibrium is not the cause of 
this biexponential behavior. We attribute these two exponential components to 
two separate conformations of the tethered photosensitizer conformations that do 
not exchange on the timescale of the luminescence measurement. The disorder 
present in the crystal structure supports the possibility of multiple conformations, 




Figure 2.10. Time resolved 630 nm luminescence decays in the absence of 
quencher. Top: RuIIK97C-FeIIIP450 (cyan), and Bottom: [RuII(bpy)2(IAphen)]2+ 
(orange). Monoexponential fits are in red, biexponential fit (RuIIK97C-FeIIIP450 only) 
is in blue. 
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In the presence of the exogenous electron transfer quencher, [Ru(NH3)6]Cl3, 
luminescence lifetimes decrease. The lifetimes in the presence of quencher appear 
to be more monoexponential, and approximate rate constants are extracted using a 
monoexponential fit. Stern-Volmer analysis of *RuIIK97C-FeIIIP450 luminescence 
decay in the presence of various [Ru(NH3)6]3+ concentrations (Figure 2.11) 
produces a bimolecular quenching rate constant (kq) of 1.4 × 109 M−1 s−1 (pH 8); 
this is close to diffusion limited (Figure 2.12).  
 
Figure 2.11. Luminescence decays of RuK97C-P450BM3 (pH 8) at various 
concentrations of [Ru(NH3)6]3+ quencher.  
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Figure 2.12. Stern-Volmer quenching of RuK97C-P450BM3 with [Ru(NH3)6]3+ at 
three pH values. Luminescence decay rates are determined from monoexponential 
fits. pH 8 borate buffer (blue circles), pH 7 sodium acetate buffer (green triangles), 
pH 6 sodium acetate buffer (red squares).  
Transient absorption 
Both the Ru photosensitizer and P450 heme have strong electronic absorbance in 
the 390-440 nm region: P450 Soret ε(λmax: 418 nm) = 95,000 M-1cm-1;7 
[Ru(bpy)2(Aphen)]2+ ε(λmax: 450 nm) = 16,600 M-1cm-1.19 The shapes and positions 
of these electronic transitions are sensitive to metal oxidation state and 
environment; each species has a distinct absorption profile. By monitoring 
multiple wavelengths (390-440 nm) over time, we can identify the formation and 
decay of ET intermediates following laser excitation. This process is greatly 
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facilitated by control studies (e.g., the absence of quencher, or the free 
photosensitizer), as well as comparison to absorption profiles in the literature. 
In the absence of exogenous quencher, TA traces of [Ru(bpy)2(Aphen)]2+ and 
RuIIK97C-FeIIIP450 following excitation (λex = 480 nm) are essentially identical. Data at 
all wavelengths reveal bleaching (ΔAbs < 0) from 390-440 nm, consistent with the 
well-characterized behavior of metal-to-ligand charge-transfer (MLCT) excited 
Ru-diimine complexes.17 The transient signals returns to baseline at the same rate 
as luminescence decays, and we find no evidence for the formation of additional 
transient species (Figure 2.13). 
 
Figure 2.13. Single-wavelength transient absorption of RuIIK97C-FeIIIP450 in the 
absence of quencher. 400 nm: blue; 420 nm: green; 440 nm: red, and a scaled 
overlay of the luminescence decay at 630 nm. The sample is in 50 mM borate 
buffer, pH 8. Laser excitation is λex = 480 nm.  
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TA analysis of the free photosensitizer [Ru(bpy)2(Aphen)]2+ in the presence of 
quencher allows us to identify transient features associated with RuIII-
photosensitizer species. TA data at all wavelengths examined are characterized by 
bleaches with biphasic recovery; the first kinetics phase is attributed to  
*RuII RuIII ET quenching, and agrees with the luminescence decay rate (Figure 
2.14). [RuIII(bpy)2(IAphen)]3+ is characterized by a bleach at all wavelengths 
examined (390-440 nm); this feature decays to baseline within 100 μs, presumably 
through back-ET with reduced quencher ([RuII(NH3)6)]2+) (see Appendix C for 
additional comments on this recombination rate). 
 
Figure 2.14. Transient Absorption data for flash-quench of [Ru(bpy)2(IAphen)]2+ 
with 17 mM [Ru(NH3)6]3+. The scaled luminescence decay (630 nm) is overlayed  
(top, pink) for comparison. 
Flash-quench of RuIIK97C-FeIIIP450 in the presence of quencher reveals substantially 
more complex kinetic behavior, indicating the presence of multiple intermediates 
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that form and disappear over the microsecond to second time range (Figure 2.15). 
The most prominent features are: a persistent bleach at 420 nm (which coincides 
with λmax of the ground state FeIII heme Soret), an increase in absorption at 390 nm 
on the microsecond timescale, and an increase in absorbance at 440 nm on the 10 
ms – 1 s timescale. These features are distinct from [RuII(bpy)2(IAphen)]3+ data in 
both timescale and wavelength profile, and suggest oxidation of the heme active 
site. The last TA feature is significantly affected by buffer pH, over the pH range of 
6-8; the amplitude of the 440 nm feature is greatest at high pH (Figure 2.16). 
 
Figure 2.15. Single-wavelength transient absorption following flash-quench (λex= 
480 nm) of RuIIK97C-FeIIIP450 at pH 8. 420 nm (blue), 390 nm (dark blue), 440 nm 




Figure 2.16. pH dependence of RuK97C-P450BM3 transient absorption features. pH 




Kinetics Analysis of TA Data 
In order to determine the number of kinetics phases, and therefore the number of 
potential intermediates formed by flash-quench, we performed a truncated 
generalized singular value decomposition analysis (tgSVD) of the TA data 
(Regularization Tools, Per Christian Hansen,25 see sample script in Appendix D) 
(Figure 2.17). The plot of the tgSVD shows the magnitude (y-axis) of the 
contribution of each rate constant k (x-axis) to the overall fitting of the transient 
absorption data. Grouping of the rate constants into five clusters indicates that as 
many as five distinct kinetic phases contribute to the recovery of TA signals to 
baseline.  
 
Figure 2.17. tgSVD of TA data for RuIIK97C-FeIIIP450 with [Ru(NH3)6]3+ at six 
wavelengths. black: 390 nm; blue: 400 nm; cyan: 410 nm; green: 420 nm; yellow: 
430 nm; red: 440 nm, in 50 mM borate buffer, pH 8.  
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The position of each of the clusters also gives a first-order estimate of the rate 
constant for each kinetics phase. These estimates greatly facilitate the success of 
multiexponential fitting procedures. Starting with these rate constants, we have 
performed a global least-squares fitting of the TA data recorded at six wavelengths 
(390, 400, 410, 420, 430, 440 nm), to a sum of five exponentials with amplitude 
coefficients ρ1-5 and observed rate constants γ1-5 (Equation 1.1) (see a sample fitting 
script in Appendix D). 
Equation 1.1: 
! 
TA("n ) = #n1 exp $%1t( ) + #n2 exp $% 2t( ) + #n3 exp $% 3t( ) + #n4 exp $% 4t( ) + #n5 exp $% 5t( )  
Based on our interpretation of the nature and decay rate of the first transient 
absorption signal (vide infra), we can fix the first observed rate constant as that for 
the luminescence quenching (obtained from monoexponential fitting of the 
luminescence decay at 630 nm). The remaining four rate constants are extracted 
from the global fitting (Figure 2.18), and are listed in Table 2.2. We find 
analogous trends in the data from pH 6 to 8. 
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Figure 2.18. Global fitting of RuIIK97C-FeIIIP450 TA data at pH 8. Light blue: data. 
Dark blue dashed: global fit. 
Table 2.2. Observed rate constants (γ1-5, s-1) extracted from global fitting of single-
wavelength TA at six wavelengths (390-440 nm). 
 
2.4. Discussion 
The five distinct kinetics phases suggest that six distinct species are formed 
following excitation of the Ru photosensitizer. The first transient species is easily 
identified as excited *RuIIK97C-FeIIIP450, by comparison to TA signals of the un-
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quenched Ru-P450 conjugate and of the free, quenched photosensitizer. The 
second species is formed in the quenching reaction with [Ru(NH3)6]3+, and can be 
identified as RuIIIK97C-FeIIIP450 using similar logic. The final species formed is 
RuIIK97C-FeIIIP450, since all TA signals return to baseline; this, along with sample 
stability over thousands of flash-quench cycles, suggests full reversibility of the 
photo-triggered reaction. Three transient species remain to be identified; these are 
most likely associated with oxidation of the P450 heme center, as they are distinct 
from any TA signals observed for the free photosensitizer. We refer to these 
species as P450(OX1-3) in the discussion below. 
2.4.1. Kinetics Model 
We have developed a sequential kinetics model for the RuIIK97C-FeIIIP450 TA data 
(Figure 2.19).  
 
Figure 2.19. Scheme for photochemical oxidation of cytochrome P450. 
Elementary rate constants k0-k7 are shown for the proposed reactions. Unidentified 
oxidized P450 species (P450(OX1-3)) are highlighted in red. 
We have solved the rate law for this model, allowing us to express the observed 
rate constants (γ1-5) and amplitude coefficients (ρ1-5) in terms of nine elementary 
rate constants (k0, k1, k2, k3, k4, k5, k6, k−6, k7) and the initial *RuIIK97C-FeIIIP450 
concentration. This method is used to extract unscaled difference spectra for each 
transient species (Figure 2.20, see Appendix C for details).  
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This system is underdetermined; there are nine elementary rate constants in the 
kinetics model, but only five observed rate constants can be determined from 
exponential fitting. Therefore, the parameters in the kinetics model cannot be 
determined by the TA data alone. Values for k1, k3, k5, and Keq = k6/k−6 must be 
supplied in order to determine molar difference spectra for the six intermediate 
species. The known spectra of *RuII- and RuIII-diimine species constrain the 
possible values of k1 and k3. The balance between k5 and k7 has no effect on the 
relative difference spectra extracted from the data, so k5 was set equal to k7. The 
equilibrium constant Keq was optimized to provide the best agreement between the 
transient difference spectra recorded at the three different pH values (Figure 2.20).  
 
 
Figure 2.20. Extracted difference spectra of intermediate species. Top: Ru-based 




Table 2.3. Extracted kinetics parameters. Top: Rate constants k (s-1) for the 
kinetics model of flash-quench. Bottom: Keq=k6/k-6; *ϕET and ϕET are the yields for 
formation of *RuII and RuIII, respectively.  
 
The difference spectra of *RuIIK97C-FeIIIP450 and RuIIIK97C-FeIIIP450 extracted from the 
kinetics analysis exhibit bleaching at 430 nm of the Ru2+ MLCT absorption band. 
Of primary interest are the difference spectra corresponding to intermediates 
labeled P450OX1-3.  
As discussed in Chapter 1, flash-quench oxidation of horseradish peroxidase 
(HRP) and microperoxidase-8 (MP-8) first proceed by transient oxidation of the 
porphyrin ring (FeIII–OH2(P+)); subsequent internal rearrangement and 
deprotonation led to the ferryl, FeIV=O(P), product (CII). The initial porphyrin 
radical in HRP and MP-8 are also characterized by a bleach of the heme Soret.15,16 
The blue shift in absorption for these porphyrin radical intermediates is also 
consistent with synthetic models of Fe(III)-porphyrin cation radicals.26 
The spectra of P450OX1 and P450OX2 are quite similar, and are also characterized by 
a bleach of the Soret absorption band (centered at 420 nm). The spectrum of 
P450OX2 displays somewhat more absorbance at 390 nm than that of P450OX1, but 
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otherwise closely resembles that of P450OX1. Reasoning by analogy to our results on 
the oxidation of HRP and MP8, and the similarity of their difference spectra, we 
suggest that P450OX1 and P450OX2 correspond to six-coordinate porphyrin radical 
cations: RuIIK97C-FeIII(OH2)P+(A)P450 and RuIIK97C-FeIII(OH2)P+(B)P450.  
The apparent equilibrium constant between P450OX2 and P450OX3 varies with pH 
(Keq: 0.8, pH 6; 2.9, pH 7; 10, pH 8), suggesting that a proton is lost in the 
formation of P450OX3. Moreover, the difference spectrum for this species indicates 
a red-shifted Soret absorption band analogous to that reported for the FeIV(OH)P 
center in CPO CII,27 as well as photochemically-generated CII in HRP and MP-8. 
Hence, we suggest that P450OX3 is RuIIK97C-FeIV(OH)PP450. Internal charge transfer 
in FeIII(OH2)P+(B)P450 is accompanied by rapid loss of a proton (possibly to water), 
producing FeIV(OH)PP450. The formation of flash-quench generated CII in HRP 
was slower (kobs of 4.1 s−1) due to rate-limiting water ligation. CII formation in 
P450 proceeds on the millisecond timescale because a water molecule already 
occupies the sixth coordination site of the ferric heme.   
The specific rate of FeIII(OH2)P+(A)P450 formation in our conjugate is comparable to 
that found for reconstituted myoglobin containing a heme tethered directly to 
Ru(diimine)32+.28 This observation suggests that a favorable pathway couples the 
P450 porphyrin to RuIII, possibly involving the Trp96-heme propionate hydrogen 
bond.29 The conversion of RuIIK97C-FeIII(OH2)P+(A)P450 to RuIIK97C-
FeIII(OH2)P+(B)P450 may be a consequence of changes in polypeptide or solvent 
conformation in the P450 heme pocket.30  
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Figure 2.21. Photo-triggered cycle for flash-quench oxidation of RuIIIK97C-FeIIIP450. 
All of these intermediates are short-lived; transient absorbance features return to 
baseline within 500 ms, indicating recovery of resting state RuIIK97C-FeIII(OH2)PP450. 
We have modeled this process as recovery from both the ferryl species (k7, 
Ru2+K97C-FeIV(OH)PP450) and its porphyrin radical cation precursor (k5, RuIIK97C-
FeIII(OH2)P+(B)P450) (Fig. 4), but it is not possible to determine the two rate 
constants since equilibration between RuIIK97C-FeIII(OH2)P+(B)P450 and RuIIK97C-
FeIV(OH)PP450 is faster than the ground-state recovery process. The precise nature 
of the resting state recovery process remains unclear. It should be described by 
second-order reaction kinetics, but the experimental data are better modeled by a 
simple exponential process. Nevertheless, [Ru(NH3)6]2+ seems to be involved in the 
recovery reaction because in the presence of [Ru(NH3)6]3+ as quencher, transient 
absorption data are consistent over the course of multiple hours, and the Soret 
absorption band appears relatively unaffected after many rounds of flash-quench 


















































([Co(NH3)5Cl]3+) induce bleaching of the Soret band and rapid sample 
degradation. 
2.5. Concluding Remarks 
We have developed a flash-quench method to oxidize the buried resting ferric 
aquo state of the P450-BM3 heme domain to CII without the use of reactive 
oxygen species (O2, H2O2). The catalytic cycle runs in reverse by photochemically 
splitting water at the heme site. It is likely that the observed ferryl species is 
protonated over the pH range of 6-8, as consistent with the current view of 
chloroperoxidase and P450 CII . The finding that internal oxidation of the iron 
center is rate limiting has allowed us to observe porphyrin radical cation 
intermediates. As porphyrin oxidation occurs on the microsecond timescale, we 
can reasonably expect a second round of flash-quench on photochemically 
generated CII to produce CI.  
Efforts toward this second oxidation step will be greatly facilitated by a better 
understanding of the coupling pathway between the photosensitizer and heme, 
and development of a system in which CII is stable on the order of seconds-to-
minutes. Examination of the role of W96 and implementation of the 
photochemical system in the thermophilic P450 CYP119 are described in  
Chapter 3. 
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intricate details of data analysis, fitting, and kinetics modeling. The synthesis of 
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2.7. Materials and Methods 
Chemicals 
Buffer salts were obtained from J.T. Baker. Dicyclohexylcarbodiimide (DCC), 
iodoacetic acid, and 5-amino-1,10-phenanthroline were obtained from Sigma 
Aldrich. Ru(2,2’-bipyridine)2Cl2 and [Ru(NH3)6]Cl3 were obtained from Strem 
Chemicals; these were used without further purification. Mutagenesis primers 
were obtained from Operon. Solutions were prepared using 18 MΩcm water 
unless otherwise noted.   
Procedures 
A detailed description of experimental protocols can be found in Appendix B. A 
brief description of the procedures is given below, highlighting any deviations 
from the general protocol. All images of protein crystal structures in this Chapter 
were made using PyMol graphics software for Mac. 
2.7.1. Ru photosensitizer 
Synthesis 
This photosensitizer was synthesized according to published procedures. Briefly, 
iodoacetic anhydride was formed by addition of N,N’-Dicyclohexylcarbodiimide 
(DCC) to a solution of iodoacetic acid in ethyl acetate. Following removal of urea 
by filtration and evaporation to dryness, the iodoacetic anhydride in acetonitrile 
 67	  
was added to a solution of 5-amino-1,10-phenanthroline in acetonitrile and stirred 
overnight at room temperature. Solid product (5-iodoacetamido-1,10-
phenanthroline, (IAphen)) was refluxed with Ru(bpy)2Cl2 in methanol for 3 hours; 
a color change from purple to red is observed. After cooling and filtration, product 
can be precipitated by addition of concentrated aqueous NH4PF6. Alternatively, 
the compound can be concentrated and redissolved in water without further 
purification. The starting material impurities do not interact with P450, and do 
not appear to impact the labeling process. 
Characterization 
The photosensitizer was characterized by nuclear magnetic resonance (NMR), 
steady-state luminescence, and transient luminescence and absorption. 
2.7.2. Mutagenesis and expression of P450-BM3 mutants 
Plasmid 
The recombinant P450-BM3 heme domain, consisting of the first 463 residues 
with an N-terminal 6-histidine tag, was obtained courtesy of Andrew Udit 
(Occidental College, Los Angeles California), within the pCWori+ vector, which 
also contains genes for ampicillin resistance and IPTG induction. 
Mutagenesis 
The triple mutant C62A/C156S/K97C was made using Qiagen QuikChange site-




GCTGGACGCATCAAAAAAATTGGTGCAAAGCGC (K97C). The P450 gene 
was sequenced (Laragen) to verify successful mutagenesis.  
Expression 
P450 enzymes were overexpressed in E. coli. Briefly, overnight Luria Bertani 
medium cultures were used to inoculate 1x Terrific Broth induction cultures with 
added mineral supplements, shaken at 37 °C. At an OD(600 nm) ~1, the 
temperature was lowered to 30 °C, expression was induced with isopropyl β-D-
thiogalactopyranoside (IPTG), and α-aminolevulenic acid was added. After 
expression for 24 or 40 hours (for P450 BM3 and CYP119, respectively), cells were 
harvested by centrifugation and stored at –80 °C. 
Extraction and purification 
P450 enzymes were extracted by sonication in the presence of protease inhibitors 
(benzamidine hydrochloride and Pefabloc SC hydrochloride). After centrifugation, 
the supernatant was purified by nickel immobilized metal affinity chromatography 
on a batch column. Samples were further purified by FPLC anion exchange 
chromatography and gel filtration. 
Purity was determined by UV-vis absorption (A418/A280), SDS-PAGE, and mass 
spectrometry. Dithiothreitol (DTT) was added to protein not intended for 





2.7.3. Ru-P450 conjugation 
The complex [Ru(bpy)2(IAphen)]2+ (IAphen = 5-iodoacetamido-1,10-
phenanthroline) was covalently coupled to triple mutant C62A/C156S/K97C 
(abbreviated as tK97C) at Cys97 to give the conjugate RuIIK97C-FeIIIP450.  
Briefly, approximately three-fold excess of [RuII(bpy)2(IAphen)]2+ was added to a 
~10 μM P450 solution in 20 mM Tris buffer, pH 8. The reaction solution shaken 
gently for ~4 hours at 4 °C in the dark, followed by desalting to remove excess 
photosensitizer and purification of Ru-labeled and unlabeled enzymes by anion 
exchange chromatography on an MonoQ or HiPrepQ FPLC column. 
This conjugate was characterized by mass spectrometry, UV-Vis and luminescence 
spectroscopies (steady state, time-resolved), and X-ray crystallography. The 
conjugate RuIIK97C-FeIIIP450 demonstrates activity in the hydroxylation of lauric acid 
via the peroxide shunt.31 
2.7.4. Crystallization and structure determination 
Crystals of RuIIK97C-FeIIIP450 were obtained by the sitting-drop vapor diffusion 
method: 27 mg/ml RuIIK97C-FeIIIP450 in 10 mM potassium phosphate, pH 8.4 was 
mixed with a crystallization well solution of 2 M (NH4)2SO4 (w/v) in a 1:1 ratio 
(v/v). Crystals formed over a period of 2 days at 4 °C, and were flash frozen 
directly from the crystallization solution. X-ray diffraction data were collected at 
100 K using beamline 7-1 at the Stanford Synchrotron Radiation Laboratory. 
Diffraction data were processed with Mosflm and Scala. Initial model for the 
RuIIK97C-FeIIIP450 structure was derived from the palmitic acid-bound P450-BM3 
structure (pdb ID 2UWH) by molecular replacement using Molrep. Coot and 
Refmac5 were used for model fitting and refinement. The final models were 
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validated using the programs Procheck, Sfcheck and Molprobity. Most of the 
above processes were done with the graphical interface to the CCP4 program suite. 
All structural graphics were generated using the Pymol Graphics System. 
Statistics for data collection and refinement are shown in the Table S1. Atomic 
coordinates and structure factors were deposited in the Protein Data Bank under 
the entry 3NPL.  
2.7.5. Preparation of laser samples 
Laser samples were composed of either RuIIK97C-FeIIIP450 or the model complex 
[Ru(bpy)2(IAphen)]2+ (~10 μM), with and without oxidative quencher (17 mM 
[Ru(NH3)6]Cl3) in buffered solution (pH 6: 20 mM sodium acetate; pH 7: 20 mM 
sodium acetate; pH 8: 50 mM sodium borate or 50 mM Tris; additionally, each 
buffer contained sodium chloride). Samples were placed in a high-vacuum four-
sided quartz cuvette, equipped with a small stir bar. Deoxygenation was achieved 
via gentle pump-backfill cycles with argon. 
For acquisition of time-resolved fluorescence and transient absorption data, 
samples were excited with 8 ns laser pulses at 480 nm. Luminescence decays were 
monitored at 630 nm. Single wavelength transient absorption (TA) kinetics were 
monitored every 10 nm from 390-440 nm, averaging ~500 shots per wavelength. 
Data from five separate timescales (2 μs, 40 μs, 400 μs, 10 ms, and 500 ms) were 
collected, log-compressed, and spliced together to produce full kinetics traces. See 
Appendix D for log-compression and splicing scripts in Matlab. 
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3.1. Background: Light to ET 
To accomplish metabolic processes that drive biological function, cells must 
deliver electrons and holes over many-angstrom distances, and generate highly 
reactive species in a very controlled manner. The photosynthetic reaction center in 
plants is a paradigm in its ability to harness the energy in sunlight to produce high-
energy states that can rapidly and efficiently separate charges (electrons and holes) 
over greater than 20 Å. This allows use of the reactive electrons to generate 
reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) and 
adenosine triphosphate (ATP) (the energy currency of the cell), and sequestration 
of the reactive holes to oxidize water and generate molecular oxygen.  
 
Figure 3.1. Photo-excitation of P680 chromophores in Photosystem II triggers 
oxidation of the oxygen evolving complex (OEC). 
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As described in Chapter 2, we have developed a ruthenium 
photosensitizer/cytochrome P450 BM3 conjugate system (Figure 3.2) that 
similarly harnesses light energy (a laser pulse) to photochemically oxidize the P450 
active site by one electron.1 We have generated the high-valent heme-hydroxo 
species known as compound II (CII) by oxidizing an axially-bound water molecule 
(Figure 3.3). This is the first step in running cytochrome P450 backwards to access 
the highly-reactive, iron-oxo ligand radical intermediate known as compound I 
(CI).  
 
Figure 3.2. Photo-excitation of the tethered ruthenium complex triggers 
oxidation of the P450 heme active site. The photosensitizer (RuII(2,2´-
bipyridine)2(5-acetamido-1,10-phenanthroline)) is highlighted in blue, the heme is 
red, and intervening tryptophan 96 is colored purple. 
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CI is capable of hydroxylating unactivated alkane C–H bonds, a critical 
transformation in the biosynthesis of steroids, among many other cellular 
processes. This reactive species has been chemically generated by rapid mixing of 
mCPBA (meta-chloroperoxybenzoic acid with the thermophilic P450 CYP119.2 
However, the processes of hydrogen atom abstraction from substrate to form CII, 
and subsequent radical rebound to generate hydroxylated product and regenerate 
the resting state, have yet to be observed directly. The rate of formation of CI is 
often slower than that for its reaction with substrate.3 Photochemical oxidation of 
the active site provides a rapid means of generating these oxidized species, with 
very high temporal resolution. 
 
Figure 3.3. Formation of high-valent CI and CII. Blue arrows: reductive 
activation of dioxygen (native catalytic cycle). Red arrows: oxidative activation of 
water. Purple arrows: hydroxylation of substrate (RH). 
Generation of CI requires two-electron oxidation of the heme (Figure 3.3, red 
arrows). If we wish to achieve, observe, and characterize this second electron 
transfer by photochemical oxidation (flash-quench), we need to first obtain a 
stable pool of the precursor CII. Photochemically generated CII decays within a 
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few hundred milliseconds. Additionally, the yield of this species low; rough 
estimates place this yield at less than 20%, based on the observed transient 
absorption features (Chapter 2), and reported absorption profile of CII species in 
chloroperoxidase (a related, thiolate-ligated heme enzyme) and P450.4,5 Thus, it 
would be extremely challenging to observe photochemical generation of CI via two 
sequential rounds of flash-quench, much less characterize the reaction of this 
active hydroxylating species with substrate. 
Instead, if we can generate CII by chemical means with sufficient yield and purity, 
we may be able to photo-trigger the second oxidation step. The rigorous 
purification that can be achieved for thermo-stable CYP119 has been cited as the 
most critical aspect for chemical oxidation to CI in high yield.6 If we can extend 
our photochemical system to CYP119, we anticipate that one-electron chemical 
oxidation followed by one-electron photochemical oxidation will form CI.  
If we wish to use flash-quench to generate observable yields of CI, we also must 
gain a better understanding of the factors affecting the rate and yield of 
photochemical heme oxidation. The rate constant for heme oxidation to the 
porphyrin radical (FeIII(OH2)P+) is k = 8x105 s-1 at pH 8.1 This rate is similar to 
that observed for heme systems containing a direct, covalent linkage between the 
photosensitizer and the porphyrin framework,7 suggesting that a favorable 
coupling pathway connects the photosensitizer and heme in our Ru-P450 
conjugate.  
The intervening protein medium between electron donor and acceptor influence 
the efficiency of ET over long distances; this is discussed in more detail in Chapter 
4. In particular, aromatic amino acid residues can participate as redox 
intermediates in multi-step ET, or electron “hopping.”8–10 Tryptophan is a redox 
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intermediate in photo-triggered electron hopping in a rhenium-modified blue 
copper protein, Pseudomonas aeruginosa azurin (Figure 3.5). The electronically 
excited rhenium carbonyl complex transiently oxidizes a nearby tryptophan, 
which in turn oxidizes the copper center.8 This multistep reaction accelerated the 
overall copper oxidation event by two orders of magnitude compared to single step 
ET tunneling over the same distance.  
 
Figure 3.4. Multistep ET in rhenium-labeled azurin. Black arrows indicate the 
two ET steps that oxidize the protein metal center. 
We noted that the photosensitizer tethering position in our Ru-P450BM3 conjugate 
is directly adjacent to tryptophan 96, which forms hydrogen bonds with a heme 
propionate. We have hypothesized that this intervening tryptophan facilitates hole 
transfer to the heme (Figure 3.5), in analogy to work on azurin. 
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Figure 3.5. Multistep ET in ruthenium-labeled cytochrome P450. Black arrows 
indicate the two ET steps that oxidize the protein metal center. 
This Chapter describes our efforts to probe the role of W96 in the photochemical 
heme oxidation of RuC97-P450 BM3, and to engineer a similar system that will 
allow photo-triggered oxidation of the CYP119 active site, with the aim of 
photochemical production of compound I in this thermostable enzyme. 
3.1.1. P450 systems: Motivation and selection 
The functional photochemical system in P450 BM3 (Chapter 2) involves a triple 
mutant of the heme domain, which will be abbreviated as C97-BM3(W). Two 
native surface-exposed cysteines were removed (C62A/C156S) and a single 
cysteine added (K97C) to achieve selective, covalent conjugation of the 
photosensitizer [Ru(2,2´-bipyridine)2(5-iodoacetamido-1,10-phenanthroline)]2+ 
(RuII(bpy)2(IAphen)) directly adjacent to W96 (Figure 3.6). 
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Figure 3.6. Putative multistep ET pathway in RuC97-BM3(W). Residue W96 
forms hydrogen-bond contacts with the heme propionates (2.7, 3.5 Å). 
Highlighted distances are: Ru-Fe (23.7 Å), Ru-porphyrin edge (20.8 Å), Ru-
W(centroid) (13.8 Å), W(centroid)-Fe (12.9 Å), W(centroid)-edge of pyrrole (9.0 
Å). 
To probe the role of this intervening tryptophan, we have generated the quadruple 
“W-negative” mutant: C62A/C156S/K97C/W96H, abbreviated C97-BM3(WH). 
Note that the subscript refers to the native residue, in this case, tryptophan. This 
mutation is expected to preserve hydrogen-bonding with the heme propionates, an 
aspect that is thought to provide structural stability to the heme.11 More 
importantly, this mutation will act as a control in which multistep electron transfer 
is not expected to occur. The His+/His reduction potential (E° = 1.5 V vs. NHE, 
phosphate buffer pH 8) is much higher than the analogous Trp+/Trp potential (E° 
= 0.98 V vs. NHE, phosphate buffer pH 8).12 The RuIII/II reduction potential is 
approximately 1.3 V vs. NHE.13,14 Oxidation of histidine would be 
thermodynamically uphill by 200 mV, whereas oxidation of tryptophan has a 
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driving force of approximately 300 mV. If this W96 is indeed involved in multistep 
electron transfer, we would expect the W96H mutation to drastically impair 
photochemical heme oxidation by RuIII oxidants. 
Alternatively, this tryptophan could act as a sink for electron holes, sequestering 
the oxidizing equivalents away from the heme and lowering the yield of compound 
II formation. Chemical oxidation of P450-cam from Pseudomonas putida and 
P450-BM3 by oxygen donors (hydrogen peroxide, peroxyacids) has been shown to 
result in formation of a so-called “compound ES”, a ferryl species in which one 
oxidizing equivalent had been transferred to an amino-acid side chain near the 
heme – either tryptophan or tyrosine.15,16 If this is the case for our photochemical 
system, we would anticipate that the W96H mutation would actually increase the 
observed rate and yield of heme oxidation.  
To develop a photochemical system in CYP119, we chose to mimic Ru-P450-BM3 
as closely as possible. In the slightly smaller, more compact CYP119 (Figure 3.7), 
the only native cysteine residue is C317; this residue is buried within the protein 
active site, and provides critical thiolate ligation to the heme. Therefore, a single 
mutation is sufficient to achieve selective photosensitizer conjugation. In the 
native structure of CYP119, H76 forms hydrogen bonds to the CYP119 heme 
propionates, analogous to W96 in P450 BM3. The adjacent residue is D77 
(analogous to K97), and we have mutated this to cysteine to allow photosensitizer 
conjugation (Figure 3.8). This mutant will be abbreviated C77-CYP119(H). 
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Figure 3.7. Structures of P450 BM3 (top, green. PDB: 2IJ2) and CYP119 
(bottom, cyan. PDB 1IO7). 
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Figure 3.8. Photosensitizer conjugation sites in P450-BM3 (left, green) and 
CYP119 (right, cyan) are highlighted in yellow. 
As discussed for the P450-BM3 systems, we wish to probe the role of tryptophan in 
assisting or impeding electron transfer. With this goal in mind, we will also 
generate a tryptophan-containing CYP119 double mutant D77C/H76W. This 
mutant is abbreviated as C77-CYP119(HW); note, again, that the subscript denotes 
the native residue. 
3.2. Results and Analysis 
3.2.1. Characterization of mutants 
It is possible that a seemingly-insignificant mutation can have large effects on 
protein stability and structure. It is critical to verify that there are no observable 
changes in structure or stability of the mutants. The three mutants have been 
characterized by UV-visible absorption, and mass spectrometry. Crystals were 
obtained for the C97-BM3(WH) mutant, and the crystal structure was determined. 
UV-visible absorbance  
All of the P450 mutants have strong Soret absorbances near 420 nm, and Q-band 
features in the 500-600 nm range. The P450-BM3 mutants have a Soret maximum 
at 418 nm, while both CYP119 mutants have a Soret maximum at 416 nm (Figure 
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3.9). The Soret maximum is very sensitive to environment, including changes in 
buffer composition and protein purity. Therefore, small changes in absorbance 
must be assessed with care. The origin of the discrepancy in absorbance between 
C97-BM3(WH) and the other three mutants has not been determined.  
 
Figure 3.9. UV-visible absorbance spectra of P450 mutants. C97-BM3(W) 
(magenta), C97-BM3(WH) (purple), C77-CYP119(H) (light green),  
C77-CYP119(HW) (dark green).  
X-ray crystal structure analysis of C97-BM3(WH)  
The crystal structure of C97-BM3(WH) has been determined with 2.2 Å resolution. 
Two monomers were found in the asymmetric unit. The C97-BM3(WH)  structure 
overlays very well with WT P450 BM3 in the open, substrate-free form (pdb: 2IJ2, 
RMSD = 0.277). C97-BM3(WH) overlays significantly less well with the closed, 
substrate-bound form (2UWH, RMSD = 0.666) (Figure 3.10). This is in contrast 
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to the crystal structure of RuC97-BM3(W), which crystallized in the open form, 
with an unidentified substrate in the pocket. 
 
Figure 3.10. Overlay of C97-BM3(WH) (purple) with open and closed WT BM3 
structures. Top: Open form (blue). Bottom: Closed form (cyan).  
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Electron density clearly shows the W96H mutation (Figure 3.11). H96 is within 
hydrogen-bond distance of the heme propionate (2.8 and 4.4 Å between His96 Nε 
and the two propionate oxygen atoms, respectively). The position of this residue 
overlays almost exactly with the indole moiety of W96 in the wild-type structure.  
 
 
Figure 3.11. C97-BM3(WH) active site. Top: Overlay of C97-BM3(WH) (purple) 
with WT P450 BM3 (PDB: 2IJ2, blue), highlighting the overlay of W96 and H96 
residues. Bottom: Electron density map showing H96 within hydrogen bond 
contact of the heme propionates.  
Based on comparison of the C97-BM3(WH) structure to that of WT P450 BM3, it 
appears that this single mutation has no significant effect on the structure. We 
anticipate that possible changes in rate or yield of heme oxidation are a direct 
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result of the tryptophan-to-histidine substitution, and not to other structural 
perturbations. 
3.2.2. Ru-P450 Luminescence 
Steady state and transient luminescence spectroscopies were used to probe the 
nature of the photosensitizer conjugated to the P450 surface. When excited with 
blue light (e.g., 480 nm), the steady-state spectrum of all Ru-P450 conjugates 
closely resembles those of the free photosensitizer [RuII(2,2´-bipyridine)2(5-
acetamido-1,10-phenanthroline)]2+ ([Ru(bpy)2(A-phen)]2+) and [Ru(bpy)3]2+ (see 
Chapter 2 for an example). None of the unlabeled P450 mutants show detectable 
luminescence. 
Luminescence decays and exponential fits of all four Ru-P450 conjugates are 
shown in Figure 3.13. Lifetimes for all four mutants are reported in Table 3.1. As 
discussed in Chapter 2, the RuIIC97-BM3(W) excited state decay is biexponential, 
with approximately 65% of a 200 ns decay component, and 35% of a 50 ns decay 
component. We interpreted this observation as two different conformations of the 
photosensitizer that do not exchange on the timescale of this measurement. In the 
presence of quencher, the luminescence lifetime is dramatically reduced, and can 
be approximated by a monoexponential decay with lifetime of 30 ns. 
The other mutants show similar luminescence decays, with minor differences. The 
histidine-containing mutants (RuIIC97-BM3(WH) and RuIIC77-CYP119(H) are nearly 
monoexponential. As is evident from the overlays (Figure 3.14), there is a strong 
similarity in the luminescence decay of the two histidine-containing mutants 
(green, blue), as well as similarity between the tryptophan containing mutants 
(red, purple). Curiously, the excited state of RuIIC77-CYP119(H) is not as effectively 
quenched by 17 mM [Ru(NH3)6]3+, in comparison to the other conjugates. 
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Figure 3.12. Time-resolved luminescence decays of Ru-BM3 conjugates in the 
presence (blue) and absence (orange) of 17 mM [Ru(NH3)6]3+ quencher. 
Monoexponential fits are shown in red, biexponential fits are shown in dark blue. 
Samples were excited at 480 nm, and luminescence was detected at 630 nm.  
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Figure 3.13. Time-resolved luminescence decays of Ru-CYP119 conjugates in the 
presence (blue) and absence (orange) of 17 mM [Ru(NH3)6]3+ quencher. 
Monoexponential fits are shown in red, biexponential fits are shown in dark blue. 
Samples were excited at 480 nm, and luminescence was detected at 630 nm. 
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Figure 3.14. Overlay of luminescence decays for four Ru-P450 conjugates. 630 
nm, in the absence (bold colors) and presence (pastels) of 17 mM [Ru(NH3)6]3+ 
quencher. RuIIC97-BM3(W) (red, pink); RuIIC97-BM3(WH) (green); RuIIC77-
CYP119(H) (blue); RuIIC77-CYP119(HW) (purple). 
Table 3.1. Excited state lifetimes of four Ru-P450 conjugates in the absence and 
presence of 17 mM [Ru(NH3)6]3+ quencher. Both major (a) and minor (b) 
components are listed for the biexponential fit. Samples were excited at 480 nm, 
and luminescence was detected at 630 nm.  
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3.2.3. Ru-P450 transient absorption 
We have probed ET in the Ru-P450 systems using single-wavelength transient 
absorption (TA) spectroscopy. As described in Chapter 2 and illustrated in Figure 
3.9, both the photosensitizer and P450 heme have strong electronic absorbance in 
the 390-440 nm region, and the shapes and positions of these electronic transitions 
are sensitive to metal oxidation state and environment.  
As found for RuIIC97-BM3(W), TA traces of the other three mutants in the 
absence of exogenous quencher reveal bleaching in the 390-440 nm region, 
consistent with formation and decay of the *Ru(II) excited state; there is no 
observed formation of electron transfer intermediates. None of the unlabeled 
proteins show detectable transient absorption features following excitation at 480 
nm (data not shown). 
P450-BM3 mutants: effect of tryptophan 96 
We first compare the tryptophan- and histidine-containing P450-BM3 
photochemical systems. As described in Chapter 2, transient absorption features 
for RuC97-BM3(W) displays complex, multiexponential kinetics in the presence of 
ET quencher, [Ru(NH3)6]3+ (Figure 3.15, left). In particular, we observed a bleach 
at 420 nm (the peak of the heme Soret) which persisted for nearly 200 ms; this was 
indicative of heme oxidation. Additionally, we observed an increase in absorption 
at 440 nm, which was attributed to the formation of high-valent CII on the 
millisecond timescale. If heme oxidation occurs in the other mutants, we expect to 
see similar TA features. 
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Figure 3.15. Single wavelength TA traces of RuK97C-P450BM3 conjugates in the 
presence of [Ru(NH3)6]3+, following excitation at 480 nm. Blue: 420 nm; Purple: 
440 nm. Top: RuC97–BM3(W). Bottom: RuC97–BM3(WH). Inset: Model 
complex [Ru(bpy)2(Aphen)]2+ with [Ru(NH3)6]3+, for comparison. 
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For the histidine-containing mutant, RuC97–BM3(WH), TA traces in the presence 
of [Ru(NH3)6]3+ are significantly simpler (Figure 3.15, right). TA features at all 
wavelengths examined (390-440 nm) show biphasic decays that return to baseline 
within 200 μs. There is no persistent bleach at 420 nm past 100 μs, nor is there an 
increase in absorption at 440 nm at any point in time. The observed features can 
be explained by a simple reaction scheme involving only the photosensitizer, with 
no heme oxidation (Figure 3.16). Indeed, the TA traces for RuC97–BM3(WH) are 
nearly identical to those seen for the free photosensitizer [Ru(bpy)2(Aphen)]2+ with 
[Ru(NH3)6]3+ (Figure 3.15, inset). 
 
Figure 3.16. Flash-quench schemes. Left: Photochemically-generated RuIIIC97–
BM3(W) oxidizes the BM3(W) heme. Multiple arrows indicate that several 
processes are required to form the Fe(IV) product. Right: Photochemically-
generated RuIIIC97–BM3(WH) nonproductively recombines with reduced quencher. 
ET reactivity of CYP119 mutants 
We have also examined flash-quench of RuC77-CYP119(H) and RuC77-
CYP119(HW) in the presence of [Ru(NH3)6]3+. For RuD77C-CYP119(H), biphasic 
kinetics are observed in the 390-440 nm region (Figure 3.17). These are nearly 





→ RuII reaction scheme, with no involvement of the heme center.  
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TA traces for RuC77-CYP119(HW) are distinct from its histidine-containing 
counterpart, and can be compared to the tryptophan-containing BM3 mutant. As 
seen for the functional system RuC97-BM3(W), there is a small but persistent 
bleach at 420 nm, and another (even smaller) increase in absorbance at 440 nm on 
the millisecond timescale. These transient signals are much smaller than for 
RuC97-BM3(W) (< 5 mOD), but they have similar wavelength profiles, and occur 
on similar timescales (Figure 3.17, inset). 
Unfortunately, the small signal amplitudes and poor signal-to-noise ratio make it 
difficult to extract rate constants for the formation and decay of intermediates in 
the RuC77-CYP119(HW) system. The ET event of interest is oxidation of the 
porphyrin to form FeIII(OH2)(porphyrin)+ species. In RuC97-BM3(W), this is 
observed as a pronounced, re-bleaching at 420 nm that reaches completion at ~ 2 
μs (see Figure 3.17, inset). Additionally, two FeIII(OH2)(porphyrin)+ species were 
identified, in addition to the formation of CII. In RuC97-BM3(WH), however, this 
second bleach not apparent, and cannot be readily distinguished from RuIII 
formation. The low signal-to-noise ratio at all wavelengths examined also makes it 
difficult to characterize intermediates (such as multiple FeIII(OH2)(porphyrin)+ 
species). Guided by the transient at 440 nm, it may be possible to determine a rate 
for CII formation. However, without knowing the identity of the preceding 
species, it is difficult to draw conclusions as to the molecular nature of that event. 
From the current TA data, we cannot quantitatively determine if the small 
amplitudes are primarily a result of decreased heme oxidation rate, or a decrease in 
yield by competition with nonproductive ET processes. It appears that the 
maximum signal amplitude at 440 nm occurs at 4 ms for RuC97-BM3(W) (Figure 
3.17 inset, red trace), while the maximum signal for RuC77-CYP119(HW) is seen at 
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30 ms; this suggests that a difference in rate of CII formation may account for 
some of the discrepancy. 
 
Figure 3.17. Single wavelength transient absorption traces of Ru-CYP119 
conjugates in the presence of [Ru(NH3)6]3+, following excitation at 480 nm. Light 
blue: 420 nm; purple: 440 nm. Left: RuC77-CYP119(H). Right: RuC77-CYP119(HW). 
Inset: Overlay of TA from RuC97-BM3(W) scaled to the magnitude of the *RuII 
bleach: 440 nm (red), 420 nm (dark blue). 
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Temperature dependence 
The flash-quench transient absorption studies for Ru-CYP119 conjugates also 
were conducted at elevated temperature (40 °C).  
 
Figure 3.18.  TA data of RuC77-CYP119(HW) at variable temperature. 420 nm 
(blue) and 440 nm (purple). Top: Room temperature. Bottom: 40 °C. 
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The magnitudes of TA features are slightly larger at a temperature of 40 °C, 
however, the increase is not sufficient to distinguish ET quenching of the 
photosensitizer (RuIII formation) from porphyrin oxidation. While the CYP119 
enzyme is stable over temperatures of 80 °C, the [Ru(NH3)6]3+ quencher noticeably 
decomposes at temperatures of 70 °C. 
Search for the transient tryptophan radical 
Direct observation of the oxidized tryptophan intermediate would provide more 
tangible support for a hopping mechanism. Tryptophan radical cation (W+) and 
neutral radical (W) species absorb in the visible region (Figure 3.19), with 
approximate extinction coefficients of ε(λmax: 560 nm) = 3000 M-1 cm-1 and ε(λmax: 
510 nm) = 2300 M-1 cm-1, respectively.17 We examined TA in the 500-600 nm 
region to see if such an intermediate could be identified in the RuC97-BM3(W) and 
RuC77-CYP119(HW) systems (see Appendix C for more details). Unfortunately, we 
are unable to identify the formation of these species.  
If the rate of tryptophan oxidation is slower than its reduction via ET from the 
porphyrin, we would not anticipate accumulation of W+/W species. It is also 
possible that any tryptophan radical transients are obscured by changes in 
absorbance of the ruthenium photosensitizer (*RuII, RuIII, < 30 μs) and the P450 Q-
bands. In particular, the latter fully overlap with the (W✚) and (W) absorbances, 
but with much higher extinction coefficients: ε(λmax: 536 nm) = 9800 M-1 cm-1 and 
ε(λmax: 568 nm) = 9570 M-1 cm-1.  
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Figure 3.19. UV-visible absorbance spectra P450 and Ru photosensitizer. 
[Ru(bpy)2(IAphen)]2+ (orange) and RuC97-BM3(W) (green), assuming ε(418 nm, 
P450 BM3)=95,000 M-1 cm-1,18 ε(450 nm, [Ru(bpy)2(Aphen)]2+)=15,000 M-1 cm-1.19  
3.3. Discussion 
We expressed and characterized a P450 BM3 mutant in which W96 has been 
replaced by histidine: C97–BM3(WH). This point mutation does not affect the 
structure of this enzyme, as examined by crystal structure analysis and comparison 
to wild-type P450 BM3. The RuC97–BM3(WH) conjugate system supports flash-
quench to form RuIII oxidants, as observed by TA. There is no observable 
formation of oxidized P450 intermediates, such as porphyrin cation radicals and 
CII species. These results suggest that in our original construct, RuC97–BM3(W), 
the W96 residue is transiently oxidized in a multi-step electron transfer reaction; 
this accelerates the ET event and allows accumulation of oxidized heme species. In 
the absence of W96, the rate of single-step heme oxidation may be unable to 
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compete with bimolecular recombination with reduced quencher (τ ~ 25 μs). We 
cannot conclusively rule out the possibility that W96 acts as a sink for some 
portion of the photogenerated holes. However, our TA data suggest that the ET 
rate advantage conveyed by W96 is a more important pathway. 
We also generated a thermostable CYP119 Ru-P450 conjugate in which the 
photosensitizer-tethering point mimics that of the Ru-BM3 system. Flash-quench 
of RuC77-CYP119(H) generates RuIII; however, no heme oxidation is observed. TA 
data are nearly identical to those of the histidine-containing P450 BM3 system, 
RuC97–BM3(WH). The H76W mutation (RuC77-CYP119(HW)) is sufficient to allow 
observation of at least a small amount of oxidized heme species. This observation 
also supports involvement of tryptophan in photochemical oxidation. We suggest 
that this residue (BM3(W) or CYP119(HW)) provides a relay station for 
accelerated multistep ET.  
Many challenges still face this analysis. The small signal amplitudes and poor 
signal-to-noise of RuC77-CYP119(HW) transient features make it difficult to extract 
rate constants for the formation and decay of ET intermediates, particularly the 
formation of the initial porphyrin radical. The tryptophan side chain is 
significantly bulkier than that of histidine, and it is possible that the H76W 
mutation has caused a larger structural change which makes ET more difficult. 
Crystallographic characterization of the CYP119 mutants would be helpful for 
identifying or ruling out structural disruptions; these efforts are ongoing.  
Another possibility for the small observed yield of heme oxidation is that the 
W+/W or por+/por reduction potentials in CYP119 may be different from those 
in P450 BM3. Unfortunately, the reactivity of these oxidized intermediates 
precludes experimental determination of reduction potentials.  
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Final thoughts and avenues for future work 
One of the main objectives of developing the photochemical system in CYP119 
was to establish a more robust framework in which we could chemically generate 
CII, followed by flash-quench to generate the active species, CI. By identifying the 
importance of the tryptophan residue in accelerating ET and/or improving ET 
yield, we have been able to observe the first indication of photochemical ET in 
CYP119. However, if we wish to observe photochemical generation of CI, we must 
make significant improvements on two fronts. 
First, we must improve the rate and yield of heme oxidation in CYP119. This can 
be facilitated by a better understanding of the complex factors affecting ET. 
Crystallization of CYP119 mutants can help elucidate whether other structural 
features affect the hopping pathway between photosensitizer and heme. The 
photosensitizer potential can be tuned and the linker-length shortened by 
synthetic modification, the conjugation-site can be changed, and other mutations 
may be made to the protein scaffold in order to optimize ET. This knowledge will 
be useful not only in developing these specific P450 systems, but in using the 
intramolecular flash-quench method to generate oxidized intermediates in other 
biological systems.  
Second, we must investigate the generation of CII by chemical means. Compound 
ES (CII with an additional hole localized on an amino acid side chain) has been 
generated in high yield and characterized in CYP158 from Streptomyces coelicolor.5 
Similar investigation must be accomplished for CYP119, focusing efforts on the 
generation of a singly oxidized CII species. Chemical oxidation of Ru-P450 
conjugates will be further complicated by the redox nature of the photosensitizer 
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itself. All of these issues must be carefully examined and optimized for before we 
can expect to observe the second oxidative electron transfer. 
3.4. Conclusions 
The single W96H mutation in P450 BM3 completely eliminates photochemical 
heme oxidation in Ru-P450 conjugates. The P450 structure and stability appear 
unaffected by this mutation, suggesting that W96 is indeed involved in the electron 
transfer event. Flash-quench oxidation of the histidine-containing RuC77-
CYP119(H) conjugate was unsuccessful, and the single H76W mutation was 
sufficient to restore a small amount of electron transfer with the heme active site. 
While we are unable to directly detect formation of a tryptophan radical species, 
the observation that heme oxidation occurs only in the presence of an intervening 
tryptophan for both P450-BM3 and CYP119 systems strongly implicates this 
residue as a redox intermediate in multistep electron transfer. We will analyze the 
kinetics of electron hopping in Chapter 4.  
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3.6. Materials and Methods 
Materials 
Buffer salts were obtained from J.T. Baker. Dicyclohexylcarbodiimide (DCC), 
iodoacetic acid, and 5-amino-1,10-phenanthroline were obtained from Sigma 
Aldrich. [Ru(2,2´-bipyridine)2]Cl2 and [Ru(NH3)6]Cl3 were obtained from Strem 
	   103	  
Chemicals. All chemicals were used as received with no further purification. 
Solutions were prepared using 18 MΩcm water unless otherwise noted. 
Mutagenesis primers were obtained from Operon.  
Procedures 
A detailed description of experimental protocols can be found in Appendix B. A 
brief description of the procedures is given below, highlighting any deviations 
from the general protocol. All figures of protein structures were made in PyMol 
graphics software for Mac. 
3.6.1. Photosensitizer Synthesis 
Synthesis 
This photosensitizer was synthesized according to published procedures. Briefly, 
iodoacetic anhydride was formed by addition of N,N’-Dicyclohexylcarbodiimide 
(DCC) to a solution of iodoacetic acid in ethyl acetate. Following removal of urea 
by filtration and evaporation to dryness, the iodoacetic anhydride in acetonitrile 
was added to a solution of 5-amino-1,10-phenanthroline in acetonitrile and stirred 
overnight at room temperature. Solid product (5-iodoacetamido-1,10-
phenanthroline (IAphen)) was refluxed with Ru(bpy)2Cl2 in methanol for 3 hours; 
a color change from purple to red is observed. After cooling and filtration, product 
can be precipitated by addition of concentrated aqueous NH4PF6. Alternatively, 
the compound can be concentrated and redissolved in water without further 
purification. The starting material impurities do not interact with P450, and do 
not appear to impact the labeling process. 
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Characterization 
The photosensitizer was characterized by nuclear magnetic resonance (NMR), 
steady-state luminescence, and transient luminescence and absorption. 
3.6.2. Protein mutagenesis, expression, and purification 
Plasmid 
The recombinant P450-BM3 heme domain, consisting of the first 463 residues 
with an N-terminal 6-histidine tag, was obtained courtesy of Professor Andrew 
Udit (Occidental College, Los Angeles California), within the pCWori+ vector (also 
containing genes for ampicillin resistance and IPTG induction). Recombinant 
CYP119 with an N-terminal 6-histidine tag was obtained courtesy of Professor 
Paul Ortiz de Montellano (University of California, San Francisco), also within the 
pCWori+ vector.  
Mutagenesis 
Qiagen Quik-Change site-directed mutagenesis was used to generate the desired 
P450 mutants. The mutagenesis primers (forward, 5’-3’) were: BM3-W96H: 
GGACGCATGAAAAAAATCATTGCAAAGCGCATAATATC; CYP119-D77C: 
GATCCCCCTCTCCATTGTGAGTTAAGATCAATGTCAGC and CYP119-
(D77C)H76W: CCTCAGATCCCCCTCTCTGGTGTGAGTTAAGATCAATGTC  
Overexpression in E. coli. 
The P450 mutants BM3-C62A/C156S/K97C/W96H (C97BM3(WH), CYP119-D77C 
(C77CYP119(H)), and CYP119-D77C/H76W (C77CYP119(HW)) were overexpressed 
in the BL21-DE3 strain of E. coli. Briefly, overnight LB cultures were used to 
inoculate 1x TB (for P450 BM3) or 2x TB (for CYP 119) induction cultures. After 
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approximately three hours at 37 °C (OD600 ~ 1) the temperature was lowered to 30 
°C, expression was induced with IPTG and α-aminolevulenic acid was added. 
After expression for 24 or 40 hours (for P450 BM3 and CYP119, respectively), cells 
were harvested by centrifugation and stored at -80 °C. 
P450 enzymes were extracted by sonication, centrifuged to pellet cellular debris, 
and purified by Ni immobilized metal affinity chromatography (IMAC) . Enzymes 
were further purified by anion-exchange FPLC and gel filtration. Dithiothreitol 
(DTT) was added to reduce intermolecular disulfide bonds for samples not 
intended for immediate use. 40% glycerol was added to these samples, which were 
flash-frozen in liquid nitrogen and stored at -80 °C. 
P450 mutants were characterized by UV-vis spectroscopy and mass spectrometry. 
3.6.3. Conjugation to Ru-photosensitizer 
Briefly, approximately three-fold excess of RuII(bpy)2(IAphen) was added to a ~10 
μM P450 solution in 20 mM Tris buffer, pH 8 (buffer-exchanged to remove DTT). 
The reaction solution shaken gently for ~4 hours at 4 °C in the dark, followed by 
desalting to remove excess photosensitizer, and purification of Ru-labeled and 
unlabeled enzymes by anion exchange chromatography on a MonoQ or HiPrepQ 
FPLC column. 
Successful conjugation and separation of Ru-P450 was verified by UV-vis, mass 
spectrometry, and fluorometry. 
3.6.4. Crystallization and structure determination 
Crystals of C97-BM3(WH) were obtained by the sitting-drop vapor diffusion 
method: 10 mg/mL C97-BM3(WH) in 10 mM Tris, 10 mM sodium chloride, pH 7.4 
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was mixed with a crystallization well solution of 0.1 M sodium cacodylate pH 6.0, 
0.14 M MgCl2, 18% PEG 3350 in a 1:1 ratio (v/v). Crystal formation could be 
observed within a period of 30 minutes, but were allowed to form over 24 hours at 
20 °C, and were flash-frozen directly from solution. X-ray diffraction data were 
collected at Stanford Synchrotron Radiation Laboratory Beamline 12-2. 
3.6.5. Preparation of laser samples 
Laser samples were composed of ~10 μM Ru-P450 conjugate, with and without 
oxidative quencher (17 mM [Ru(NH3)6]Cl3) in buffered solution (pH 8: 50 mM 
sodium borate or 50 mM Tris); additionally, each buffer contained sodium 
chloride to prevent precipitation. Samples were placed in a high-vacuum four-
sided quartz cuvette with high-vacuum Teflon valve, equipped with a small stir 
bar. Deoxygenation was achieved via gentle pump-backfill cycles with argon. 
For acquisition of time-resolved fluorescence and transient absorption data, 
samples were excited with 10 ns laser pulses at 480 nm. Luminescence decays were 
monitored at 630 nm. Single wavelength transient absorption (TA) kinetics were 
monitored every 10 nm from 390-440 nm, averaging ~500 shots per wavelength. 
Data from five separate timescales (2 μs, 40 μs, 400 μs, 10 ms, and 500 ms) were 
collected, log-compressed, and spliced together to produce full kinetics traces. See 
Appendix D for log-compression and splicing scripts in Matlab. 
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4.1. Electron transfer through proteins 
Biological energy conversions are critical for cellular function. Photosynthesis 
harnesses the energy from sunlight to generate reactive chemical bonds in 
adenosine triphosphate (ATP) and reduced nicotinamide adenine dinucleotide 
(NADH).1,2 Cellular respiration generates those same species using energy stored 
in the chemical bonds of sugars (glucose).3,4 These complex reactions are carried 
out by an intricate network of membrane-bound multi-protein systems (Figure 
4.1). More than 10 individual electron transfer (ET) steps take place during the 
catalysis that couples ATP and NADH synthesis to the oxidation of water 
(photosynthesis) or the reduction of O2 (respiration). 
 
 
Figure 4.1. Multistep ET in biological energy conversion systems. Top: 
Photosynthetic reaction scheme. Bottom: Aerobic respiration in mitochondria. 
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A simpler energy conversion system was discussed in Chapters 2 and 3; light 
energy (a laser pulse) was used to generate the high-valent compound II (CII) in 
Ru photosensitizer–cytochrome P450 conjugates by oxidizing a water molecule 
bound to the heme. Even within this artificial system, as many as four individual 
ET events maybe contribute to CII formation (Figure 4.2): ET quenching of the 
*RuII excited state to form RuIII, transient oxidation of tryptophan96, hole transfer 
to the porphyrin ring, and hole transfer to the iron center. 
In all of these systems, native and artificial, electrons and holes must be rapidly 
and efficiently separated, and transported across many-angstrom distances. 
Recombination of these electron-hole pairs would result in nonproductive loss of 
energy as heat, without accomplishing the desired reactions. For examples of scale, 
the width of a membrane lipid bilayer can span be 30 Å or more,5 and the Ru-Fe 
distance in Ru-P450 conjugates is 24 Å. 
In order to address these complex, multi-ET processes, we must first understand 
the factors that govern single-step ET within simple systems (e.g., small, model 
proteins). We then can asses how enzymes use multiple, short ET steps (electron 




Figure 4.2. Sequential ET steps in the photo-triggered oxidation of Ru-P450 
conjugates. Blue arrows represent individual ETs. Oxidized species are colored red. 
Q is an exogenous quencher. 
Method for examining ET in proteins: photochemical triggering 
The Gray group and others have spent decades studying fundamental aspects of 
ET within proteins by tethering inorganic photosensitizers to protein surfaces 
(Figure 4.3). As mentioned for Ru-P450 conjugates, laser pulses trigger ET 
between the photosensitizer excited (or quenched) state, and a redox active center 
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within the protein. Redox active centers include copper in Pseudomonas 
aeruginosa azurin,6–9 heme iron in cytochrome c,10–13 and also amino acid side 
chains within complex enzymes such as ribonucleotide reductase (the enzyme that 
deoxygenates nucleotides, necessary for DNA, Figure 4.4).14 By varying the nature 
and location of the tethered photosensitizer, as well as the composition of the 
intervening protein, the effects of distance, driving force, and biological medium 
can be examined.6,13 These studies and others have shown that ET events through 
biological media can be analyzed using semiclassical ET theory.  
 
 
Figure 4.3. Photosensitizers and metallo-proteins. Top: A variety of 
photosensitizers tethered to amino acids. Bottom: redox active model proteins. 
Left to right: P. aeruginosa azurin (PDB: 1JZG, Cu in blue), horse heart 
cytochrome c (PDB: 1HRC, heme Fe in red), cytochrome b562 (PDB: 256B, heme 
Fe in red). All images of protein crystal structures in this Chapter were made using 
















































Figure 4.4. Ribonucleotide reductase from E. coli. Amino acid side chains along 
an ET path between Tyr122 radical-initiation and Cys439 active site (alpha, R1 
subunit: blue, PDB 1RLR; beta, R2 subunit: green, PDB 1MRX). 
This Chapter first offers a basic description of the theoretical underpinnings 
required for analyzing single-step ET, and some of the conclusions that have come 
out of single-step analysis in biological systems. This is followed by extension of 
electron tunneling to describe electron hopping, with a discussion of biochemical 
systems that employ this mechanism. We describe the step-by-step generation of a 
“hopping map,” a plot of multistep ET rate dependence on driving force for the 
first and overall reaction steps. We examine the utility of the hopping map for 
analyzing photo-triggered two-step hopping in rhenium-labeled azurin, and draw 
some general conclusions from this reactivity. We address some of the challenges 
and limitations of this type of analysis, and discuss the applicability to native ET 
systems. Finally, we address the utility of this hopping analysis for multistep ET in 
ruthenium-labeled cytochrome P450 (Chapters 2 and 3). 
4.2. Single-step electron tunneling: semiclassical theory 
We will begin examining ET reactions using semiclassical theory. ET between an 
electron/hole donor (D) and an acceptor (A) can be described using two harmonic 
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potential energy surfaces (Figure 4.5), where the positions along the horizontal 
axis describe nuclear configurations and geometries, and the vertical axis describes 
the system’s free energy. The parabolic surface on the left (red) describes the 
reactant state in which the electron or hole (denoted as a dot) resides on the donor 
moiety: (D|A). The right surface (blue) describes the product state, in which the 
electron/hole has been transferred to the acceptor (D|A).  
 
Figure 4.5. Energy diagram illustrating thermodynamic parameters for an ET 
reaction. The vertical axis is increasing energy; the horizontal axis describes the 
nuclear coordinate. Reactant state (D|A): red; product state (D|A): blue. 
The thermodynamic driving force for the reaction (–ΔG°) is given by the 
difference in energy between the minima of the reactant and product state surfaces 
(points a and b, respectively). Different nuclear and solvent configurations 
stabilize the reactant and product states (the energy minima are at different 
positions along the horizontal axis); thus, both inner sphere (nuclear) and outer 
sphere (solvent) rearrangements must accompany the ET reaction. This 
reorganization energy, λ, is a sum of nuclear (λinner) and solvent (λouter) 
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components. In Figure 4.5, λ is defined as the difference in energy of the reactant 
(or product) state in the reactant (a) and product configurations (c).  
The Franck-Condon principle states that the movement of electrons is much faster 
than the movement of nuclei. For thermal ET to occur with conservation of 
energy, the reactant and product geometries (and energies) must be equal. This is 
the point at which the reactant and product state surfaces intersect (d). The energy 
difference between the reactant state minimum (a) and this intersection (d) is the 
activation energy (ΔG‡) required in order for the reaction to proceed. 
For ET to occur, the two diabatic states must mix to form two adiabatic states 
(Figure 4.6, dashed lines). The electronic coupling matrix element which mixes 
the reactant and product states is known as HAB; the energy difference at the point 
of intersection between the upper and lower adiabatic curves is equal to 2HAB. 
From this diagram, it should be evident that enhanced electronic communication 
between the reactant and product states (larger HAB, and more mixing between the 
states) lowers the activation barrier for thermal ET. 
 
Figure 4.6. Energy diagram illustrating diabatic (solid lines) and adiabatic 
(dashed lines) states, and the coupling parameter HAB. 
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The specific rate of ET (kET) between donor and acceptor can be described by 
Equations 4.1 and 4.2. (For more details on the origin and development of this 














⎟  (4.1) 
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HAB = HAB r0( )exp −
1






⎟  (4.2) 
Here, kB and h are the Boltzmann and Planck constants, respectively. The ET rate 
is dependent on reaction driving force (–ΔG°), reorganization energy (λ), and 
distance between electron/hole donor and acceptor (r). HAB is related to the D-A 
distance by Equation 4.2, where β is the decay constant for tunneling, r0 is the limit 
of contact (taken as the sum of van der Waals radii), and r is as given above. In 
general, ΔG° and λ depend on D and A molecular composition and local 
environment, while HAB is a function of D-A distance and the structure of the 
intervening medium (described by β).  
If all other parameters are held constant, increased driving force (more negative 
ΔG° values) results in increased ET rate – but only up to a point. The maximum 
ET rate occurs when –ΔG° is equal to λ; this is known as a “driving force 
optimized” reaction. Further increases in driving force result in decreased ET 
rates; this is known as the “inverted region.”  
For reactions that are driving force optimized, the exponential term in Equation 
4.1 becomes unity, and the ET rate depends primarily on donor-acceptor distance 
and the intervening medium. Assuming that λ is constant across a series, it can be 
seen from Equation 4.2 that a plot of log(kET) is linearly proportional to the D-A 
separation (r-r0), with a slope that is proportional to β. 
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Experimental Measurements 
Investigations by the Gray group and others have probed this driving force 
optimized regime in abiological model systems (small molecules, frozen organic 
glasses) and proteins. By analyzing aggregate data from myriad experiments, a 
tunneling timetable can be constructed to describe the distance dependence of ET 
through different media, including proteins (Figure 4.7). As described by 
semiclassical theory, log(kET) is linearly related to the D-A separation (r-r0), with a 
slope that is proportional to β. 
 
Figure 4.7. Tunneling timetables for driving force-optimized ET reactions.19 The 
“tunneling time” on the y-axis is the inverse of the ET rate constant. Left: 
comparison of ET through different media. Right: comparison of ET rates for 
different protein systems.  
One of the most important messages in Figure 4.7 is that as D-A distances 
increase linearly, the ET time increases exponentially. Single-step ET processes 
over large distances ( > 30 Å, such as the width of a membrane bilayer), could take 
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minutes or days, even for reactions that are driving force optimized. Another 
mechanism is needed to accomplish such long-distance ET events rapidly enough 
to support cellular processes. As will be demonstrated, breaking the overall ET 
event into multiple shorter (and therefore faster) hopping steps can allow the net 
ET reaction to proceed on a relevant timescale.  
4.3. Multistep electron transfer  
If there is an additional redox site between D and A that can accommodate an 
electron/hole, the overall transfer from D to A can occur in two shorter-distance 
(and potentially faster) tunneling steps; D to I, then I to A. In order to understand 
natural and model biological systems, and other multistep ET reactions, we would 
like to compare these hopping pathways to those of single-step ET. Since each of 
the hopping steps obeys the ET rate dependence based on its individual values of 
ΔG°, λ, and r, we can calculate the overall hopping reaction rate and compare it to 
that for single-step tunneling, to see if there is a “hopping advantage.”  
Two-step hopping requires three sites: the initial electron (hole) donor (D), a relay 
station to which this electron (hole) is temporarily transferred (I), and the final 
electron (hole) acceptor (A). Oxidized or reduced I is a real intermediate that, in 
principle, can be detected spectroscopically. It is helpful to think of these three 
sites together as a single system that can be described by the location of the 
electron/hole, as shown in Equations 4.3a-c.  
 
€ 
X = D+ /− ⋅ ⋅ ⋅ I ⋅ ⋅ ⋅ A  (4.3a) 
 
€ 
Y = D ⋅ ⋅ ⋅ I+ /− ⋅ ⋅ ⋅ A  (4.3b) 
 
€ 
Z = D ⋅ ⋅ ⋅ I ⋅ ⋅ ⋅ A+ /−  (4.3c) 
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We write the hopping reactions as follows: 
€ 
   












dt = k3[Y ] − k4[Z] (4.4c) 
By solving this set of differential equations, we obtain expressions for each of the 
concentrations as functions with respect to time (i.e., [X](t), [Y](t), [Z](t)). We 
assume that the initial concentrations of Y and Z are zero; the resulting equations 
are more complicated without this assumption. Mathematica software (Wolfram 
Research) can be used to solve these equations analytically. We are interested in 
the overall electron transfer rate constant from the initial donor to the acceptor, 
therefore, the function [Z](t) is particularly useful. The very lengthy output from 
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  (4.5) 
where a, b, and c are defined as: 
 
€ 




b = k1k3 + k1k4 + k2k4  (4.6b) 
 
€ 
c = a2 − 4b  (4.6c) 
Eventually we will want to compare the overall rates of single-step ET and two-
step hopping, therefore, an analogous expression for [Z](t) using the single-step 




X = D+ /− ⋅ ⋅ ⋅ A (4.7a) 
 
€ 
Z = D ⋅ ⋅ ⋅ A+ /−  (4.7b) 
Solving the differential equations in the same manner as described above, the 




[X]0k5 1− exp − k5 + k6( )t( )[ ]
k5 + k6
 (4.8) 
Comparison of the [Z](t) functions for both mechanisms (Equations 4.5 and 4.8, 
respectively) shows that hopping is a biexponential process, while single-step 
tunneling is monoexponential. In order to compare these two mechanisms directly 
(and determine the rate advantage for hopping), we need to determine an average 
ET time (τ). The “survival probability” function, F(t) (Equation 4.9) gives the 
probability (from zero to one) that an electron at any point in time will have not 
yet undergone the complete ET to generate product (Z).  
 
€ 
F(t) = [Z](t) − [Z](∞)[Z](0) − [Z](∞)  (4.9) 
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∫  (4.10) 
Substitution with the [Z](t)hopping and [Z](t)tunneling functions from Equations 4.5 




k1 + k2 + k3 + k4








For construction of the hopping map, we are interested in average ET time with 
respect to ΔG° of the first hopping step, which is the branching point between the 
two mechanisms, as well as the driving force of the overall reaction. Accordingly, 
the expressions for τ in terms of rate constants (k1 through k6) must now be 
converted to expressions in terms of ΔG° and the other ET parameters (β, λ, HAB, 
r). Substitution of Equation 4.2 into Equation 4.1 and collection of constants yield 
a general equation for a single-step tunneling:  
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kET = C0 exp −β r − r0( ) −














2  (4.14) 
We also define expressions for the reverse rate constants (k2, k4) in terms of 












⎟  (4.15) 
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⎟  (4.16) 
 
€ 
ΔG°DA = ΔG°DI + ΔG°IA  (4.17) 
where ΔG°DI and ΔG°IA are the standard free energy changes for the first and 
second hopping steps, respectively, and ΔG°DA is the overall reaction free energy 
change. Note that this notation assumes that the reaction starts from a donor, D. 
Depending on the particular system, this can be either an electron donor or a hole 
donor. Substitution of Equations 4.13-4.16 into Equations 4.11 and 4.12 and 
subsequent simplification yields τ in terms of the ET parameters (Equations 4.18 
and 4.19). These expressions have been simplified by assuming that a single β and 
λ apply for all ET reactions in the system, but this is not necessary (as will be seen 
for hopping maps, vide infra). 
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τhop =
exp β r2 − r0( ) +
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The values r1, r2, and rT correspond to the D–I, I–A, and D–A distances, 
respectively. Note that these are straight-line distances, so rT need not be the sum 
of r1 and r2.  
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Substitution of Equation 4.18, using Equation 4.17, gives τhopping in terms of ΔG°DI 
and ΔG°DA. The dependence of τhopping on ΔG°DA and ΔG°IA can be represented 
graphically on a hopping map. The values of τhopping span many orders of 
magnitude, so we construct contour plots of –log10(τhopping) (represented by the 
color gradient), with –ΔG°DA as the x-axis, and –ΔG°DI as the y-axis.  
A computer program for the construction of hopping maps is available for 
download at http://www.bilrc.caltech.edu. The Matlab scripts used to generate this 
program also can be found in Appendix D.  
4.4. Construction of Hopping Maps: an example for Re-Azurin  
We will first examine use of the hopping map program to construct a hopping 
map for a known rhenium-labeled azurin system in which tryptophan acts as the 
redox intermediate.20  
 
Figure 4.8. The ReH124-W122-Azurin hopping system. The Re photosensitizer is 
highlighted in yellow, W122 in purple, and the Cu center in blue. PDB 2I70. 
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Inputs in two prompts are required to generate each map. The first prompt 
requests the ET parameters for the system of interest, namely temperature T (K), 
donor-intermediate-acceptor distances r (Å), and the parameters β (Å-1), and λ 
(eV) (Figure 4.9).  
 
Figure 4.9. Prompt #1: ET parameters. In this notation, “A” is the donor, or 
starting point, “I” is the intermediate, and “B” is the acceptor, or end point of the 
ET reaction. 
In all cases, the van der Waals contact (r0) is assumed to be 3 Å, and HAB(r0) is 
0.0231 eV. These parameters affect the rates and contours associated with each 
map. For demonstration purposes, the default variables in this prompt are those 
used for the ReH124-W122-Azurin system. Note that the hopping map program 
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allows variation of β and λ values for each individual ET. For all analyses in this 
Chapter, we will use constant β and λ values within a system. The effect of 
variability/uncertainty in each ET parameter is discussed in Section 4.5.  
Pressing “OK” in the first prompt brings up a second one (Figure 4.10). This 
prompt accepts parameters that define hopping map visualization: the range of 
driving forces to be examined (ΔGDI° and ΔGDA°, eV), resolution, and contour 
intervals. Note that these parameters do not affect the fundamental hopping rates 
associated with a given system. Maps with larger range and higher resolution take 
more time to generate; this prompt gives the user control over the speed and 
quality with which each map is generated. 
 
Figure 4.10. Prompt #2: Hopping Map parameters 
Pressing “OK” in the second prompt will generate the hopping map. Once the map 
has been generated, the prompts will re-appear, to allow construction of another 
map. This time, the default parameters are the previously input values. When no 
more maps are desired, pressing “Cancel” on both prompts exits the program. 
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A sample hopping map for ReH124-W122-Azurin has been generated using the 
values shown above Figure 4.11. The program output includes the hopping map 
with labeled axes, a record of the ET parameters used in the generation of this 
map, and a color bar indicating the hopping time associated with each color.  
 
Figure 4.11. Sample hopping map for ReH124-W122-Azurin. ET parameters are 
displayed in the side bar. A black dot has been placed at ΔGtotal° = –0.94 eV,  
ΔG1st step° = –0.028 eV. 
The color contours represent the predicted hopping time, for any given ΔGDI° for 
intermediate formation, and ΔGDA° for the complete reaction. Redder, or “hotter” 
regions indicate faster hopping and smaller time constants τ. For example, the 
reddest, most inner region of this map (ΔGDI° ~ –0.3 eV, ΔGDA° ~ –1.2 eV) 
corresponds to a –log(τ) value of 8.2-8.3, or a hopping time of 5-6 ns; the bluest 
edge (upper left corner) corresponds to a –log(τ) value of 2.2-2.4, or a hopping 
time of 4-6 ms. 
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Two portions of the map are shown in white; these are regions in which we would 
not predict to observe hopping. The region in the upper right is one in which 
τhopping/τtunneling < 1; in other words, where hopping is predicted to be equal to or 
slower than single-step ET. As will be seen, the position and shape of this 
perimeter vary based on the assumed ET parameters. The bottom left hand corner, 
to the left of the solid black line, is the region in which the second hopping step is 
endergonic. In this case, the intermediate acts as an electron/hole sink, instead of 
promoting the second ET step. This black line corresponds to ΔGDI° = ΔGDA°, and 
is the same for all maps. 
By examining the driving forces at work in ReH124-W122-Azurin, we can place this 
system on the map and compare predicted and experimental ET rates. The driving 
force for the first ET step (tryptophan oxidation) was determined to be –28 meV, 
based on kinetics analysis of the forward and reverse ETs between W122 and 
*Re.20,21 On the map, this regime is indicated by a horizontal dashed line. Photo-
induced metal-to-ligand charge transfer (MLCT) generates a highly oxidizing 
triplet excited state (*ReIIdmp–); this excited state potential (E°(*ReIIdmp–
/(ReIdmp–)) is taken to be 1.25 V vs. NHE; all reduction potentials are vs. NHE, 
unless otherwise noted.22,23 The azurin CuII/I potential was determined at 0.31 V 
(pH 7).24 Thus, the overall driving force is 0.94 eV. The black dot in Figure 4.11 
represents this location, with a predicted time constant of 44 ns. This within a 
factor of 2 of the experimentally determined time constant (31 ns).20  
A number of important features are evident in the hopping map. In cases where 
the first hop occurs with little driving force (ΔGDI° ~ 0, on the vertical axis), the 
horizontal nature of the map contours indicates that overall ET rate is much more 
sensitive to changes tryptophan oxidation (ΔGDI° ) than in the overall driving force 
(ΔGDA°). As an example, let’s again examine the black dot on the map. Increasing 
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or decreasing the driving force for tryptophan oxidation by 50 mV (without 
affecting the overall driving force) results in a range of time constants of 54-570 ns, 
variation by an order of magnitude. Similar variation in total driving force 
(without affecting the driving force for tryptophan oxidation) only results in a 
range of 145-160 ns, roughly 10% variability. Conversely, for systems in which 
ΔGDI° is very negative (bottom rows of the map), the contours are more vertical, 
and total ET time (τ) is much more dependent on the overall driving force.  
Another key feature is the border along the upper right hand corner. This indicates 
that the multistep advantage is lost for systems in which the first ET event is 
endergonic by more than ~200 mV. Such systems may still undergo ET, but it is 
more likely to proceed via single step tunneling.  
A final observation is that the hopping map displays the inverted region with 
respect to overall driving force; ET times associated with ΔGDA° = –1.5 V are 
slower than those at ΔGDA° = –1.2 V across the entire range of ΔGDI°.  
4.5. ET parameters: selection process, effects, and limitations 
For the ReH124-W122-Azurin system, many of the ET parameters can be measured 
directly, and all of the fundamental rate constants have been determined 
experimentally by transient luminescence and absorption spectroscopies.20 
However, the values of β, λ, r1 and r3 are still subject to interpretation, even for this 
well-characterized protein system. Additionally, there is debate over the precise 
reduction potentials (and therefore, driving forces) associated with donor, 
intermediate, and acceptor. For more complex biochemical systems, the process of 
selecting parameters and analyzing the hopping map becomes even more 
complicated. 
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In this section we use the Re-Azurin system to illustrate the effect that these ET 
parameters (and uncertainty in their values) have on the rates and shapes 
associated with the hopping map, and discuss various approaches for determining 
or estimating these parameters. To facilitate comparison, all hopping maps in this 
section are scaled to the same ET time (τ) axis: 100 ms (dark blue) to 1 ns (dark 
red). 
Temperature 
The first variable requested by the Hopping Map program is temperature. This is 
often the easiest parameter to determine for an experimental system, and will be 
ambient temperature (298 K) for a large number of biological systems.  
 
Figure 4.12. Temperature dependence of the ReH124-W122-Azurin hopping map. 
r1=8.1 Å, r2=12.8 Å, rT=19.4 Å; β=1.1 Å-1; λ=0.8 eV. The black dot is located at 
ΔGtotal° = 0.94 eV, ΔG1st step° = –0.028 eV. 
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These maps highlight the fact that the region of hopping advantage shrinks at 
lower temperature. This indicates that for this system, hopping is more sensitive to 
temperature than single-step tunneling; it slows down more at low temperatures, 
and speeds up more at high temperatures. By T= 98 K, we do not expect to observe 
hopping for ReH124-W122-Azurin. 
Another observation from these maps is that the optimal total driving force 
(ΔGDA° = –1.2 V) is constant across a nearly 300 K range of temperatures. In other 
words (and, as is expected from Equation 4.1), the inverted region does not shift 
with temperature. As will be seen, the only parameter that affects the point of 
inversion is λ. 
Distance 
In a case such as Re-Azurin, where the ET system has been crystallographically 
characterized, it seems straightforward to determine values for r. However, these 
straight line distances do not account for specific ET pathways.25–27 As a first 
approximation, the total ET distance (Cu to Re) is measured as the straight line 
between the metal centers: 19.4 Å. However, the intermediate ET steps which 
transiently oxidize W122 in are not as well defined.  
The original, published hopping analysis used distances to and from the 
tryptophan C2 carbon: (r1=8.9 Å, r2=11.1 Å, rT=19.4 Å).20 However, for a 
delocalized, aromatic π system, the electron does not necessarily originate from a 
single atom. One could, alternatively, use the average distance between the 9 atoms 
in the Trp indole and the Re or Cu center (r1=8.1 Å, r2=12.8 Å, rT=19.4 Å); these 
are the distances we have used in the example hopping maps thus far. One could 
also use the closest edge-to-edge distances (r1=6.3 Å, r2=10.8 Å, rT=19.4 Å). As yet 
another alternative, one could take into account calculated descriptions of the 
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highest occupied molecular orbital (HOMO) of indole as the source of the electron 
for the first ET step, and calculated and experimental formulations of the spin 
density on Trp radical cation as the source of the hole for the second step.28 As a 
simplification of this formulation, we use the average distance of the six benzyl 
atoms to Re as r1 (7.4 Å), the average distance of the five pyrrole atoms to Cu as r2 
(11.8 Å) and the Re-Cu distance as rT (19.4 Å).  
 
Figure 4.13. Hopping maps for ReH124-W122-Azurin with differing distance 
formulations. β=1.1 Å-1; λ=0.8 eV. The black dot is located at ΔGtotal° = –0.94 eV, 
ΔG1st step° = –0.028 eV. 
These different distance formulations change the rate by just over an order of 
magnitude (at the black dot), but do not greatly affect the perimeter (area of 
hopping advantage) or map contours, particularly in the region of interest. We 
conclude that changes of less than ± 1 Å usually affect the hopping times by less 
than a factor of 10. 
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Tunneling decay constant, β 
Based on experimental data, the average tunneling decay constant (β) for proteins 
is 1.1 Å-1 (shown in the tunneling timetable (Figure 4.7). The original hopping 
analysis used this value. However, there is significant scatter in the tunneling 
timetable, and different protein systems may have different decay constants. A 
superexchange coupling model that takes into account structural complexity can 
be used to explain this scatter.26,27,29–33 Experimental determination of β for each 
individual system is impractical, and so approximations must be made. Knowledge 
of specific ET pathways facilitates estimation of β. The hopping maps allow us to 
easily investigate how variation in β results in discrepancies in τhopping. 
 
Figure 4.14. Hopping maps for ReH124-W122-Azurin with differing values of β. 
λ=0.8 eV, r1=8.1 Å, r2=12.8 Å, rT=19.4 Å. The black dot is at ΔGtotal° = –0.94 eV, 
ΔG1st step° = –0.028 eV. 
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Larger values of β result in increased hopping total ET times, just as in single-step 
tunneling. In this case, single-step tunneling is more sensitive to β than is hopping; 
as β (and ET times) decrease, the region of hopping advantage also shrinks. This is 
opposite what was observed for temperature, where a decrease in ET times was 
accompanied by an increase in the region of hopping advantage.  
Within the context of a protein, the parameter β is essentially bound by the 
limiting values of tunneling through aqueous glasses (β = 1.6)34,35 and conjugated 
xylyl chain (β = 0.76).36 In practice, the lower bound can be raised further, to that 
for an alkane chain (β = 1.0).37 Of the 32 data points for electron-tunneling 
through the protein medium, (Figure 4.7), only two fall above the line of β = 1.0; 
hopping has been implicated in both cases. In the case of ReH124-W122-Azurin, 
variation of β by ± 0.2 Å-1 (from the starting value of 1.1 Å-1) results in increase or 
decrease in ET time by less than a factor of four. 
Reorganization energy, λ 
As discussed previously, the reorganization required for a given reaction is 
composed of both inner- (nuclear) and outer-sphere (solvent) rearrangements. 
Electron transfer events are charged, by nature. Thus, a polar environment (such 
as solvation by water molecules) reorganizes more in response to ET. By 
sequestering redox cofactors within a hydrophobic protein environment, enzymes 
reduce reorganization and the energy of activation for ET. The inner-sphere 
reorganization energy of many metalloproteins also is small, particularly when 
there is no change in spin state, and/or when the ligand geometry is constrained.38 
Experimental reorganization energies have been determined by varying the driving 
force for single-step ET (Table 4.1). The reorganization energy used in the original 
hopping was 0.8 eV, based on these types of experimental investigations.9,19 
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However, different systems, particularly those not evolved for rapid ET, may have 
alternate values of λ. 
Table 4.1. Reorganization energies for various proteins. Table is adapted from Ref 




Figure 4.15. Hopping maps for ReH124-W122-Azurin with differing values of λ. 
β=1.1 Å-1, r1=8.1 Å, r2=12.8 Å, rT=19.4 Å. The black dot is at ΔGtotal° = –0.94 eV, 
ΔG1st step° = –0.028 eV.  
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Changes in λ affect both the rates and contours of the map. As λ increases, the 
“hottest” center widens and shifts to more negative values of both ΔGDA° and 
ΔGDI°. At the driving forces of interest for the ReH124-W122-Azurin system (ΔGDA° 
=–0.94 eV, ΔGDI°=–0.028 eV), there is inversion with respect to λ; the maximum 
rate occurs at λ=0.6-0.8, and decreases at both smaller and larger values. 
ReH124-W122-Azurin is nearly driving force optimized for λ. There is little variation 
between λ=0.6 and 0.8 eV. However, outside of that optimal range, ET times 
change dramatically with variation in λ (as is expected). For driving force 
unoptimized systems in which λ is uncertain, hopping maps provide only a rough 
approximation of ET times, and must be assessed with care. 
Driving forces 
The parameters discussed above (T, β, λ, r) are needed for the construction of the 
map. However, complete hopping analysis requires placing the system of interest 
on the map, and determining the predicted τ values and rate advantage of 
hopping. In order to do this, one needs to have knowledge of the driving forces 
associated with the first and overall ET steps.  
Unfortunately, the E° of relevant cofactors often are unknown. Due to the 
reactivity of many of the intermediates (such as amino acid radicals), there is 
significant variation in the reported values. Additionally, these potentials can be 
shifted from the solution values by the protein environment, and, if coupled with 
protonation/deprotonation, can be affected by pH and hydrogen-bonding. 
For example, the solution W✚/W potential has been estimated at +1.15 V 
(water),22 +1.24 V (water, pH 7),46 or 0.98 V (water, pH 8).47 Based on the 
experimentally measured rate for tryptophan oxidation in ReH124-W122-Azurin 
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(where W122 is relatively solvent exposed), ΔGDI° was determined to be –0.028 V; 
assuming a *ReII(dmp–)/ReI(dmp–) potential of 1.25 V,22 this places the W✚/W at 
1.22 V. Driving forces for ET can be further complicated by changes in 
protonation state. Tryptophan radical cation is significantly more acidic than the 
neutral species (pKa=4.5 vs. ~21).48 Another redox active amino acid (and potential 
hopping intermediate), is tyrosine; this intermediate is much more sensitive to pH. 
The tyrosine neutral species has a pKa of 10, and a radical cation pKa of –2.49 For 
both of these amino acids, the relevant driving forces are influenced by pH and 
hydrogen bonding (Figure 4.16). 
 
Figure 4.16. Square scheme for tryptophan (left) and tyrosine (right), including 
relevant reduction potentials and acid dissociation constants.48,49 Gray values 
indicate DMSO solutions.  
4.6. Hopping Map Limitations 
In the best cases, the hopping maps give insight into the advantage of hopping 
over single-step ET, and provide an estimate of hopping times within an order of 
magnitude. From the above analysis, small uncertainties in ET parameters (r: ± 1 
Å; β ± 0.2 Å-1, λ ± 0.1 eV) can change the hopping times (τ) by less than a factor of 
NH3
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10. Additionally, the Hopping Maps program allows quick and facile analysis of 
the effect of these uncertainties for any given system.  
However, these ET parameters can be greatly affected by the specific protein 
environment, and experimental measurement of many of these parameters is 
extremely difficult. Even once a hopping map has been constructed with 
confidence, accurate comparison between computed and experimental hopping 
rate constants requires accurate assessment of reaction driving forces. This is 
greatly complicated by the paucity of reliable reduction potential data for 
biological ET reactions that, for a given cofactor, strongly depend on the protein 
environment.  
Even when exact comparison of experimental and predicted time constants is not 
possible, assessment of multiple maps can provide a range of expected values, and 
in some cases, may provide insight into the advantage of hopping over single-step 
tunneling. We will examine one of these highly underdetermined cases to assess 
the possibility of hopping in a ruthenium-cytochrome P450 system.  
4.7. Application to the P450-W-Ru system 
As described previously, we developed a system for phototriggered heme oxidation 
in a Ru-cytochrome P450 conjugate that requires the presence of a tryptophan 
situated between Ru and heme sites. We have experimentally determined the rate 
of porphyrin oxidation, which proceeds on the microsecond timescale with 
relatively little driving force. By examining a series of hopping maps, we aim to 
determine the feasibility of oxidative (hole) hopping in this system. Is hopping 
possible? And, based on our analyses, is hopping probable? 
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Figure 4.17. Hopping system in RuK97C-W96-P450BM3 (PDB: 3NPL). The P450 
heme is highlighted in red, W96 in purple, and the Ru photosensitizer in orange. 
Estimates and Challenges 
Hopping in the Ru-W-P450 system is underdetermined. Nevertheless, we can 
make estimates, and probe to what extent error in those estimates affects the 
hopping map. Temperature is the most certain parameter: 293 ± 2 K. We have no 
direct measurement of β and λ, but will begin by assuming the typical parameters 
of β=1.1 Å-1; λ=0.8 eV, which apply to many systems (as discussed previously).  
The Ru-W-P450 system has been crystallized, and we will use the crystallographic 
distances as our first estimates for r1, r2, and rT. However, as described for ReH124-
W122-Azurin, the ET origin associated with the aromatic tryptophan side chain is 
ill-defined. Additionally, the hole-acceptor in this case is not a metal center, but 
the large, conjugated porphyrin ring. Furthermore, the ruthenium photosensitizer 
is tethered to the protein surface via a flexible acetamido linker. Significant 
disorder in one unit of the crystal structure, and the biexponential luminescence 
decay support the existence of multiple conformations (and thus, multiple possible 
distances) in solution.  
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The crystallographic Ru-Fe distance is 23.7 Å. We are interested in oxidation of 
the porphyrin ligand; however, this center is approximately the average of the 
distances between the photosensitizer and conjugated porphyrin (23.9 Å). We will 
also examine the distance to the nearest pyrrole edge on the porphyrin: 20.8 Å. It is 
possible to bring the photosensitizer center even closer to the porphyrin by 
bending it into a depression in the surface (above the buried heme). Such an 
arrangement could decrease the through-space Ru-porphyrin distance by as much 
as 4 Å, and also bring Ru an estimated 2 Å closer to the tryptophan. 
 
Figure 4.18. Model of the Ru-P450 surface. The photosensitizer is highlighted in 
blue, the cysteine linker in yellow, W96 in purple, and the buried heme in red. 
Finally, we must make estimates for ΔGtotal° and ΔG1st step°. Instead of placing a dot 
on the map, we will define a region in which we reasonably expect to find our Ru-
P450 system. (As a reminder, all reduction potentials are referenced versus NHE.) 
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The oxidatively quenched photosensitizer has E°(RuIII/II) ≈ 1.3 V.50,51 The E°(FeIV/III) 
in other heme enzymes (e.g., horseradish peroxidase) have been reported in a 
range of 0.72-1 V.52 A P450 relative, the heme-thiolate enzyme chloroperoxidase, 
has E°(FeIV/III) estimated at 1.3 V.53 We will assume that the P450 E°(FeIV/III) is 
within the range of 0.9-1.3 V, and that the E°(por✚/por) is at or above this value 
(so that the entire reaction is exergonic). For all analyses, we will use the driving 
force range: –ΔG°total = 0 to 0.3 V. As discussed previously, a range of W✚/W 
potentials have been reported (1-1.3 V), and these can be influenced significantly 
by hydrogen bonding and protein environment. Therefore, we will assume a range 
of driving force for first hop step (–ΔG°1st step) of –0.10 to +0.3 V.  
Single-step tunneling 
To provide a comparison for the hopping rates, we will first examine the RuK97C-
W96-P450BM3 system using single-step ET (Equations 4.1 and 4.2). Predicted ET 
times (τ) are listed in Table 4.2. Note that at low driving force, with a distance of 
~24 Å, single-step ET takes nearly a second. 
Table 4.2. Calculated single-step tunneling times for porphyrin oxidation, using a 




By constructing a series of hopping maps, we aim to determine whether or not 
there is a clear hopping advantage within reasonable ET parameters. We will 
systematically vary ET parameters (r, β, λ) for the Ru-P450 system, and determine 
the effects on two-step hopping versus single-step tunneling. Each map is 
constructed with the same range of driving forces and same color scale as the Re-
W-azurin system (to facilitate comparisons). The range of expected driving forces 
is bordered by dashed lines. Heme oxidation was observed experimentally, so we 
assume that –ΔG°DA > –ΔG°DI; in other words, the system does not fall in the 
white, bottom left corner of the maps. 
Table 4.3. Minimum driving forces necessary to obtain the experimental ET time 
(within a factor of 3) for each hopping map. 
 
Within the context of each map, we can also determine minimum driving forces to 
give a time constant within a factor of three of the experimental value; these are 
given in Table 4.3. These values are mainly intended to orient the reader to the 
map, not to place the Ru-W-P450 system at a defined driving force.  
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Varying Distances 
We first examine the longest distance for ET (case A), using the ruthenium center, 
the porphyrin centroid (average Ru-por distance = 23.9 Å), and the W centroid 
(average Ru-W, W-por distances). The other ET parameters are β=1.1, λ=0.8, as 
used previously for the original ReH124-W122-Az system. In case A, hopping is 
clearly advantageous over the entire expected driving force range. The 
experimental time constant of 1.3 μs can be reproduced (within a factor of three) 
assuming reasonable driving forces of 300 meV and 180 meV (for –ΔG°DA and   
–ΔG°DI, respectively). This is a rate advantage of four orders of magnitude 
compared to single-step ET. 
Next, we set rT as the distance to the nearest edge of the porphyrin: 20.8 Å (case B). 
The horizontal contours in this map (as well as all the others that follow) shows 
that hopping is limited entirely by the first step: tryptophan oxidation. The region 
of hopping advantage decreases. However, hopping still beats single-step tunneling 
within all of the expected driving forces, and the experimental time can be 
reproduced with milder overall driving forces (~150 meV). 
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Figure 4.19. Hopping maps for RuC97-W96-P450BM3 heme oxidation: Distance 
formulations. 
If we change the distance formulation to use the tryptophan edges (case C) instead 
of the centroid, we decrease the distance of the first hopping step. This decreases 
the overall hopping times, and increases the area of hopping advantage. Very little 
driving force (~ 0.02 eV) is required to reproduce the experimental time constant, 
using this formulation. Once again, hopping has a rate advantage of four orders of 
magnitude. 
As discussed for the single-step analysis, a final possibility for distances is that the 
photosensitizer bends over, bringing it in closer proximity to the porphyrin (and 
also to the tryptophan). Comparison between cases B and G shows that rates 
increase by over an order of magnitude, and the region of hopping advantage 
significantly decreases. The hopping advantage is lost only in cases where the first 
hop is endergonic (>0.05 eV), and the overall driving force is large. 
	  145	  
Varying β and λ  
We can also examine the effects of uncertainty in β and λ on the RuK97C-P450BM3 
hopping map. A significant rate increase is seen by lowering β to 1.0 Å-1 (case D), 
and a significant decrease is seen by raising β to 1.3 Å-1 (case E). However, the 
region of hopping advantage does not change significantly. Since ET must proceed 
mainly through bonds, but with at least one through-space hop (between Trp96 
and the porphyrin edge), we suspect that the original value of 1.1 Å-1 is a 
reasonable approximation. Changes in λ significantly affect hopping times, and the 
region of hopping advantage (cases F and G). In each case, the experimental time 
constant can be reproduced, and hopping is advantageous at all expected driving 
forces. 
 
Figure 4.20. Hopping maps for RuK97C-P450BM3 photochemical heme oxidation: 
Altering β and λ. 
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All of these maps show a clear hopping advantage, even if single-step ET can 
reproduce the experimental rate constant within the expected driving forces. What 
would it take for single-step ET to out-compete hopping?  
We present one final, “worst case” hopping scenario (case I). rT is small in 
comparison to r1 and r2 (as the photosensitizer bends toward the P450 surface), β is 
small (tunneling through a conjugated chain), and λ is large. As shown in Figure 
4.21, the Ru-W-P450 system is situated exactly where hopping is most 
advantageous: low overall driving force. Even if the first hop (e.g., tryptophan 
oxidation) is endergonic by 100 mV, the two-step process can be faster. 
 
Figure 4.21. Hopping maps for RuK97C-P450BM3 photochemical heme oxidation: 
Worst case hopping scenario. 
These hopping map analyses strongly support the idea of hopping in the Ru-P450 
system. In every scenario examined, the experimental rate constant can be easily 
reproduced with reasonable ET parameters, and there is a rate advantage to 
hopping in the majority of driving forces.  
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4.8. Conclusions 
This tutorial demonstrates the usage, utility, and limitations of Hopping Maps for 
the analysis of multistep ET events. We have used this analysis to examine the 
multistep photochemical heme oxidation in RuK97C-P450BM3, and have shown that 
there is a clear hopping advantage at nearly all parameters explored. Creation of 
hopping maps is greatly facilitated by the availability of the hopping map program. 
However, construction and interpretation of hopping maps that have any relation 
to real chemical systems requires detailed knowledge of ET parameters. 
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5.1. Background: reductive activation of dioxygen 
The cytochrome P450 superfamily of heme enzymes catalyzes a wide variety of 
biologically important transformations, including the metabolism of fatty acids 
and biosynthesis of signaling molecules. As described in Chapter 1, one-electron 
reduction of the ferric heme active site induces binding of dioxygen; a second 
reduction, followed by protonation and heterolysis of the O–O bond generates the 
catalytically active species, compound I (CI, Figure 5.1). Natively, the electrons 
originate from reduced nicotinamide adenine dinucleotide (phosphate), 
NAD(P)H, and are passed to the heme by a series electron transfer (ET) partner 
proteins. However, these native ET steps are much slower than the reaction of CI 
with substrate.1–3 
 
Figure 5.1. Canonical P450 catalytic scheme, highlighting the reductive ET 
events that activate dioxygen.  
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Many methods have been implemented in an effort to artificially generate and 
study this active species. Chemical oxidation by rapid mixing with peroxyacids 
such as meta-chloro-peroxybenzoic acid (mCPBA) was used to generate CI in 
highly purified samples of CYP119.2 This method was successful for achieving 
spectroscopic characterization of the reactive intermediate, as well as single-
turnover kinetics investigation of the reaction with substrate. However, the events 
of hydrogen abstraction to generate compound II (CII, Figure 5.1), and radical 
rebound to form hydroxylated substrate have yet to be observed directly. The 
dead-time of mixing experiments (e.g., 0.25-5 ms for Bio-Logic® SFM-400) 
preclude observation of reaction events that include hydrogen abstraction from 
substrate to form CII, and radical recombination which produces hydroxylated 
substrate. 
In Chapter 2, we described how covalent tethering of a ruthenium photosensitizer 
to the P450 surface (Figure 5.2) can be used to photochemically generate the 
catalytically-relevant one-electron oxidized species, CII. The deadtime for 
monitoring these photo-triggered events is limited only by the laser pulse-width 
(~8 ns in the systems employed for these studies) and instrument response (< 30 
ns). We were able to observe CII formation on the low millisecond timescale; this 
is at least two orders of magnitude faster than expected production by a chemical 
mixing reaction. 
However, this photochemical method has significant limitations. The yields of 
oxidized products are low (estimated at < 20%). Additionally, each laser pulse can 
only initiate a single ET event; two oxidizing equivalents are needed to generate 
CI. Furthermore, photochemical heme oxidation proceeds at low driving force, 
and is sensitive to the intervening medium (see Chapters 3 and 4). Efforts to 
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reproduce this ET reactivity in the thermophilic CYP119 generated CII with even 
lower yield (< 5%).  
 
Figure 5.2. Structure of the Ru-P450BM3 conjugate. (PDB: 3NPL) 
As described in Chapter 1, many features of the cytochrome P450 structure have 
evolved to facilitate enzyme reduction and the activation of dioxygen - not 
oxidative ET and activation of water. By using our tethered photosensitizer as a 
replacement for the native ET partners, we anticipated that reductive flash-quench 
(Figure 5.3) could be used to study other important aspects of the catalytic cycle, 
and may even be used to rapidly access CI. 
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Figure 5.3. Flash-quench cycles for ET with the heme active site. 
By supplying an appropriate small molecule quencher such as para-
methoxydimethylaniline (pMeODMA), we can photochemically generate a 
reduced photosensitizer (Ru1+, best characterized as RuIIbpy–). This species has 
almost 1 eV of driving force for reduction of the P450 heme: E°(RuIIbpy/RuIIbpy–) 
= –1.3 V vs. NHE;4,5 E°(P450 FeIII/II) = –0.43 V vs. NHE.6 These flash quench 
methods have been used to photochemically reduce Ru-labeled cytochrome c.7 
They also were used to reduce Ru-labeled cytochrome P450-BM3 at residue 387, 
however, conjugation of the photosensitizer at residue 62 curiously showed no 
heme reduction.8 
We set out to examine each successive step of P450 oxygen activation by photo-
triggered methods, using tethered Ru photosensitizers as the source for reductive 
ET. We examine photochemical heme reduction, the first step in catalysis. We 
anticipated that this phototriggered method also could be used to initiate the 
second step in the native P450 catalytic cycle: binding of dioxygen to the active 
site. The binding of dioxygen to ferrous heme results in formation of a ferric-
superoxo; this species is not thermally stable at room temperature, and 
decomposes to release superoxide (auto-oxidation).9 Carbon monoxide is often 
used as a more stable diatomic analogue. In some P450 variants, the FeII-CO 
species undergoes protonation and/or dissociation of the proximal cysteine 
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thiolate ligand to generate an inactive species known as “P420.”10–12 In our hands, 
the ferrous-CO complex of CYP119 is stable for up to seven months at 4 °C with 
no apparent change to the UV-visible absorbance spectrum. This approach of 
photo-triggering heme reduction and observing gas binding has been 
implemented by others, using organic photosensitizers; UV excitation of NADH 
was used to trigger P450 reduction via the NADH triplet excited state, and the 
authors observed binding of CO.13 
The rate of CO binding to heme enzymes also can be examined by photolysis and 
rebinding. Excitation into the FeII–CO Soret or Q-bands causes nearly 
instantaneous photolysis and dissociation of CO. Some portion of the dissociated 
CO is remains trapped within the protein pocket and rebinds rapidly to the five-
coordinate ferrous heme – this is known as geminate recombination.14–16 Another 
portion of the dissociated CO has sufficient energy to escape into solution, and 
thus takes significantly longer to re-enter the protein cavity and rebind to the 
heme. Photolysis has been used to measure the rates of rebinding for both P450 
BM3,15,16 and CYP11917. However, in the latter case of thermophlic CYP119, only 
room temperature rebinding has been reported, and sub-nanosecond kinetics have 
not been examined. 
 
Figure 5.4. Cartoon of CO photolysis and rebinding. The blue shape represents 
the protein framework. 
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The third step in P450 catalysis involves a second ET event to produce the ferric 
superoxo; this final species converts directly to CI. This second electron also could 
be supplied by flash-quench. However, as addressed in Chapter 3, the yields and 
lifetimes of flash-quench generation of intermediates precludes the use of two 
sequential flash-quench cycles. It would be more effective to chemically generate a 
semi-stable pool of FeIII–O2–. A stable ferric superoxo can be generated for the 
substrate bound P450 BM3 at low temperature (-60 °C) in Tris buffer.18 At these 
temperatures, the cryosolvent of 70:30 glycerol:Tris buffer behaves as a semi-solid 
glass, which would greatly inhibit bimolecular quenching reactions. There may be 
a higher temperature at which the FeIII–O2– lifetime is sufficiently long; one 
minute or more would allow flash-quench ET to generate FeIII–O22–, and observe 
the conversion to CI. 
Another significant challenge facing flash-quench reduction of FeIII–O2– is that the 
ruthenium metal-to-ligand charge transfer (MLCT) bands overlap significantly 
with the P450 Soret and Q-bands; excitation into these protein absorptions can 
cause photodissociation of O2, analogous to FeII–CO. If the yields of 
photodissociation are competitive with yields of ruthenium excited state, it will be 
difficult or impossible to observe reduction of FeIII–O2– to FeIII–O22– and 
subsequent formation of CI.   
In this Chapter, we examine the kinetics of flash-quench heme reduction and 
assess the possibility for monitoring photochemical reduction-triggered gas 
binding. We then examine the kinetics of photo-triggered CO dissociation and re-
binding to the heme for the thermophilic CYP119 under varying conditions of 
laser power, temperature, and the presence or absence of substrate. We identify 
unique aspects of CYP119 conformational dynamics, and assess thermodynamic 
activation parameters for the rebinding process. 
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5.2. Results and Analysis 
5.2.1. Reductive flash-quench 
We examined the photochemical reduction of four Ru-P450 conjugates that are 
described in Chapter 3: two are mutants of P450 BM3 from Bacillus megaterium 
(RuC97-BM3(W96), RuC97-BM3(WH96)) and two are mutants of CYP119, the 
thermophilic P450 from Sulfolobus acidocaldarius (RuC77-CYP119(H76), RuC77-
CYP119(HW76)). Subscripts after Ru indicate the tethering location, i.e., non-native 
cysteine 97 or 77; subscripts in parentheses indicate the native residue. The 
presence of tryptophan directly adjacent to the tethering point (W96 or W76, for 
P450 BM3 and CYP119, respectively) was found to facilitate photochemical heme 
oxidation by acting as a redox intermediate for multistep hole transfer. However, 
we did not anticipate that these residues can participate in multistep reductive ET. 
Luminescence 
As described in Chapters 2 and 3, excitation at 480 nm results in luminescence 
(λmax = 630 nm) of both the free photosensitizer ([Ru(2,2´-bipyridine)2(5-
acetamido-1,10-phenanthroline)]2+, abbreviated [Ru(bpy)2(Aphen)]2+) and the Ru-
P450 conjugates. The photosensitizer has a monoexponential luminescence decay 
rate of 720 ns in deoxygenated buffer (50 mM sodium borate, pH 8). All of the Ru-
P450 conjugates display biexponential luminescence decays; we attribute this 
observation to multiple conformations of the photosensitizer, which do not 
exchange on the timescale of this measurement. In the presence of 10 mM 
pMeODMA, luminescence lifetimes are significantly quenched (Figure 5.5), and 
can be fit to a monoexponential decay. Unlike what was observed for oxidative 
quenching with [Ru(NH3)6]3+ in Chapter 3, there is very little difference in the 
quenched lifetimes among the different Ru-P450 conjugates (Table 5.1). 
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Figure 5.5. Luminescence decay at 630 nm of four Ru-P450 conjugates in the 
presence and absence of pMeODMA. λ(excitation) = 480 nm. 
Table 5.1. Luminescence lifetimes, taken from biexponential (unquenched) and 
monoexponential (quenched) fits.  
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Single-wavelength transient absorption 
We have used single-wavelength transient absorption spectroscopy to monitor the 
flash-quench heme reduction in Ru-P450 systems. As described in Chapters 2 and 
3, both the Ru photosensitizer and P450 heme have strong electronic absorbance 
in the 390-440 nm region (P450 Soret ε(λmax: 418 nm) = 95,000 M-1cm-1;1 
[Ru(bpy)2(Aphen)]2+ ε(λmax: 450 nm) = 16,600 M-1cm-1 19). The shapes and 
positions of these electronic transitions are sensitive to metal oxidation state and 
environment; and each species has a distinct absorption profile. By monitoring 
multiple wavelengths over time, we can identify the formation and decay of ET 
intermediates following laser excitation. This process is greatly facilitated by 
control studies (e.g., the absence of quencher), as well as comparison to absorption 
profiles in the literature. 
In the absence of pMeODMA quencher, we observe transient bleaching (ΔOD<0) 
in the 400-440 nm visible region that is due to bleaching of the Ru photosensitizer 
MLCT band (see Chapters 2 and 3 for experimental data). The wavelength profiles 
of these transients are essentially identical for the free photosensitizer and the Ru-
P450 conjugates, and the features return to baseline with the same decay constant 
as the luminescence lifetimes. 
The Ru-P450 conjugates display multiphasic TA kinetics in the presence of 
pMeODMA (Figure 5.6).  
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Figure 5.6. Single-wavelength transient absorption data of Ru-P450 at various 
wavelengths. Sample composition: 10 μM RuC97-BM3(W96), 10 mM pMeODMA, 
50 mM sodium borate, pH 8. 
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Figure 5.7. Single wavelength transient absorption data for flash-quench of four 
Ru-P450 mutants. λexcitation = 480 nm, λprobe = 420 nm (green), 440 nm (red). 
Samples consisted of 10 μM Ru-P450, 10 mM pMeODMA, 50 mM sodium borate, 
pH 8. Top left: RuC97-BM3(W96). Top right: RuC97-BM3(WH96). Bottom Left: 
RuC77-CYP119(H76). Bottom Right: RuC77-CYP119(HW76) 
Assignment of Intermediates 
This first transient is assigned as the *RuII excited state, in analogy to control 
studies; this feature decays rapidly, with the same decay constant as the quenched 
luminescence lifetime. A transient absorption feature at 510 nm appears at this 
same rate, and decays on the microsecond-to-millisecond timescale. Quenching of 
the Ru excited state results in formation of a pMeODMA radical cation; this 
species has been characterized by transient absorption, with an absorbance 
maximum of 484 nm (ε(484)=7200 M-1cm-1).20,21 This wavelength is too close to 
	   164	  
the excitation wavelength to reliably probe, but there is still significant 
pMeODMA+ absorbance at 510 nm, and we attribute our transient feature to this 
species. 
Additionally, a new transient absorption feature appears on the microsecond 
timescale that is characterized by a bleach centered at 420 nm and a concomitant 
increase in absorption centered at 440 nm. TA at all wavelengths decay to baseline 
within the course of one second, indicating that the ET reaction is reversible.  
It is of note that the red-shift associated with the observed transient species is 
different from the blue-shift and broadening associated with dithionite-induced 
heme reduction (Figure 5.8). The ferrous-ferric difference spectrum of WT P450 
BM3 has maxima at 390, 460, and 550 nm, and a minimum at 420 nm; the 
transiently reduced spectrum has a maximum at 440 nm and minimum at 420 nm. 
This discrepancy also was observed for photochemical reduction of inducible 
nitric oxide synthase using non-covalently bound ruthenium wires.22 The spectral 
differences were attributed to a difference in spin state and coordination; 
chemically-reduced P450 and NOS are five-coordinate and high-spin. However, 
the rate of photochemical reduction may exceed ligand-loss and spin-conversion, 
resulting in a transient, low-spin ferrous species. The TA features of 
photochemically-reduced Ru-P450 conjugates are consistent with that observed 
upon flash-quench reduction of cytochrome P450cam using imidazole-terminated 
Ru-photosensitizer wires that bind in the P450 substrate channel and ligate the 
heme iron (Figure 5.8, inset).23 Cryoreduction of P450cam at 77 K similarly 
resulted in a low-spin six-coordinate ferrous species with absorption around 440 
nm, which converted to five-coordinate, high-spin upon annealing at higher 
temperatures.24 Thus, we assign the feature at ~100 μs to low-spin ferrous P450. 
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This reversibly reoxidizes to ferric on the millisecond timescale, and we observe no 
additional intermediates. 
 
Figure 5.8. Spectra of ferric (blue) and ferrous (red) wild-type P450-BM3, and 
the ferrous – ferric difference spectrum (purple). Inset: Transient difference 
spectrum of photochemically reduced cytochrome P450cam by noncovalent Ru-
wires.23  
Fitting 
Three kinetics phases are evident in the TA data. Thus, we performed a global 
least-squares fitting of the TA data recorded at 420 and 440 nm (and, for select 
mutants, 400, 410, 430 nm). Data were fit to a sum of three exponentials with 
amplitude coefficients ρ1-3 and observed rate constants γ1-3 (Equation 5.1). For 
fitting, see sample script in Appendix D. Similar to our analysis for photochemical 
heme oxidation described in Chapter 2, we fix the first observed rate constant as 
the quenched luminescence decay rate, as obtained from monoexponential fitting 
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of the luminescence decay at 630 nm. The remaining two rate constants are 
extracted from the global fitting, and are listed in Table 5.2. 
 
€ 
y(n,t) = ρn1 exp −γ1t( ) + ρn2 exp −γ 2t( ) + ρn3 exp −γ 3t( ) (5.1) 
Table 5.2. Rates of heme reduction extracted from global fitting of transient 
absorption data. 
 
The transient bleach at 420 nm and transient absorption at 440 nm observed on 
the microsecond timescale were assigned23 as photochemical heme reduction 
(Figure 5.8, inset). Therefore, we assign the second rate constant as that of heme 
reduction. All four mutants exhibit very similar reduction rates, with maximum 
heme reduction complete at approximately 100 μs.  
Interestingly, after normalizing by the magnitude of the *RuII excited state bleach 
(440 nm), the magnitudes of the transient features associated with heme reduction 
(e.g., absorption at 440 nm) differ greatly among the different mutants. In 
particular, both of the CYP119 mutants exhibit signals which are greater by a 
factor of 2-3 (Figure 5.9). Since we do not have extinction coefficients for the 
transiently reduced species, we cannot tell how much of this difference in signal is 
attributable to a difference in yield. However, it would be surprising if a difference 
in extinction coefficients could account for the entirety of this discrepancy.  
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Figure 5.9. Normalized overlay of TA for the four Ru-P450 systems. 420 nm 
(ΔOD < 0 at 100 μs) and 440 nm (ΔOD > 0 at 100 μs), normalized to the intensity 
of the initial *RuII bleach (~10 ns) at 440 nm. RuC97-BM3(W96) (red); RuC97-
BM3(WH96) (yellow), RuC77-CYP119(H76) (green), RuC77-CYP119(HW76) (blue). 
All transient features decay to baseline within 100 ms; this return rate is extremely 
sensitive to small amounts of oxygen. In our proposed flash-quench scheme 
(Figure 5.10), re-oxidation of the ferrous center occurs via bimolecular 
recombination with oxidized pMeODMA. This recombination is expected to be a 
second order process; however, the disappearance of the transient features can be 
modeled as a first order process.  
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Figure 5.10. Flash-quench scheme for heme reduction. 
Curiously, the transient absorbance at 510 nm, attributed to the oxidized 
pMeODMA radical, disappears much more quickly than reoxidation of the heme 
center (Figure 5.6). Accelerated quencher recovery was also observed upon 
oxidative quenching of Ru-P450 with methyl viologen (see Appendix C). This may 
be due to reaction of quencher radicals with trace amounts of oxygen. However, if 
this is the case, it remains unclear what reaction regenerates the resting state 
enzyme. 
5.2.2. Reductive ET in the presence of CO 
We anticipated that gas binding could be induced upon photochemical heme 
reduction. To that end, reductive flash-quench experiments were conducted under 
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an atmosphere of CO. However, the observed kinetics were irreproducible, and 
varied depending on the number of laser shots. Additionally, we observed the 
appearance of a shoulder at 450 nm in the sample absorbance spectrum, 
suggesting accumulation of FeII-CO. While we expected heme reduction and CO 
binding to be reversible, this observation suggests that newly generated FeII-CO 
persists on the order of minutes to hours. Somewhat unexpectedly, we also 
observed appearance of this shoulder at 450 nm even for pure protein samples in 
the absence of both photosensitizer and quencher (Figure 5.11). 
 
Figure 5.11. UV-visible absorbance spectra of FeIII-P450 BM3 (double mutant: 
C62A/C156S, which contains no surface-exposed cysteines) under an atmosphere 
of argon (red) or an atmosphere of CO: before (green) and after (blue) excitation 
at 480 nm. 
Samples that are not as rigorously deoxygenated do not show build-up of FeII–CO . 
This spontaneous reduction under irradiation of UV and visible light was observed 
for heme proteins, including P450.25–27 It is possible that transient photo-reduced 
species are trapped by the CO. This process severely complicates the analysis of 
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transient data, as the FeII-CO concentration is in flux; and we cannot conclusively 
measure a rate for CO binding using this method of photo-triggered reduction. 
This observation, along with other cited sources, brings into question the 
effectiveness of methods to photo-trigger heme reduction by excitation of 
NAD(P)H.13 The organic reductant absorbs in the near UV, and overlaps 
extensively with the P450 absorption band at 360 nm. If P450 photo reduction and 
CO binding can be observed with excitation at 4 mJ/pulse of 480 nm, in the 
absence of any obvious chemical reductant, it is almost certain that 200 mJ/pulse 
radiation into the near-UV region of the P450 spectrum also would result in P450 
reduction, albeit by a different mechanism than what was suggested by the 
authors.12,13 
5.2.3. CO photolysis and rebinding 
The rate of CO rebinding can be measured following photolysis the FeII–CO bond 
of chemically-reduced ferrous–CO. In particular, we set out to examine the 
kinetics of CO rebinding for thermophilic CYP119 over a range of temperatures, 
in the presence and absence of substrate, and with a variety of laser pulse powers.  
Samples for photolysis consist of WT CYP119 reduced with dithionite under an 
atmosphere of CO, in specialized, high-vacuum quartz cuvettes (see Appendix B). 
The P450 ferrous-CO species is characterized by a split-Soret spectrum with a 
Soret absorbance maximum at 448 nm. Photolysis of the Fe–CO bond produces a 
five-coordinate ferrous species, for which the Soret band is broader and 
significantly blue-shifted (Figure 5.12). 
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Figure 5.12. UV-visible absorbance spectra of five-coordinate, dithionite-reduced 
WT CYP119 (blue) and the corresponding six-coordinate ferrous CO species 
(red). 
The multi-wavelength transient absorption spectra following excitation at 486 nm 
clearly show loss of the FeII–CO band at ~450 nm, and increase in absorption at 
~400 nm (Figure 5.13). This transient spectrum is in excellent agreement with the 
FeII/FeII-CO difference spectrum (Figure 5.13, inset). By 4 ms, absorption has 
entirely returned to baseline, indicating full recovery of the starting, CO-bound 
ferrous species. 
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Figure 5.13. Transient difference spectra following flash-photolysis of WT 
CYP119 FeII-CO in 100 mM potassium phosphate buffer, pH 7.4, 20 °C. 
Excitation: 486 nm. A narrow notch filter blocks scattered laser light (and the 
probe light) 475-495 nm. Inset: FeII-FeII–CO difference spectrum. 
As observed by single-wavelength transient absorption (Figure 5.14), two major 
kinetics components contribute to the recovery of the FeII-CO species. This 
behavior is commonly observed for CO rebinding in heme enzymes, including 
P450.14–16 The fast rebinding phase is associated with geminate recombination, and 
typically occurs on the picosecond-to-nanosecond timescale. The slow rebinding 
phase is associated with CO that has escaped into solution and must diffuse back 
into the active site; this typically occurs on the millisecond timescale. 
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Figure 5.14. Single-wavelength TA following flash-photolysis of WT CYP119 
FeII-CO in 100 mM potassium phosphate buffer, pH 7.4 buffer, 20 °C. Excitation: 
460 nm. Single-wavelength transient absorption traces at 450 nm (red) and 410 
nm (blue). Inset: FeII-P450CYP119 (blue) and FeII-CO-P450CYP119 (red). 
 In the presence of excess CO, one expects both geminate recombination and 
rebinding of escaped CO to obey first order and pseudo-first order kinetics 
(respectively). However, the single-wavelength TA data display complex kinetics 
behavior that cannot be fit to a sum of two exponentials. This also has been 
observed in flash photolysis of FeII-CO P450 BM3, and was attributed to multiple 
protein conformations with slow interconversion.15 There is also evidence for 
multiple solution conformations of substrate-free CYP119, as examined by NMR 
spectroscopy and dynamics simulations.28 Interestingly, these studies both suggest 
that P450 BM3 and CYP119 lock down into a dominant conformation in the 
presence of tightly binding substrates. 
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Power dependence and yield of CO escape 
There is a nonlinear power dependence on the yield of CO escape, which appears 
to saturate around 10 mJ/pulse (Figure 5.15). If we assume that this saturation 
corresponds to 100% photolysis of the Fe–CO bond, then we can determine the 
yield of CO escape following photolysis.  
Using the initial absorption spectrum of the FeII-CO sample (A450=0.42), and the 
steady-state and transient difference spectra (Figure 5.13), we can determine the 
expected absorption at 100% conversion to five-coordinate FeII. The 
corresponding ΔOD(406)max = 0.27; our maximum signal at power saturation is 
0.13, just under 50% of the maximum signal. This is significantly lower than the 
previously reported CO escape yield of 64%.17 
 
Figure 5.15. Power dependence of CO escape, 460 nm excitation, A450=0.42. Left: 
Single-wavelength transient absorption at 406 nm. Right: Magnitude of CO escape 
for two samples, extracted from single wavelength TA data at 1 μs (red and blue 
dots; red corresponds to the figure on the right). 
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Temperature dependence (substrate-free) 
CYP119 is an extremely thermostable protein, tolerating conditions of up to 90 °C 
or more. Therefore, we can examine a wide range of temperatures and determine 
its effect on the yields of CO escape and rates of rebinding. This temperature 
dependence is important for understanding the function of CYP119 under 
conditions that approximate those within its thermophilic parent organism, 
Sulfolobus acidocaldarius. 
 
Figure 5.16. Temperature dependence of CO rebinding (no substrate). Abs(λmax : 
449 nm)=0.41, λ(excitation) = 460 nm, 2 mJ/pulse. 
Reassuringly, temperature appears to have had little affect on the magnitude of the 
initial TA signal, and we assume that the total photolysis yield is constant. As 
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temperature increases, there is an increase in the yield of CO escape, as evidenced 
by the increased signal magnitude at ~ 1 μs. Additionally, the rate of CO rebinding 
increases with increased temperature.  
Temperature dependence in the presence of laurate 
We have examined the effect of bound fatty acid substrate on the rates of CO 
rebinding following photolysis. The native substrate of CYP119 is yet unknown, 
but this variant does tightly bind and hydroxylate various fatty acids in vitro.29 
Lauric acid (dodecanoic acid) is used here as a model substrate; the binding 
constant is reported to be 1.2 μM in CYP119.29 Upon binding, the fatty acid 
partially displaces the axial water molecule, causing a shift to high-spin. This 
results in blue-shifting of the Soret band for laurate-bound CYP119 (Figure 5.17). 
 
Figure 5.17. UV-visible absorption spectra of WT CYP119 with and without 
laurate. Green: Ferric, substrate-free. Purple: Ferric, 30 μM laurate. Red: Ferrous-
CO, with 30 μM laurate. Samples have approximately equal concentrations. 
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Figure 5.18. Temperature dependence of CO rebinding in the presence of 30 μM 
laurate. Abs(λmax : 449 nm)=0.37, λ(excitation) = 460 nm, 2 mJ/pulse. 
A similar temperature dependence of CO rebinding dynamics is observed in the 
presence of laurate; as temperature increases, there are increases in both the yield 
of CO escape and the rate of CO rebinding. In contrast to the substrate-free form, 
there appears to be a greater temperature dependence on yields of CO escape. At 
lower temperatures, there is a dramatic decrease in CO escape yield for the laurate-
bound form (Figure 5.19, left); this discrepancy decreases as temperature 
increases. 
	   178	  
 
Figure 5.19. Comparison of laurate-free and laurate-bound CO rebinding 
kinetics (from Figure 5.16 and 5.17). Left: 20 °C. Dark blue, substrate free. Light 
blue, lauric acid bound; Right: 70 °C. Red, substrate free. Pink, substrate bound. 
Substrate-free traces have been multiplicatively scaled (x 1.06) to normalize the 
initial signal magnitude. 
Picosecond transient absorption measurements 
At high temperatures, geminate recombination appears to be complete within the 
instrument response in our nanosecond pulsed TA experiments; this is true in 
both substrate-free and substrate-bound forms. We have investigated the earlier 
timescales using picosecond-pulsed TA experiments (see appendix B for 
instrumentation). The signal-to-noise ratios are smaller for picosecond data, but 
the single-wavelength kinetics traces overlay nicely with nanosecond data (Figure 
5.20, see Appendix C for a sample overlay).  
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Figure 5.20. Picosecond-to-millisecond TA data for CO rebinding in substrate-
free CYP119 at various temperatures. The picosecond data at 70 °C is significantly 
noiser and has been omitted. 
Non-negative lease squares fitting  
In order to more quantitatively assess the temperature dependence of CYP119 CO 
rebinding kinetics, we have subjected our transient absorption data to a 
nonnegative lease squares (nnls) fitting procedure. This is similar to the singular 
value decomposition analysis described in Chapter 2; single-wavelength transient 
absorption data are fit to a series of rate constants, and the fitting process provides 
amplitude coefficients corresponding to each rate constant. An additional 
constraint was added to limit the difference in amplitudes for adjacent rate 
constants (see Appendix D for matlab scripts). 
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Figure 5.21. Amplitude coefficients derived from nonnegative least squares fitting 
of CYP119 CO rebinding kinetics. Conditions: 20 °C, no substrate. The lambda 
value associated with this fit is 1.297. 
An example of the amplitude coefficients is shown in Figure 5.21; data from 
analysis of all temperatures can be found in Appendix C. As seen above, the rate 
constants from nnls fitting are divided into two major populations: the fast 
population (centered at log10(k) ~ 8) corresponds to geminate recombination, 
while the slow population (centered around log10(k) ~ at.5) corresponds to 
rebinding of the escaped CO.  
In order to further analyze the temperature dependence, we have integrated each 
population, and determined their first moment (mean), and second centered 
moment (variance).  
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Figure 5.22. Integration of rate constant amplitudes at varying temperature 
(substrate free). Red: fast population corresponding to geminate recombination. 
Blue: slow population corresponding to rebinding of escaped CO. 
 
Figure 5.23. First moment of populations at varying temperature (substrate free). 
Note the break in the y-axis. Red: fast population corresponding to geminate 
recombination. Blue: slow population corresponding to rebinding of escaped CO. 
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Figure 5.24. Second centered moment of populations at varying temperature 
(substrate free) Red: fast population corresponding to geminate recombination. 
Blue: slow population corresponding to rebinding of escaped CO. 
As temperature increases, the integrated amplitude associated with the slow 
population increases in a nonlinear fashion (Figure 5.22); this corresponds to the 
increased yield of escaped CO. Due to increased noise associated with the fast 
component, it is not clear whether the integrated amplitude remains constant or 
decreases. The first moment of both the fast and slow components increase with 
temperature in a linear fashion (Figure 5.23). We use these population centers to 
do an Eyring analysis of the CO rebinding (vide infra). The second centered 
moment of both the fast and slow populations decreases as temperature increases 
(Figure 5.24). Intuitively, one might expect the opposite; as temperature increases, 
more conformations may become thermally accessed, leading to broadening of the 
population (and increase in the second centered moment). It is possible that there 
are multiple sub-populations within the fast and slow components, and that these 
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populations merge as temperature increases. Investigations into this possibility of 
subpopulations is ongoing in the Gray group.  
The CO rebinding data for laurate-bound CYP119 are more preliminary, and have 
not been acquired on the picosecond timescale. Nevertheless, we have performed 
non-negative least squares fitting on the nanosecond-to-microsecond TA data (see 
Figure 5.18 for TA data), and provide an initial comparison between rebinding of 
escaped CO in the presence and absence of laurate. 
 
Figure 5.25. Comparison of amplitude integrations for the slow population in 
substrate-free and laurate-bound CYP119. Integrations of substrate-free data have 
been scaled multiplicatively by a factor of 1.06 to account for the slight difference 
in sample concentration and laser power. 
As noted earlier, there is a larger temperature dependence for the yield of CO 
escape in the presence of laurate. It is plausible that the presence of substrate 
blocks some of the CO escape pathways, lowering the escape yield (and 
correspondingly lowering the integration of amplitudes). This is observed at lower 
temperature (< 50 °C). However, at high temperatures, the amplitudes associated 
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with CO escape appear to be higher in the presence of substrate. This intriguing 
phenomenon has not yet been explained, and deserves additional exploration.  
 
Figure 5.26. Comparison of slow population first moment in substrate-free and 
laurate-bound CYP119. 
 
Figure 5.27. Comparison of slow population second centered moment (variance) 
in substrate-free and laurate-bound CYP119. 
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The rates of CO rebinding are faster in the presence of substrate; this is true 
throughout the temperature range, although the effect appears to diminish at 
higher temperatures. Interestingly, the opposite affect was observed for CO 
rebinding in P450 BM315 and P450cam.30 This may indicate alternate pathways for 
CO re-entry among different P450 variants. 
The final note in the substrate free/bound comparison is that the second moment 
(variance) in that the slow population distribution is significantly lower in the 
presence of substrate, over the entire temperature range. This is unsurprising, as 
tight binding to substrate causes significant structural shifts (see Chapter 1) and 
generates a single dominant conformation in solution.28  
Eyring Analysis 
We have performed an Eyring analysis on the kinetics of rebinding for escaped CO 
(slow population) in the substrate-free form. The data are consistent between 
samples, and are linear over the range of 10-70 °C (Figure 5.28). The extracted 
activation parameters are listed in Table 5.3. These thermodynamic parameters 
can be compared with those for other heme proteins, including P450cam 29 and 
myoglobin.31  
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Figure 5.28. Eyring plot for rebinding of escaped CO in CYP119. The green 
triangles and blue circles represent two separate samples. 
Table 5.3. Thermodynamic activation parameters for CO rebinding in CYP119 
and various heme enzymes. a: this work. b: Reference 29. c: Reference 31. 
 
5.3. Discussion, Conclusions and Future works 
We achieved rapid, photochemical reduction of the P450 active site of four Ru-
P450 conjugates with a rate of 50,000 s-1. By comparison, native ET between the 
fused reductase and heme domains in P450 BM3 occur at 220 s-1.32 Unlike the 
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photochemical oxidation discussed in Chapters 2 and 3, this reduction is not 
sensitive to intervening medium, and proceeds with rapid (microsecond) rates and 
good yields for all mutants examined. We also used photo-triggered methods to 
examine the kinetics of CO rebinding to wild type CYP119 following photolysis. 
We have identified key differences in the yields of CO escape, rates of rebinding, 
and population variance in the presence and absence of substrate, and have 
determined thermodynamic activation parameters for the substrate-free form. By 
selecting appropriate conditions of temperature, excitation wavelength, and buffer 
composition, we anticipate that these methods can be further refined to examine 
photochemical formation of ferric hydroperoxo species from chemically generated 
ferric superoxo, with the goal of observing the rearrangement to form CI. 
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5.5. Materials and Methods 
Chemicals 
Sodium dithionite (86%) was obtained from Fluka. Other buffer salts were 
obtained from J.T. Baker. para-methoxydimethylaniline (pMeODMA) used in 
these experiments was obtained courtesy of Dr. Charlotte Whited. Solutions were 
prepared using 18 MΩcm water unless otherwise noted.  
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Ru-P450 conjugates 
The P450 mutants used for this study are: P450 BM3 C62A/C156S/K97C (C97-
BM3(W)), C62A/C156S/K97C/W96H (C97-BM3(WH); CYP119 D77C (C77-
CYP119(H)), D77C/H76W (C77-CYP119(HW)). The selection, mutagenesis, 
expression, and purification of cytochrome P450 mutants, as well as 
photosensitizer synthesis, conjugation, and purification, are described in Chapters 
2 and 3.  
Synthesis/purification of reductive quencher 
The reductive quencher para-methoxydimethylaniline can be synthesized by 
previous published methods.7 pMeODMA used in these experiments was obtained 
courtesy of Dr. Charlotte Whited, purified by sublimation and characterized by 1H 
NMR.  
pMeODMA is only sparingly soluble in water. 40 mM aqueous stock solutions 
were prepared by dissolving 5 mg in 200 μL of dimethylsulfoxide (DMSO), 
followed by dropwise (10 μL) addition of aqueous buffer (50 mM sodium borate, 
pH 8) to a total volume of 500 μL. Oxygenated solutions of pMeODMA change 
from clear to pinkish/purple in ambient light, with an absorbance increase at 550 
nm. For that reason, fresh solutions were prepared immediately prior to use, and 
protected from light wherever possible. 
Preparation of laser samples for flash-quench heme reduction 
Laser samples were prepared in a high-vacuum four-sided quartz cuvette, sealed 
with a high-vacuum valve, and equipped with a small stir bar. Deoxygenation was 
achieved via gentle pump-backfill cycles with argon. For flash-quench in the 
presence of carbon monoxide, samples were subsequently pump-backfilled with 
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CO. Flash-quench samples consisted of approximately ~10 μM Ru-P450 (RuC97-
BM3(W), RuC97-BM3(WH), RuC77-CYP119(H) or RuC77-CYP119(HW)) with 10 mM 
pMeODMA in buffered solution: 50 mM sodium borate buffer, pH 8. Samples 
were excited with 8 ns laser pulses at 480 nm. Luminescence decays were 
monitored at 630 nm. Single wavelength transient absorption (TA) kinetics were 
monitored every 10 nm from 390-440 nm, averaging ~500 shots per wavelength. 
Data from five separate timescales (2 μs, 40 μs, 400 μs, 10 ms, and 500 ms) were 
collected, log-compressed, and spliced together to produce full kinetics traces. See 
Appendix D for log-compression and splicing scripts in Matlab. 
Preparation of samples for FeII-CO photolysis/rebinding 
Flash-photolysis samples were prepared in a specialized high-vacuum 4-sided 
quartz cuvette containing an attached 10 mL bulb compartment and a 24/40 
adaptor; each compartment could be sealed separately by a high-vacuum valve 
(Kontes) (see diagram in Appendix B). Approximately 1.5 mL of ferric wild-type 
CYP119 (3-10 μM for ns-pulsed experiments, 30-60 μM for ps-pulsed 
experiments) in 100 mM potassium phosophate buffer, pH 7.4, was placed in the 
cuvette portion. A few grains of sodium dithionite were added to the bulb 
compartment, and the entire apparatus was degassed by gentle pump-backfill 
cycles with argon. The cuvette was then subjected to gentle pump-backfill cycles 
with carbon monoxide to obtain a headspace of CO. While sealed from the 
atmosphere, the ferric protein solution was mixed with sodium dithionite in the 
bulb, and then returned to the cuvette portion. 
For nanosecond-to-millisecond TA experiments, samples were excited with 8 ns 
laser pulses at either 460 nm (single wavelength TA) or 486 nm (multi-wavelength 
TA). For single-wavelength transient absorption measurements, a narrow 
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bandpass filter (centered at 406 nm, Appendix C) was used to block the majority of 
the white probe light. 
For picosecond-to-nanosecond TA experiments, samples were excited with 30 ps 
laser pulses at 532 nm with 0.5-1 mJ/pulse, and a 405 nm laser diode was used as 
probe light.  
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6.1. Background: Controlled electron flow through P450 
Initiation of catalysis by cytochrome P450 heme enzymes requires the controlled 
flow of electrons. In the native catalytic cycle, the redox cofactor NAD(P)H 
supplies necessary reducing equivalents, which are shuttled to the P450 heme 
active site via the redox cofactors flavin adenine dinucleotide (FAD) and flavin 
mononucleotide (FMN) that are housed in cytochrome P450 reductases. The self-
sufficient enzyme P450 BM3 from the soil bacterium B. megaterium contains a 
flavin reductase domain fused to the heme domain (Figure 6.1), which facilitates 
reduction of the heme1 and allows for high turnover rates (> 103 per minute).2  
 
Figure 6.1. Structure of P450 BM3. (PDB: 1BVY) The oxygenase domain is 
colored green (heme: red), and the reductase domain is colored blue (flavin: 
purple). All images of protein structures in this Chapter were made using PyMol 
graphics software for Mac. 
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In many P450s, including P450 BM3, an important gating mechanism controls 
this electron flow by modulating the heme reduction potential in the presence or 
absence of substrate. As described in Chapter 1, the resting state enzyme is low-
spin, six-coordinate ferric, where the distal ligation site is occupied by a water 
molecule; the reduction potential of this species is too negative to be efficiently 
reduced by NADH via the flavin cofactors. The binding of native substrates 
displaces the labile water molecule, inducing a positive shift in reduction potential 
that allows heme reduction.  
Controlled electron flow is a critical element of all P450 redox chemistry, including 
engineered catalytic reactivity. We became interested in electron flow in a series of 
P450 BM3 mutants designed by Frances Arnold’s group at Caltech that catalyze 
the cyclopropanation of styrene by ethyldiazoacetate (EDA) (Figure 6.2). Directed 
evolution was used to generate P450 mutants that display high levels of 
regioselectivity (for either cis or trans isomers) and enantioselectivity in such 
cyclopropanation reactions.3 In analogy to the native P450 cycle (Figure 6.3, left), 
and by comparison to the mechanisms for small molecule metalloporphyrin-
catalyzed cyclopropanations, the Arnold group proposed a catalytic scheme for the 
reactivity of engineered P450s (Figure 6.3, right). 
 
Figure 6.2. P450-catalyzed cyclopropanation of styrene. 
Just as in the native catalytic cycle, reduction of the ferric resting state is essential 
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experimentally supported by the inactivity of ferric enzyme in the presence of EDA 
and styrene, and by the requirement of reductant to initiate catalysis. Furthermore, 
the net reaction is inhibited by carbon monoxide, which readily binds to ferrous 
hemes, but not ferric.4 
 
Figure 6.3. Schemes for native and engineered P450 catalysis. Left: Consensus 
P450 catalytic cycle for oxygenations, showing hydroxylation of a fatty acid. Right: 
Proposed catalytic scheme for the cyclopropanation of styrene.  
Strong reductants, such as dithionite, are required to initiate catalysis in these 
mutants; very low levels of activity were observed in the presence of the biological 
reductant NADH. It was presumed that styrene was ineffective at displacing the 
labile water molecule and opening the electron gate; a low binding affinity is 
indicated by the Michaelis-Menten constant (KM ~ 5 mM).3 This can be 
circumvented for solutions of purified enzyme; dithionite can easily be added to 
solutions. However, the development of enzymatic cyclopropanation for 
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whole cell biocatalyst systems. In that case, the reductant scope is limited to 
endogenously produced redox cofactors, including NADH. 
Enzyme engineering to more tightly bind styrene could facilitate the substrate 
gating issue, but this process would need to be repeated for each new substrate, 
and the P450 catalyst would lose its desirable substrate promiscuity. Alternatively, 
the enzymes could be engineered with higher resting state reduction potential, 
effectively propping open the electron gate. Many factors tune the reduction 
potential of heme enzymes, including the environment in the proximal pocket,5 
and the nature of the proximal ligand. The reduction potentials of axial mutants of 
the heme protein cytochrome c span a range of 650 mV, from –390 mV for a 
Cys/His ligated mutant to +262 for the Met/His variant.6 Interestingly, the 
potential of cysteine-ligated cytochrome c (–390 mV) is similar to that of P450. 
Replacement of the strong, axial thiolate with a weakly donating water molecule 
results in a positive shift of almost 350 mV. 
To this end, the Arnold group designed a second generation of mutants in which 
the axial cysteine ligand (C400) is replaced with other amino acids, including 
serine. It was hypothesized that the more weakly donating serine ligand would 
result in a positive shift in reduction potential, similar to the observations for 
cytochrome c. As described in Chapter 1, cysteine ligation is critical for the 
activation of dioxygen and generation of the ferryl porphyrin radical active species 
known as compound I (Figure 6.3 left, highlighted green).7 Mutation of the axial 
cysteine to serine in mammalian P450s abolishes monooxygenation activity.8 
However, this ligation was not expected to be necessary for cyclopropanation, as 
free hemin also catalyzes this reaction.  
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This is in fact the case; serine-ligated P450 BM3 mutants are highly active for 
cyclopropanation reactions, and show selectivity for cyclopropanation over 
epoxidation of styrene, even under aerobic conditions (Figure 6.4, right).9 The 
Arnold group chose to examine one mutant in particular, which contains 13 
mutations to the active site and periphery and the C400S mutation. This mutant 
catalyzes over 300 turnovers in vitro, and is characterized by a ferrous-CO species 
with an absorbance max at 411 nm.9 For the purposes of this Chapter, this 
particular mutant will be referred to as P41113-Ser. The serine-ligated P450-BM3 
heme domain (C400S) has been characterized by X-ray crystallography, which 
indicates serine-ligation of the heme active site (Figure 6.4, left).  
 
Figure 6.4. P41113-Ser structure and activity.9 Left: electron density maps show 
serine ligation to the heme of P41113-Ser heme domain. Right: Total turnover 
numbers (TTN) for P450-catalyzed reactions.  
The central question for the function of this catalyst, and improvement to future 
catalysts is: Does the cysteine-to-serine mutation in P450 also result in a positive 
shift in reduction potential? Furthermore, is this shift sufficient to make reduction 
by NADH and flavin cofactors thermodynamically favorable? 
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Determination of reduction potentials is difficult for enzymes such as P450s. 
Standard voltammetry techniques are fraught with challenges, including slow 
diffusion of the large proteins, and poor communication between the buried heme 
and the working electrode. Additionally, the ferrous state of cytochrome P450 is 
extremely sensitive to oxygen, and readily auto-oxidizes to ferric. Any method to 
determine P450 E°´(FeIII/II) must be done under strictly anaerobic conditions. 
Various methods exist for determining reduction potentials, including 
spectrophotometric titrations, spectroelectrochemical titrations, potentiometric 
titrations, and direct electrochemistry of immobilized or freely-diffusing enzymes. 
However, these techniques result in a wide range of reported potentials. For 
example, a range of potentials from –368 mV to –427 mV are reported for solution 
measurements of wild-type (WT),5,10 substrate free P450 BM3. Protein film 
voltammetry has led to even more positive reported values of approximately –133 
to +4 mV.10–12 Careful determination of solution reduction potentials and internal 
comparison between wild type and mutant enzymes is needed. 
This Chapter reports the measurement of ferric/ferrous reduction potentials for a 
variety of P450 mutants. It also describes the advantages and limitations of various 
techniques that may be used to determine solution ferric/ferrous reduction 
potentials for P450 variants. In particular, we address whether the ligation change 
results in a shift in reduction potential within range of biological reductants 
(NADH, FMN). Unless specified otherwise, all potentials are measured at neutral 
pH, and are reported versus the normal hydrogen electrode (NHE). 
Enzymes  
In order to avoid complications with the optically- and redox-active flavin 
cofactors, all measurements use only the heme domains of all P450 BM3 mutants, 
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rather than the holo enzyme. To test titration methods and provide an internal 
reference for reduction potentials, we have examined WT enzymes P450 BM3, and 
CYP119 from Sulfolobus acidocaldarius. To probe the effect of axial ligation on 
E°´(FeIII/II), we examined BM3 axial mutants: C400S, C400M, C400H, C400Y, 
C400A, and C400D. We also examined two mutants specifically engineered for 
cyclopropanation activity. The first mutant, which will be referred to as P45013-
Cys, contains the 13 mutations V78A, F87V, P142S, T175I, A184V, S226R, 
H236Q, E252G, T268A, A290V, L353V, I366V and E442K (Figure 6.5). The 
second mutant, P41113-Ser, is identical to P45013-Cys except that it contains C400S 
serine ligation.  
 
Figure 6.5. Structure of P45013-Cys, highlighting mutations in blue (PDB 4H23). 
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6.2.  Methods Development for Redox Titrations 
Spectrophotometric Titration 
Spectrophotometric titrations present an experimentally straightforward means to 
determine reduction potentials. An enzyme sample is titrated by addition of 
chemical oxidant/reductant of known potential, and absorption spectra are 
acquired at each point along the titration. Absolute concentrations of reduced and 
oxidized species are determined based on the absorption profile, to determine Keq 
(Equation 6.1). The enzyme reduction potential is determined using Equation 6.3, 
where ΔE° is the reduction potential of the enzyme, and ΔE is the difference in 
potentials between the enzyme and titrant. 
For a reaction: 
€ 





[Enz(ox)][A(red)]  6.1 
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⎟  6.3 
The requirements for this method are: 1) Enzyme, in which the reduced and 
oxidized forms of the protein have distinct absorption profiles with known 
extinction coefficients; 2) A chemical oxidant/reductant with a known reduction 
potential within ~100 mV of the enzyme, and in which the reduced and oxidized 
forms have distinct absorption profiles with known extinction coefficients. 
Advantages of this method are that low concentrations and volumes of protein can 
be employed, and no specialized equipment is necessary, other than a 
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spectrophotometer and cuvette under anaerobic atmosphere (e.g., within a 
glovebox). 
As discussed previously, the E°´(FeIII/II) for WT P450 BM3 is expected to fall within 
the range of –365 to –430 mV. Methyl viologen radical cation (MV+) was chosen 
as the chemical reductant; this species has strong absorbance in the visible region 
(Figure 6.6), and its reduction potential E°´(MV2+/MV+) = –446 mV13,14 falls 
within 100 mV of the expected P450 potential. MV+ can be generated from MV2+ 
dichloride, which is optically transparent, by mixing an aqueous MV2+ solution 
with zinc powder under anaerobic conditions.15 The radical reacts quickly with 
oxygen to regenerate MV2+; however, under anaerobic conditions, it is stable for 
many hours.16  
 
Figure 6.6. Absorption spectrum of the methyl viologen radical cation. 
Reduction was accomplished by mixing over zinc powder in a glovebox. 
	   204	  
Addition of aliquots of MV+ to a solution of ferric, WT P450 results in a series of 
titration spectra, shown in Figure 6.7. There is significant overlap between the 
MV+ and P450 absorbance spectra in the range of 350-600 nm; this makes spectral 
deconvolution more difficult. 
  
Figure 6.7. Chemical titration of WT P450 BM3 with MV+. 
There are other significant concerns with regards to the success of these titrations. 
Importantly, trace amounts of oxygen can affect the data. Oxygen reacts rapidly 
with both the ferrous P450 and with MV+. This adds a third redox couple to the 
reaction, yet there are no optical signals to indicate the concentration of oxygen, or 
of the oxidized MV2+. It is extremely difficult to remove all traces of oxygen from 
protein samples; multiple freeze-thaw cycles (e.g., freeze-pump-thaw) or sparging 
can be detrimental to the protein structure, and therefore, redox properties. There 
was also a significant amount of error with respect to titrant volumes; the positive 
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pressure necessary in the glovebox makes accurate pipetting of microliter 
quantities very difficult. Furthermore, this method requires use of a titrant within 
~100 mV of the expected reduction potential. A new titrant would need to be 
found for each mutant, decreasing the generalizability of the method. For all of 
these reasons, spectrochemical titrations were abandoned for measurement of 
P450 BM3 reduction potentials. 
Electrochemical titration 
Electrochemical titrations require a more complex, experimental setup, but 
determination of ferric/ferrous P450 concentrations and relevant potentials is 
more straightforward. In this method, reduction of the enzyme is accomplished 
using a narrow-pathlength spectroelectrochemistry cuvette, with a three-electrode 
setup (Figure 6.8).  
 
Figure 6.8. Spectroelectrochemical setup. Quartz cuvette with 1mm pathlength, 
Pt mesh working electrode, Pt wire counter electrode, and AgCl/Ag reference 
electrode. 
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When the potential at the electrode approaches the heme reduction potential, 
electrons flow from the large-surface area working electrode to the P450 heme, 
relayed via a mixture of small molecule mediators with varying E°´ (Figure 6.9). 
After equilibration at each potential, spectra are recorded to determine the relative 
concentrations of reduced and oxidized enzyme (Figure 6.10).  
 
Figure 6.9. Electron relay between the Pt mesh working electrode and the P450 
heme (red). “M” represents the small molecule mediators. 
For these measurements with short path length (1 mm), the enzyme concentration 
(~30-70 μM) is greater than that of the mediators. Only the ferric and ferrous P450 
species contribute significantly to the visible absorbance spectrum, facilitating 
spectral deconvolution. A plot of relative %FeII versus applied electrode potential 
can be fit to the one-electron Nernst equation to determine E°´ for the enzyme. 
We performed a spectroelectrochemical reduction of the WT BM3 heme using the 
setup described above, applying electrode potentials over a range of –100 to –530 
mV (Figure 6.10). Following this reduction, an aliquot of sodium dithonite was 
added to accomplish complete heme reduction, and the analogous, reverse 
titration (oxidation) was performed (Figure 6.11).  
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Figure 6.10. Absorption spectra taken during the spectroelectrochemical 
reduction of WT BM3.  
 
Figure 6.11. Absorption spectra taken during the spectroelectrochemical 
oxidation of dithionite-reduced WT BM3.  
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We deconvoluted the spectra (300-600 nm) into ferric and ferrous components 
using a Matlab program (see Appendix D). A plot of % ferrous P450 versus applied 
potential is shown in Figure 6.12. 
 
 
Figure 6.12. Plot of the electrochemical titration of WT BM3. Blue circles: 
reductive titration. Red squares: oxidative titration. 
Significant hysteresis was observed between the reductive and oxidative titrations, 
making it impossible to fit the data to the Nernst equation. This hysteresis is most 
likely due to slow equilibration between the electrode and the bulk solution at low 
concentrations of redox mediators (1-10 μM). Using higher concentrations of 
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redox mediators is undesirable, as these optically active small molecules interfere 
with the spectral deconvolution of ferric and ferrous P450 concentrations. 
Additionally, in these initial experiments (and for space reasons within the 
spectroelectrochemical cuvette), the counter electrode was not kept in a separate 
fritted compartment; it is likely that reoxidation/rereduction at the counter 
electrode precluded full conversion between oxidized and reduced states of the 
enzyme. For these practical reasons, we have modified this approach, as described 
below. 
Potentiometric titration 
Potentiometric titrations are very similar to the electrochemical titrations, except 
that the supply of reducing/oxidizing equivalents is accomplished by addition of 
chemical reductants/oxidants. In this case, reduction is accomplished by addition 
of sodium dithionite, and re-oxidation is accomplished by addition of potassium 
ferricyanide. The open circuit potential (OCP, potential applied by the electrode at 
which no current flows) is measured after every chemical addition to determine 
the solution potential. %FeII is again determined by deconvolution of absorption 
spectra into ferric and ferrous components. 
Chemical (rather than electrochemical) reduction/oxidation results in faster 
equilibration of the sample volume upon manual mixing. For these measurements, 
the electrode need not be high surface area (in contrast to the 
spectroelectrochemical titration). A single wire working electrode can be used. The 
reduction potential of aquo-ligated WT P450 BM3 is fairly negative (vide infra), 
and approaches the thermodynamic potential for proton reduction (at pH 7). 
Clean platinum wires begin to evolve hydrogen at the relevant potentials, which 
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complicates the OCP measurements. Implementation of a gold wire working 
electrode greatly improved potentiometric titrations. 
Test: Wild-type P450 BM3 
The spectra during titration with dithionite show clean conversion from ferric to 
ferrous with multiple isosbestic points (Figure 6.13). Reoxidation by ferricyanide 
also proceeds cleanly (Figure 6.14). 
 
Figure 6.13. Absorption spectra of WT BM3 during reductive potentiometric 
titration. Ferric: black dashed line. Ferrous: black solid line.  
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Figure 6.14. Absorption spectra of WT BM3 during oxidative potentiometric 
titration. Ferrous: black solid line. Ferric (pre-titration): black dashed line.  
There is only minor drift in open circuit potentials over the course of the 
measurement (10 min), almost always toward more positive values (Figure 6.15). 
The drift was generally less than 1.5 mV/min; in cases where drift exceeded this 
benchmark, an additional 5 minute period was recorded. Excessive amounts of 
drift (5 mV/min, or more) generally indicated incomplete mixing, the presence of 
oxygen, sample impurities, or a dirty working electrode. In these cases, manual 
mixing was repeated, or samples, buffers and electrodes were removed from the 
box, cleaned/purified and re-deoxygenated, and the titration was attempted again 
from the beginning. 
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Figure 6.15. Open circuit potential measurements of WT BM3 during 
potentiometric titration. Dashed black line: first titration point. Solid black line: 
fully reduced (excess dithionite). 
Spectra were deconvoluted to ferric and ferrous components, as discussed 
previously (see Appendix D). Relative percent ferrous was plotted against the final 
OCP value at each point in the titration (Figure 6.16). No hysteresis is observed 
between the reductive and oxidative titrations (Figure 6.16). An overlay of the 
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Figure 6.16. Redox titration plot of wild-type P450 BM3. Reduction by sodium 
dithionite: green circles. Re-oxidation by potassium ferricyanide: red squares. 
6.3. Results 
6.3.1. Wild-type Enzymes: P450 BM3 and CYP119 
Wild Type P450 BM3 
The reduction potential for WT P450 BM3 measured by potentiometric redox 
titration is –420 mV (Figure 6.17). This matches closely to the published value of 
–427 mV.5 The authors also note that this value agrees with calculations. Most 
importantly, this value is repeatable, and provides a benchmark with which to 
compare other mutants (see Appendix C for discussion of errors and 
repeatability). 
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Figure 6.17. Titration curve of WT P450 BM3. The overlayed one-electron 
Nernst function (black line) has E°´=–420 mV. 
Wild Type CYP119 
We also used this titration method to determine the reduction potential of WT 
CYP119. The only other report of the WT CYP119 reduction potential, to our 
knowledge, was determined by protein film voltammetry to be E°´(FeIII/II) of –210 
mV vs. AgCl/Ag;17 this corresponds to an anomalously positive value of –10 mV 
vs. NHE. The same report suggested that CYP119 and myoglobin have the same 
reduction potential, which is striking as the axial ligation and heme environments 
of P450 and myoglobin are very different. It is unclear why the CYP119 potential 
should be 400 mV more positive than other P450s, including P450 BM3.  
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Potentiometric titration of WT CYP119 with dithionite gives clean conversion 
from ferric to ferrous, with multiple isosbestic points (Figure 6.18). Open circuit 
potential measurements are stable and consistent (Figure 6.19).  
 
Figure 6.18. Absorbance spectra of WT CYP119 during potentiometric titration 
with dithionite. Dashed: ferric. Solid black: ferrous. 
 
Figure 6.19. Open circuit potential measurements for WT CYP119.  
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Figure 6.20. Potentiometric titration of WT CYP119 with overlayed Nernst 
function, E°’ = –420 mV. 
The WT CYP119 potential is –420 mV (Figure 6.20); this is within error of the 
value for P450 BM3, and significantly more negative than what was reported by 
protein film voltammetry. 
6.3.2. Potentiometric titration of mutants for in vivo cyclopropanation 
With a consistent method and reproducible WT BM3 potentials in hand, we set to 
determine the reduction potentials of P450 BM3 mutants engineered for 
cyclopropanation. In particular, we were interested in the effect of axial ligation. 
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C400S axial mutation 
The reduction potential of the single mutant C400S was measured by 
potentiometric titration as described above. Clean isosbestic points are observed in 
the titration spectra (Figure 6.21). The potential for C400S is –290 mV (Figure 
6.22). This single mutation results in a positive shift of 130 mV compared to WT 
enzyme, which is sufficient to allow reduction by NAD(P)H. 
 
Figure 6.21. Absorption spectra of P450 BM3 C400S. Ferric: dashed; ferrous: 
solid. 
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Figure 6.22. Redox titration curves of C400S (blue triangles) and wild-type (green 
circles), overlayed by the one-electron Nernst function (black line) with E°´= –420 
mV for WT, and –290 mV for C400S.  
Engineered cyclopropanation mutants 
Reduction potentials were also determined for P45013-Cys and P41113-Ser (Figure 
6.23). The 13 mutations to the active site and periphery result in a positive shift of 
68 mV from that of WT. Of note, these 13 mutations and the C400S mutation are 
not additive: P41113-Ser is only 148 mV positive of wild type, as opposed to the 
additive value of 191 mV. 
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Figure 6.23. Titration curves for four mutants.  
6.3.3. Additional axial mutants 
The Arnold group also expressed a number of other axial mutants, including: 
C400M, C400H, C400A, and C400Y. 
Titration of C400M yielded a reduction potential of –110 mV (Figure 6.24). 
Somewhat curiously, the titration curve appears to be shallower than the one-
electron Nernst function.  
	   220	  
 
Figure 6.24. Redox titration curve of C400M overlayed by the one-electron 
Nernst function with E°´ = –110 mV(black line). Inset: Titration spectra. Dashed: 
ferric; solid: ferrous. 
We also attempted potentiometric titrations of C400H, C400A, C400D, C400Y. 
Unfortunately, none of these mutants converts cleanly between ferric and ferrous; 
isosbestic points are not retained, and reoxidation with ferricyanide does not 
return the initial spectrum (Figures 6.25-6.28). These mutants have not been 
structurally characterized, and electrochemical measurements may be complicated 
by the presence of impurities, or heterogeneous populations with mixed ligation. 
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Figure 6.25. Reduction of C400Y shows loss of isosbestic points. Inset: Close-up 
of Soret region. Ferric: black. Ferrous: dark blue. 
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Figure 6.26. Spectra of C400A during potentiometric titration. Inset: close-up of 
Soret region shows non-retention of isosbestic points. 
 
Figure 6.27. Loss of isosbestic points in C400A absorption spectra during 
titration. Dashed: initial, ferric spectrum. Gray: partial reduction by sodium 
dithionite. Blue: ferrous spectrum, with excess sodium dithionite. Red: spectrum 
upon reoxidation with potassium ferricyanide. 
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Figure 6.28. Spectra of C400H during potentiometric titration. Inset: close-up of 
Soret region shows non-retention of isosbestic points. 
6.4. Discussion 
Using potentiometric redox titration, the reduction potential of wild-type P450 
BM3 is –420 mV, in agreement with the more negative reported potential.5 The 
engineered cyclopropanation mutant P45013-Cys has a more positive potential of –
360 mV, however this is still too negative to be efficiently reduced by NADH, 
relayed through the flavin cofactors (Table 6.1). The single axial mutation, C400S, 
raises the WT reduction potential by 130 mV; this shift the same magnitude as the 
shift conferred by substrate binding to WT BM3. The engineered mutant P41113-
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Ser has a similar, positively-shifted reduction potential of –270 mV. Furthermore, 
this mutant is active in the presence of NADH, and can catalyze cyclopropanation 
in vivo. Whole cell catalysis is capable of generating 27 g/L of cyclopropanes with 
high enantioselectivity (99% eecis). E. coli cells expressing this mutant can be 
lyophilized with cryoprotectant and stored for weeks without loss of activity or 
selectivity. 
Table 6.1. Reduction potentials of ferric P450 and redox active cofactors  
(pH 7)5,18,19  
 
a: ref 18. b: ref 19, c: ref 5, d: this work. 
6.5. Conclusions and Future Work 
We determined the reduction potentials of wild-type and mutant P450 enzymes 
using potentiometric redox titrations. Among the enzymes analyzed are a series of 
P450 BM3 mutants designed for cyclopropanation activity. Mutants containing 
serine-ligation have a formal reduction potential sufficiently positive to allow 
reduction by endogenously produced NADH, allowing the development of in vivo 
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cyclopropanation. Other mutations in and around the active site that are beneficial 
for cyclopropanation also affect reduction potentials more positive, but to a lesser 
degree; the combined axial and active site mutations are not directly additive. 
Potentiometric titration is limited to highly pure samples that are stable to 
reduction by dithionite, and accurate potentials cannot be determined for mutants 
that do not cleanly convert between ferric and ferrous forms. 
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6.7. Materials and Methods 
Chemicals 
All chemicals were used as received, without further purification. Buffer salts were 
obtained from J.T. Baker. Sodium dithionite (86%) was obtained from Fluka. 
Methyl viologen, benzyl viologen, hydroxynaphthoquinone, and potassium 
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ferricyanide were obtained from Sigma Aldrich. Solutions were prepared using 18 
MΩcm water unless otherwise noted. 
Instrumentation  
Electrochemistry was performed using a WaveNow potentiostat (Pine Research 
Instrumentation). Spectra were recorded using an Ocean Optics spectrometer 
(USB2000+). 
Procedures 
A detailed description of experimental protocols can be found in Appendix B. A 
brief description of the procedures is given below, highlighting any deviations 
from the general protocol. 
Preparation of samples for redox titration 
P450 BM3 mutants supplied by the Arnold group at Caltech. Enzyme samples 
included: wild type, C400S, C400M, C400Y, C400A, C400H, and P45013-Cys, 
(referred to elsewhere as BM3-CIS: V78A, F87V, P142S, T175I, A184V, S226R, 
H236Q, E252G, T268A, A290V, L353V, I366V, E442K), P41113-Ser (referred to 
elsewhere as P411-CIS; the same as P45013-Cys with an additional mutation: 
C400S).  
Enzyme samples were buffer-exchanged into 100 mM KPO4, 100 mM KCl, pH 7.4. 
and deoxygenated via 4 x 20 gentle pump-backfill cycles with argon, with care 
taken to avoid bubbling.  
Water was sparged for 2-3 hours, followed by three cycles of freeze-pump-thaw in 
an ice/salt/water bath (–10 °C). Pre-weighed, dry salts (buffers, mediators) were 
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pumped into the glovebox, and stock solutions were prepared by addition of 
deoxygenated water in the anaerobic atmosphere glovebox. To verify buffer pH, a 
small sample was removed from the glovebox and measured by pH meter. 
Dithionite solutions were made fresh (within the box) for each titration, and 
potassium ferricyanide solutions were remade every few days. 
Protein samples consisted of approximately 600 μL of 50-100 μM enzyme with the 
following mediators added to ensure electrochemical communication between the 
protein and electrode: 4 μM methyl viologen (MV), 8 μM benzyl viologen (BzV), 
12 μM 2-hydroxy-1,4-naphthaquinone.  
Potentiometric redox titration 
Enzyme samples were titrated by addition of ~2 μL aliquots of 1-4 mM sodium 
dithionite stock. The open circuit potential (OCP) of the cell was monitored over a 
10-min equilibration period; if the drift was more than 15 mV/ 10 min, the OCP 
was monitored for an additional 5-10 minutes (or until stable). The final OCP 
value was used to construct the titration curve. Absorption spectra were recorded 
at the beginning and end of each OCP measurement to assess enzyme stability; the 
latter spectrum was used to construct the titration curve. Each spectrum was 
vertically adjusted to achieve zero baseline in the 750-800 nm region (ΔAadjust < 
0.015 OD). Percent Fe(II) was achieved by using a Matlab script (see Appendix D). 
The midpoint potential was determined by least-squares fitting to a single one 
one-electron Nernst curve. 
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PHOTOCHEMICAL OXIDATION OF  
NITRIC OXIDE SYNTHASE 
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A.1. Introduction to Nitric Oxide Synthases 
Nitric oxide (NO) is a biological regulator and signaling molecule, and is involved 
in immune response of eukaryotes.1,2 Biological NO production is catalyzed by 
Nitric Oxide Synthase (NOS), a heme monooxygenase that shares the thiolate-
ligation motif with chloroperoxidase and cytochrome P450. Three isoforms of 
NOS exist in mammals, including endothelial, inducible, and neuronal NOS. All 
three isoforms exist as homodimers, and are composed of two domains  
(Figure A.1).3 The oxygenase domain contains the thiolate-ligated heme and the 
redox cofactor tetrahydrobiopterin (THB or H4B). The calmodulin-linked 
reductase domain contains the flavin cofactors flavin adenine dinucleotide (FAD) 
and flavin mononucleotide (FMN); this domain is responsible for delivering 
electrons to the heme.  
 
Figure A.1. Cartoon of the NOS homodimeric structure, highlighting pathways 
for electron flow (reproduced from ref. 10, Thesis by G. E. Keller). 
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Recently, NOS-like enzymes have also been found in bacteria (Figure A.2).4,5 
These enzymes have strong structural and sequence similarities to their 
mammalian counterparts, though many are composed solely of the oxygenase 
domain (and lack the reductase domain).6 Bacterial NOS enzymes have been 
shown to produce NO in vitro and in vivo,6 and can be used as more stable 
homologues in which to study aspects of NOS catalysis.  
 
Figure A.2. Dimeric structure of NOS from Geobacillus stearothermophilus.  
PDB: 2FLQ. 
NOS catalyzes the production of NO in two turnovers from L-arginine, releasing  
L-citruline as a biproduct (Figure A.3). Many aspects of the catalytic cycle have yet 
to be determined for NOS, including the identity of the catalytically active species. 
However, the first turnover is believed to be similar to P450 catalysis, involving 
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production of a ferryl-ligand radical cation species known as compound I (CI) 
(Figure A.4, blue arrows).  
 
Figure A.3. NOS-catalyzed production of nitric oxide from L-arginine. 
 
Figure A.4. Proposed catalytic cycle for NOS. Blue arrows indicate the first 
turnover, green arrows indicate the second turnover. Possible catalytically active 
species are in brackets.  
In both turnovers, two reductive electron transfers (ET) steps activate molecular 
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electrons are relayed to the heme via flavin cofactors from a reductase domain, the 
second electron in NOS catalysis is delivered from the bound THB cofactor. The 
active species (proposed to be CI) hydroxylates the guanidinyl nitrogen of L-
arginine, producing N-hydroxy-L-arginine as a stable, bound intermediate, and 
regenerating the resting (ferric) form of the enzyme. The second turnover, which 
produce NO, is an odd-electron process that is unique in biology.7 Again, an 
equivalent of molecular oxygen is activated, to form either a CI or ferric-peroxo 
active species (Figure A.4, in brackets). N-hydroxy-L-arginine is oxidized to 
produce L-citrulline and release nitric oxide. Full NO production requires THB; in 
the absence of this cofactor, nitrite and cyano-ornithine are produced rather than 
nitric oxide and citrulline.8 
As described in Chapters 2-5, we developed photosensitizer-P450 conjugates that 
replace native ET partners with ruthenium diimine complexes that are bound to 
the P450 surface at a non-native cysteine. Laser-triggered flash-quench methods 
(Figure A.5, described in Chapter 1) allowed rapid oxidation or reduction of the 
P450 heme, on the microsecond timescale. 
 
Figure A.5. Flash-quench cycle for oxidizing the heme active site (Fe). 
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Inspired by the proposed similarities, and intriguing differences, between NOS and 
P450 catalytic cycles, we set out to determine whether similar flash-quench of Ru-
NOS conjugates could be used to probe NOS catalysis. In particular, we were 
interested in investigating the thermophilic bacterial NOS from Geobacillus 
stearothermophilus (gsNOS), which has been examined by other members of the 
Gray group.9,10 This Appendix describes the development and photophysical 
characterization of Ru-NOS conjugates, and analysis of photochemical NOS 
oxidation using time-resolved transient absorption (TA) studies. 
A.2. Results 
A.2.1. Ru-photosensitizer conjugation 
Selection of NOS mutant and Ru photosensitizer 
Analogous to the Ru-P450 systems, cysteine-specific labeling was chosen to 
covalently tether the ruthenium photosensitizer. A mutant enzyme containing a 
single surface-exposed cysteine was designed by Dr. Charlotte Whited (Figure 
A.6). Two native, surface-exposed cysteines have been removed by mutagenesis: 
C227S/C269S, and a single cysteine installed: K115C. The exposed cysteine 
(K115C) is distant from the dimer interface, and it was anticipated that Ru-
labeling at this site would not perturb dimer formation.  
We have labeled K115C gs NOS with the photosensitizer [Ru(2,2´-bipyridine)2(5-
iodoacetamido-1,10-phenanthroline)]2+ (abbreviated [Ru(bpy)2(IAphen)]2+), in 
analogy to studies with cytochrome P450. Ru-NOS conjugation is achieved in high 
yield within 4 hours at 4 °C.  
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Figure A.6. Location of the photosensitizer tethering site. The NOS heme is 
colored red, K115C is highlighted in yellow. Top: Four native cysteines (including 
the one that ligates the heme) are circled in orange. Bottom: Space filling model, 
showing surface exposure of K115C, away from the dimer interface.  
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Characterization of Ru-NOS 
The Ru-NOS conjugate has been characterized by mass spectrometry and UV-
visible absorption (Figure A.7). The mass of Ru-NOS (MW = 44,516 Da) 
corresponds to that of apo (heme-free) K115C NOS (MW = 43866) plus the mass 
of the photosensitizer minus the mass of iodide (MW = 652 Da). In addition to 
typical NOS Soret and Q-bands, the absorption spectrum of Ru-NOS clearly shows 
a shoulder at 450 nm, which is attributed to photosensitizer absorbance. The 
crystal structure of this conjugate, RuC115-NOS, has been obtained by the Crane 
laboratory in collaboration with Dr. Gretchen Keller (Figure A.8).10 
 
Figure A.7. UV-visible absorption of unlabeled and labeled Ru-NOS and free 
photosensitizer.  
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Figure A.8. Structure of Ru-NOS. The Ru-NOS dimer is shown in gray and cyan; 
the latter monomer is overlayed with wild-type NOS (green, PDB 2FLQ). The 
tethered Ru complex is colored pink. Figure reproduced from ref 10, G. E. Keller. 
 
Figure A.9. Tryptophan 243 is located between the photosensitizer and heme in 
Ru-NOS. The Ru-Fe distance is 25 Å. Figure reproduced from ref 10, G.E. Keller. 
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A.2.2. Ru-NOS Luminescence  
All time-resolved experiments are performed using deoxygenated samples (see 
sample preparation in Materials and Methods). 
As described in Chapters 2, the free [Ru(bpy)2(Aphen)]2+ photosensitizer is 
emissive (λmax=620 nm) when excited with blue light (e.g., 480 nm). The time-
resolved luminescence decay of this complex in deoxygenated water can be fit to a 
monoexponential decay with a lifetime of 720 ns. In contrast, the time-resolved 
luminescence decay of Ru-NOS is clearly biexponential (Figure A.10). In 
deoxygenated buffer (50 mM sodium borate, pH 8), the major decay component 
(~75%) has a decay constant τA = 150 ns, while the minor component (~25%) is 
significantly longer, with τB = 1100 ns. Bi-exponential luminescence decay also was 
observed for Ru-P450 conjugates (see Chapters 2 and 3), and was attributed to 
multiple conformations of the photosensitizer that do not exchange on the 
timescale of luminescence decay.  
Given the dimeric nature of NOS in solution,9 we were interested to investigate 
whether this biexponential luminescence was related to a monomer-dimer 
equilibrium. The ratio of major and minor decay components is invariant over a 
Ru-NOS concentration range of 1-20 μM (Table A.1). This ratio and 
concentration-independence is identical at high ionic strength (500 mM sodium 
chloride) (Table A.2). Interestingly, the luminescence decay rate of the major 
component is affected by ionic strength, while the minor component is not 
(Figure A.11). 
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Figure A.10. Top: Luminescence decay of Ru-K115C NOS, fit to a single (red) 
and double (blue) exponential function. Bottom: Residuals from mono- (red) and 
bi- (blue) exponential fits. 
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Table A.1.  Luminescence lifetimes of Ru-NOS in 50 mM borate buffer, pH 8. A 
and B are the major and minor components of biexponential decay, respectively. 
 
 
Table A.2.  Luminescence lifetimes of Ru-NOS in 500 mM sodium chloride, 50 
mM borate buffer, pH 8. A and B are the major and minor components of 
biexponential decay, respectively. 
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Figure A.11.  Luminescence lifetimes of Ru-NOS at varying ionic strengths. Major 
(blue) and minor (green) decay components are plotted with respect to 
concentration of sodium chloride.  
Luminescence quenching with [RuIII(NH3)6]3+ 
We also examined ET quenching of the Ru-NOS excited state by [RuIII(NH3)6]3+. 
As observed for P450, addition of [RuIII(NH3)6]3+ causes protein precipitation in 
buffers of low ionic strength; this occurs for both Ru-labeled and unlabeled NOS 
samples. Little or no precipitation is observed for protein samples in buffers of 
high ionic strength (~200 mM sodium chloride). All quenching experiments are 
performed in buffers with 250 mM sodium chloride, in addition to 50 mM sodium 
borate, pH 8.  
Interestingly, the major component is significantly more affected by 
[RuIII(NH3)6]3+ concentration than the minor component (Figure A.12). 
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Additionally, the ratio of major-to-minor decay components increases at high 
quencher concentration (Figure A.13). 
 
Figure A.12. ET quenching of Ru-NOS with [RuIII(NH3)6]3+.  
 
Figure A.13. Relative amplitudes of the major (blue) and minor (green) 
luminescence decay components for Ru-NOS. 
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A.2.3. Transient Absorption  
As described for Ru-P450, both the Ru photosensitizer and NOS heme have strong 
electronic absorbance in the 390-440 nm region: NOS Soret ε(λmax: 400 nm) = 
79,000 M-1cm-1;9 [Ru(bpy)2(Aphen)]2+ ε(λmax: 450 nm) = 16,600 M-1cm-1.11 The 
shapes and positions of these electronic transitions are sensitive to metal oxidation 
state and environment; each species has a distinct absorption profile. By 
monitoring transient absorption (TA) at multiple wavelengths (390-440 nm) over 
time, we can identify the formation and decay of ET intermediates following laser 
excitation.  
TA data for flash-quench of Ru-NOS is shown in Figure A.14. As described in 
Chapters 2, 3 and 5, the initial transient absorption feature (10 ns) is a bleach 
(ΔOD < 0) at all wavelengths examined, with maximum ΔOD at 440 nm. Based on 
control studies of free photosensitizer, this feature is attributed to the 
photosensitizer excited state (*RuII-NOS). This feature decays by ET quenching to 
form the oxidized, RuIII-NOS species (~100 ns) that is characterized by a similar, 
bleached absorption profile. TA at 440 nm recovers to baseline within 20 μs. 
However, TA at 400 nm (λmax of the NOS Soret) remains bleached up to two orders 
of magnitude longer (2 ms). This is indicative of heme oxidation. 
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Figure A.14. Transient absorption data at six wavelengths for flash-quenched Ru-
NOS.  
In order to determine the number of kinetics components associated with Ru-NOS 
kinetics, and therefore, the number of species, we have subjected TA data at six 
wavelengths to truncated generalized singular value decomposition analysis 
(tgSVD) (Regularization Tools, Per Christian Hansen,12 see sample script in 
Appendix D). The plot of the tgSVD shows the magnitude (y-axis) of the 
contribution of each rate constant k (x-axis) to the overall fitting of the transient 
absorption data. Grouping of the rate constants into three clusters indicates that as 
many as three distinct kinetic phases contribute to the recovery of TA signals to 
baseline. This is different from analysis of Ru-P450 TA data, in which 5 kinetics 
phases were identified. 
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Figure A.15. tgSVD of TA data for flash-quench of Ru-NOS. Red: 440 nm; yellow: 
430 nm, green: 420 nm; cyan: 410 nm; blue: 400 nm; black: 390 nm. 
We have used the position of each grouping in the tgSVD analysis as an initial 
guess for multiexponential fitting. Starting with these rate constants, we have 
performed a global least-squares fitting of the TA data recorded at six wavelengths 
(390, 400, 410, 420, 430, 440 nm), to a sum of three exponentials with amplitude 
coefficients ρ1-3 and observed rate constants γ1-3 (Equation A.1, Table A.3) (see a 
sample fitting script in Appendix D).  
 
€ 
TA(λn ) = ρn1 exp γ1t( ) + ρn2 exp γ 2t( ) + ρn3 exp γ 3t( )  A.1 
Table A.3.  Rate constants extracted from global fitting of TA data. 
 
	   247	  
 
Figure A.16.  Global fitting of TA data at six wavelengths. 
We can compare the transient features for flash-quenched Ru-NOS to those 
observed for Ru-P450. In the latter case (see Chapter 2), bleaching of Soret 
wavelengths on the microsecond-to-millisecond timescale was attributed to 
formation of porphyrin radical species. These transient intermediates converted to 
high-valent compound II, which was characterized by a red-shifting of the Soret 
band. The transient species for flash-quenched Ru-NOS that appears from 10 μs – 
2 ms is characterized by bleaching of the NOS Soret (400 nm). This is consistent 
with formation of the porphyrin radical. No additional intermediates were 
observed. 
A.3. Discussion 
Conjugation of [Ru(bpy)2(Aphen)]2+ at non-native cysteine115 generates a Ru-
NOS conjugate with a Ru-Fe distance of 25 Å; this is very similar to the analogous 
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distance in Ru-P450 conjugates. Interestingly, there is also an intervening 
tryptophan (residue 243) between the photosensitizer and heme. This residue may 
play a role in facilitating oxidative ET in Ru-NOS, as observed for Ru-P450 (see 
Chapters 3 and 4). Site directed mutagenesis to modify this residue would help 
elucidate whether transient oxidation of tryptophan243 facilitates ET over the 25-
Å distance. 
The biexponential luminescence decay of Ru-NOS indicates the presence of two 
photosensitizer conformations that do not exchange on the timescale of the 
luminescence decay. The relative ratio of major and minor decay components (τA 
and τB, respectively) is not affected by Ru-NOS concentration, nor by the ionic 
strength of the buffer. This suggests that the two conformations are not a result of 
monomer-dimer equilibrium. τA is significantly shorter (150 ns vs. 1100 ns), and 
its decay rate is more affected by ionic strength and quencher concentration than 
is τB. We suggest that the major component arises from a conformation in which 
the photosensitizer is more solvent exposed, while the minor component is 
attributed to a conformation in which the photosensitizer is nestled against the 
protein framework, possibly through hydrophobic contacts. 
ET quenching of the RuII-NOS excited state with [RuIII(NH3)6]3+ generates a RuIII-
NOS species within 100 ns, which in turn oxidizes the NOS active site  
(Figure A.17). We can compare the transient features for flash-quenched Ru-NOS 
to those observed for Ru-P450. In the latter case (see Chapter 2), bleaching of Soret 
wavelengths on the microsecond-to-millisecond timescale was attributed to 
formation of porphyrin radical species. These transient intermediates converted to 
high-valent compound II, which was characterized by a red-shifting of the Soret 
band. The transient species for flash-quenched Ru-NOS that appears from 10 μs – 
2 ms is characterized by bleaching of the NOS Soret (400 nm). Thus, we tentatively 
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assign this species as a porphyrin radical cation. No additional intermediates were 
observed for Ru-NOS. 
 
Figure A.17.  Scheme for photochemical oxidation of the NOS heme. 
A.4. Conclusion 
We have developed Ru-NOS conjugates for photo-triggered ET oxidation of the 
NOS active site. Transient absorption data indicate rapid oxidation of the NOS 
heme, with a rate constant of (25 μs). We suggest that this proceeds via formation 
of the porphyrin radical cation, with no evidence of CII formation. Additional 
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A.6. Materials and Methods 
Plasmid for the triple mutant C227S/C269S/K115C NOS with a 6-histidine tag in 
the pACYCDuet-1 vector (chloramphenicol resistance) was provided by Dr. 
Charlotte Whited.  
Expression Protocols 
Plasmid was transformed into BL21DE3 cells (see Appendix B). Overnight 
cultures of Luria Bertani broth (LB) (25 mL) containing 34 µg/mL 
chloramphenicol and a single E. coli colony (transformed with the mutant plasmid 
of interest) were incubated at 37 °C overnight, shaking at 180-200 rpm. Induction 
cultures of LB (3 x 2L) containing 34 µg/mL chloramphenicol were inoculated 
with the overnight culture and incubated at 37 °C until reaching an optical density 
of ~1 at 600 nm (~3 hours). Cultures are induced by addition of 1 mM IPTG , and 
0.5 mM α-aminolevulenic acid (a heme precursor) and 1 mM FeCl3 is added 
(values refer to final concentrations in the induction flask). After 24 hours of 
expression, cells were harvested by centrifugation (5000 rpm, 10 min), and cell 
pellets are stored at -80 °C until needed. 
Extraction and purification 
Cell pellets were resuspended in cold Resuspension Buffer (50 mM HEPES pH 7.5, 
500 mM sodium chloride, 5 mM imidazole). A small spatula tip each of two 
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protease inhibitors (benzamidine hydrochloride and Pefabloc SC) were added, and 
cells were lysed by five cycles of probe-tip sonication (2s on, 2s off, repeat for 2 
minutes), cooled by an ice-water bath. Centrifugation (16,000 rpm, 1 hr, 8 °C) 
pelleted cellular debris, the supernatant was filtered through 0.22 μM filters and 
loaded onto a HiPrep HisTrap Ni FPLC column (GE Healthcare) equilibrated with 
Wash Buffer (50 mM HEPES pH 7.5, 500 mM sodium chloride, 10 mM 
imidazole). After thorough washing with Wash Buffer, protein was eluted with 
Elution Buffer (300 mM imidazole in Wash Buffer), and the colored (red/orange) 
fractions are collected.  
100 μL of thrombin was added, and the solution was gently agitated at 4 °C 
overnight to cleave the 6-histidine tag. Following cleavage, the enzyme sample was 
concentrated using 30 kDa centrifugal filters and subjected to gel filtration  on a 
Superdex 200 FPLC column equilibrated with 50 mM Tris, 150 mM sodium 
chloride, pH 7.5. Samples were buffer exchanged into 20 mM Tris, pH 7.5 with 20 
mM dithiothreitol to reduce intermolecular disulfide bonds. Samples were 
characterized by UV-vis absorption (A420/A280), SDS-PAGE, and mass 
spectrometry. Protein not intended for immediate use was flash-frozen in liquid 
nitrogen (with 40% glycerol added to solution as cryoprotectant) and stored at -
80°C. 
Ru-NOS conjugation and purification 
Photosensitizer synthesis and Ru-enzyme conjugation protocols are described in 
Appendix B. Ruthenium-labeled and unlabeled NOS were separated by FPLC 
using a HiTrap Q (GE Healthcare). FPLC Buffers A (column equilibration) and B 
(elution) were 20 mM Tris, pH 8, and 20 mM Tris, 500 mM sodium chloride, pH 
8, respectively. After loading the Ru-NOS sample, the column was washed (3 
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ml/min) with buffer A until absorbance returned to baseline. The gradient was 
ramped to 25% (5 min), followed by a slow gradient 25-70% Buffer B over 60 min. 
Laser sample preparation, and instrument and data acquisition details for transient 
luminescence and absorption details are described in Appendix B.  
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B.1. Instrumentation 
Polymerase Chain Reaction (PCR) was performed on a MJ Research PT150 
Minicycler. UV-visible absorbance spectra were obtained on an Agilent 8453 diode 
array spectrophotometer. Mass spectrometry was performed using MALDI-TOF 
in the Mass Spectrometry Facility at Caltech, or LC-MS at the Caltech 
Protein/Peptide MicroAnalytical Laboratory (PPMAL). Fast protein liquid 
chromatography (FPLC) was performed on an AKTApurifier FPLC (GE 
Healthcare) using HiPrep desalting, HiPrep Q anion exchange, and Superdex 75 
gel filtration columns. Steady-state fluorescence spectra were acquired on a Jobin 
Yvon Spec Fluorolog®-3-11 fluorometer. 
B.2. Site-directed mutagenesis 
Mutations to the P450 gene were made using Qiagen QuikChange site-directed 
mutagenesis kit. Samples were prepared on ice:  
38.5 μL milliQ water 
5 μL Buffer stock (10X) 
2 μL parent plasmid,  
1.25 μL of forward primer 
1.25 μL of reverse primer 
1 μL dNTPs.  
 
1 μL of enzyme was added to this mixture as the final component.  
The following PCR protocol was used: 
1. 95 °C  1 min 
2. 55°C  1 min 
3. 68°C  8 min 
4. Repeat steps 1-3, x 17 
5. 4°C  4 hrs (until pickup) 
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 Digestion of methylated DNA (parent plasmid) is achieved by addition of 1 μL 
dpn1 enzyme and incubation at 37 °C for one hour, followed by denaturation at 65 
°C for 15 minutes. The PCR mixtures are stored at –20 °C until needed. 
B.3. Transformation Protocol 
Plasmid for the desired mutant (1-2 μL) is incubated on ice with (ultra)competent 
cells (30-50 μL) for 30 min, followed by 45 seconds of heat shock at 42 °C. 
Following an additional 2 minute incubation on ice, NZY+ broth (250 μL) is added 
and the transformation mixture is incubated for 1 hour at 37 °C with gentle 
agitation. 5-150 μL of the transformation mixture are plated on LB/Agar culture 
plates containing 100 µg/mL ampicillin. These are incubated overnight at 37 °C; 
BL21-DE3 cells are incubated ~16 hours, XL-1 Blue/Nova Blue are incubated 24 
hours. 
B.4. Amplification and purification of plasmid DNA 
To amplify plasmid DNA, such as for sequencing, the purified plasmid DNA or 
PCR mixture is transformed into XL-1 Blue or Nova Blue supercompetent cells 
(see Transformation Protocol). 
Overnight cultures containing 5 mL Luria Bertani broth, 100 μL/mL ampicillin, 
and a single E. coli colony are grown for 16 hours at 37 °C. Cells are pelleted by 
centrifugation (10 min, 5000 rpm), and supernatant is discarded. Plasmid DNA is 
extracted using a Qiagen miniprep kit. To verify successful mutagenesis, 10 μL 
samples are submitted for sequencing (Laragen) along with sequencing primers. A 
combination of forward (ptac-ptac promoter: TTGACAATTAATCATCGGC, 
TM=53.7 °C) and reverse (pCWrev: CTTTCGTCTTCAAGCAGATCTG, TM=60.8 
°C) primers are used to sequence the entire P450 gene. 
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B.5. P450 overexpression in E. coli, extraction and purification 
All P450 mutants were expressed in E. coli BL21(DE3) cells, with minor differences 
for P450-BM3 and CYP119 variants. 
Expression 
Overnight cultures of Luria Bertani broth (25 mL) containing 100 µg/mL 
ampicillin and a single E. coli colony (transformed with the mutant plasmid of 
interest) are incubated at 37 °C overnight, shaking at 180-200 rpm. Induction 
cultures of TB (1x TB for P450 BM3, 2x TB for CYP119; 1L in 4L flask or 2 L in 6L 
flask) containing 200 µg/mL ampicillin, 1 µM thiamine, 0.4% glycerol, and 250 µL 
mineral supplements (100 mM FeCl3, 10 mM ZnCl2, 8.5 mM CoCl2, 8.5 mM 
Na2MoO4, 7 mM CaCl2, 7.5 mM CuCl2 , 8 mM H3BO3), are inoculated with the 
overnight culture and incubated at 37 °C until reaching an optical density of ~1 at 
600 nm. Cultures are induced by addition of 1 mM IPTG, and 0.5 mM α-
aminolevulenic acid, a heme precursor, is added. The temperature is lowered to 30 
°C; the P450 BM3 expression period is 24 hours, CYP119 expression period is 40 
hours. Following expression, cells are harvested by centrifugation (5000 rpm, 10 
min), and cell pellets are stored at –80 °C until needed. 
Extraction and purification 
Cell pellets are resuspended in cold Wash Buffer (50 mM Tris pH 8, 300 mM 
sodium chloride, 20 mM imidazole). A small spatula tip each of two protease 
inhibitors (benzamidine hydrochloride and Pefabloc SC) are added, and cells are 
lysed by two to three cycles of probe-tip sonication (0.5 s on, 0.5 s off, for 5 
minutes), cooled by an ice-water bath. 
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Centrifugation (15,000 rpm, 1 hr, 8 °C) pellets cellular debris, and the supernatant 
is loaded directly onto a Ni batch column. After thorough washing with Wash 
Buffer (1.5-2 L), protein is eluted (200 mM imidazole in Wash Buffer), and the 
colored (red/orange) fractions are collected and concentrated in 30 kDa 
centrifugal filters. Gel filtration chromatography is used to remove fragmented 
proteins, followed by buffer exchange into 20 mM Tris, pH 8 with 20 mM 
dithiothreitol (DTT) added to reduce intermolecular disulfide bonds. Purity is 
determined by UV-vis absorption (A420/A280), SDS-PAGE, and mass spectrometry. 
Protein not intended for immediate use is flash-frozen in liquid nitrogen (with 
40% glycerol added to solution as cryoprotectant) and stored at -80°C. 
B.6. Ru-P450 conjugation 
The complex [Ru(bpy)2(IA-phen)]2+ (IA-phen = 5-iodoacetamido-1,10-
phenanthroline) was covalently coupled to P450 mutants containing a single, 
surface exposed cysteine, to afford the respective RuII-FeIIIP450 conjugates. 
Approximately three-fold excess of [Ru(bpy)2(IA-phen)]2+ is added to a 20 μM  
solution of P450 mutant in 20 mM Tris buffer (pH 8), and shaken in the dark at 4 
°C. Labeling progress can be monitored by MALDI mass spectrometry; no further 
increase in the peak corresponding to the predicted mass of RuII-P450 is observed 
after two hours. Excess [Ru(bpy)2(IA-phen)]2+ is removed during concentration in 
30 kDa filters, followed by desalting on an FPLC HiPrep column.  
To separate photosensitizer-labeled and unlabeled enzymes, protein samples are 
loaded onto an anion exchange MonoQ or HiPrep Q column equilibrated with 20 
mM Tris buffer, pH 8 (Q Wash Buffer). The column is washed with Q Wash 
Buffer until UV-visible absorbances return to baseline. The gradient is ramped 
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quickly to 59% Q Elution Buffer (Q Wash Buffer + 250 mM sodium chloride), 
followed by a slow gradient of 59-65% Q Elution Buffer over 60 minutes. 
B.7. Preparation of laser samples 
Laser samples are composed of approximately 10 μM RuII-FeIIIP450 or the model 
complex [Ru(bpy)2(IAphen)]2+, with and without oxidative quencher (17 mM 
[RuIII(NH3)6]3+) in buffered solution (pH 6: 20 mM sodium acetate; pH 7: 20 mM 
sodium acetate; pH 8: 50 mM sodium borate or 50 mM Tris). High ionic strength 
(100-200 mM sodium chloride) helps to prevent protein precipitation in the 
presence of quencher. Samples are placed in a specialized, high-vacuum, four-
sided quartz cuvette (Starna Cells) with a high-vacuum Teflon valve (Kontes) and 
14/20 adaptor (Figure B.1), equipped with a small stir bar (1 x 3 mm). Solutions 
are stirred constantly during deoxygenation and data collection. Deoxygenation is 
achieved via 3 x 10-15 gentle pump-backfill cycles with argon on a Schlenk line, 
with 15 minutes of equilibration between each set of cycles.  
     
Figure B.1. Two high-vacuum cuvettes for laser studies. Left: typical cuvette for 
flash-quench. Right: cuvette for FeII-CO photolysis and rebinding. 
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B.8. Laser details 
Nanosecond-to-second transient spectroscopies 
Excitation for nanosecond-to-millisecond transient luminescence and absorption 
experiments was provided by visible light (e.g., 480 nm) pulses from a tunable 
optical parametric oscillator (Spectra Physics, Quanta-Ray MOPO-700) pumped 
by the third harmonic from a Spectra Physics Q-switched Nd:YAG laser (Spectra-
Physics, Quanta-Ray PRO-Series, 8 ns pulse width) operated at 10 Hz.  
 
Figure B.2. Nanosecond-pulsed single-wavelength transient luminescence and 
absorption setup: NSI. 
The setup for single-wavelength transient luminescence and absorption studies 
(“NSI”) is shown in Figure B.2. Probe light was provided by a 75-W arc lamp (PTI 
Model A 1010) that could be operated in continuous or pulsed mode, and passed 
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through the sample collinearly with the excitation pulse. After rejection of 
scattered light by appropriate long- and short-pass filters, and intensity 
modulation by a neutral density filter, probe wavelengths were selected by a double 
monochromator (Instruments SA DH-10) with 1 mm slits. Transmitted light was 
detected by a photomultiplier tube (PMT, Hamamatsu R928), and amplified by a 
200 MHz wideband voltage amplifier DHPVA-200 (FEMTO). 
 
Figure B.3. Nanosecond-pulsed multi-wavelength transient absorption setup: 
NSII. 
The setup for multi-wavelength transient absorption studies (“NSII”) is shown in 
Figure B.3. Probe light was provided by white flashlamp, and transmitted to the 
sample by fiberoptic cables. A partial reflector directed approximately 30% of the 
probe light around the sample as a references beam, while the majority was aligned 
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through the sample, collinearly with the excitation beam. Scattered excitation light 
was rejected by a narrow notch filter (centered at 486 nm), and the transmitted 
probe light was detected into two photodiode arrays (Ocean Optics S1024DW 
Deep Well Spectrometer). Measurements were made with: neither probe light nor 
excitation light (dark correction), probe light only (background), excitation light 
only (fluorescence correction), and probe light and excitation light (TA). The 
timing of laser fire, flashlamp fire, and photodiode array readout were controlled 
by a series of timing circuits, and the readout was interfaced with a PC via a 
National Instruments multifunction input/output card. Difference spectra were 
averaged over approximately 150 shots. 
  
Figure B.4. NSI instrument response to scattered laser light, collected on a 2 μs 
window (pulse width: 8 ns).  
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Picosecond-to-nanosecond transient spectroscopy 
The setup for picosecond-pulsed single wavelength transient absorption 
measurements is shown in Figure B.5. 
 
Figure B.5. Picosecond-pulsed single-wavelength transient absorption setup: 
PSI. 
Excitation pulses for picosecond single-wavelength transient absorption 
measurements were generated by a Continuum Regenerative Amplifier (RGA 60 
Series) operated at 10 Hz, seeded by a 70 MHz train provided by the first harmonic 
(1064 nm) of a mode-locked DPSS Nd:YAG (Spectra Physics Vanguard 2000 
HM532). A small portion of the seed laser (2nd harmonic, 532 nm output) was used 
for timing. The excitation pulse (pulse width ~10 ps) was tuned to the second 
harmonic (532 nm) by a harmonic generator, and converted to circularly polarized 
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light by a Berek Retardation Polarizer Compensator (5540) operating in ¼ wave 
plate mode, before being directed through the sample. Continuous probe light was 
provided by a Sony 405 nm 100 mW focusable laser diode. After passing through 
the sample, excitation pulses were rejected using a 532 diochroic mirror, and probe 
light was tramsitted through a monochromator and into a picosecond streak 
camera (C5680 Hamamatsu Photonics) in photon counting mode, operated by a 
Hamamatsu controller. Samples were stirred continuously, with typical laser 
powers of 0.5-0.75 mJ/pulse. Kinetics traces were collected on 5 ns and 50 ns time 
windows, averaged over 10,000 exposures. 
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B.9. Data workup 
To generate a complete kinetics picture of TA data on the picosecond-to-second 
timescale, individual kinetics traces were log-compressed, overlaid, and spliced 
together.  
On the NSI system, timescales 400 μs and shorter were amplified and digitized by 
the fast amp/digitizer system, while timescales 10 ms and longer are amplified and 
digitized by the slow amp/digitizer. It was noted that transient absorption data 
using the slow amp had inconsistent magnitudes that could vary by a factor of 2-3 
when compared between different time-windows. Fast-amp traces were more self-
consistent. Thus, the magnitude of the fastest trace (2 μs window) was taken as the 
standard amplitude for each data set; TA data at other time-windows 
multiplicatively scaled to achieve overlap. 
Data collected on the picosecond streak camera had significantly lower signal-to-
noise ratios, and showed larger variations in intensity compared to ns1 data. When 
overlaying ps1 and ns1 data, the magnitude of the ns1 trace from the 2 μs window 
was taken as the standard amplitude for each data set, and other time-windows 
were multiplicatively scaled to achieve overlap. 
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C.1. Notes for Chapter 2 
Ru-P450 luminescence: dependence on concentration 
Normalized luminescence decays at four concentrations (2, 4, 8, 12 μM) are 
superimposable. 
 
Figure C.1. Luminescence decays of RuK97C-BM3 at four concentrations. Red: 2 
μM; Yellow: 4 μM; Green: 8 μM; Blue: 12 μM. 
Low-temperature experiments 
We have examined flash-quench of Ru-P450 BM3 at reduced temperatures to try 
and increase the lifetime of the observed compound II species. Solutions 
containing 25% glycerol enable examination of temperatures down to –15 °C. 
Luminescence lifetimes increase as temperature decreases, for both quenched and 
unquenched samples (Figure C.2). While it does appear that transient absorption 
features decay more slowly at low temperature, the magnitude of transient features 
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(and thus, yield of oxidized species) also decreases (Figure C.3). This strategy is 
unlikely to facilitate further characterization of photogenerated compound II. 
 
Figure C.2. Luminescence decays at variable temperature. Top: Quenched and 
unquenched luminescence decays of RuC97-BM3(W) at variable temperature. 
Bottom: Luminescence lifetimes at variable temperature. 
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Figure C.3. TA at variable temperature for RuK97C-P450 BM3(W), pH 6. 	  
C.2. Notes for Chapter 3 
Search for the tryptophan radical cation intermediate 
Tryptophan radical cation (W✚) and neutral radical (W) species absorb in the 
visible region, with approximate extinction coefficients of ε(λmax: 560 nm) = 3000 
M-1 cm-1 and ε(λmax: 510 nm) = 2300 M-1 cm-1, respectively.1 If such a radical 
species is indeed formed as a true intermediate along the multi-step electron 
transfer pathway, it is theoretically possible that we could observe it by transient 
absorption. Using the RuK97C-P450BM3(W96) system (in which we have observed 
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photochemical heme oxidation) we have examined TA of the 500-600 nm region 
to see if such an intermediate can be identified. 
We first examined flash-quench of the photosensitizer model complex 
[Ru(bpy)2(Aphen)]2+ to determine absorption components of the photosensitizer 
in this region. Approximate transient difference spectra at various timepoints were 
generated using ΔOD from single-wavelength data. We the examined RuK97C-
P450BM3(W96) and RuD77C-P450CYP119(HW76) , and generated analogous transient 
difference spectra. 
 
Figure C.4. Transient difference spectra of [Ru(bpy)2(Aphen)]2+ (top), RuK97C-
P450BM3(W96) (bottom left) and RuD77C-P450CYP119(H76W) (bottom right) at 
various time points following excitation at 480 nm and quenching with 
[Ru(NH3)6]3+. 
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As seen for [Ru(bpy)2(Aphen)]2+, the ruthenium excited state (*RuII) absorbs in the 
500-570 nm region. Photons from excited state emission give rise to the apparent 
bleach from 560-580 nm. The RuIII species is characterized by a bleach of the 
MLCT band, which tails into the 510-540 nm region; this species can be seen at 
300 ns and 30 μs timescales. There is no increase at 510 nm or 560 nm associated 
with the oxidized photosensitizer. 
If we are to identify any tryptophan radical species as true intermediates in the 
electron transfer pathway, we must observe their formation prior to that of heme 
oxidation (i.e., porphyrin radical cation formation); this occurs within 10 μs. 
Unfortunately, we are unable to detect any increases in absorbance on this 
timescale for the W-containing Ru-P450 conjugates. Additionally, TA on longer 
timescales are complicated by the P450 Q-bands; these also absorb in the 500-600 
nm with extinction coefficients > 10,000 M-1cm-1, and are expected to shift upon 
oxidation of the heme. It is quite likely that heme-associated TA signals will 
obscure any possibility of observing the tryptophan radical. 
C.3. Notes for Chapter 5 
Selection of probe wavelength for CO rebinding kinetics 
For single-wavelength transient absorption  measurements, it was observed that 
the arc-lamp probe light was enough to induce CO-photolysis and generate the 
inactive form: P420. Thus, a narrow bandpass filter (centered at 406 nm, Figure 
C.5) was used to reject the majority of the probe light. This wavelength has large 
ΔOD associated with the interconversion between FeII and FeII-CO forms, and is 
far enough from the Soret peak that it causes little photolysis. 
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Figure C.5. 406 nm narrow band pass filter. 
Overlay of PSI and NSI kinetics traces 
Single-wavelength transient absorption data collected on the picosecond-to-
nanosecond timescale (“PSI”) and the nanosecond-to-second timescale (“NSI”) 
overlay well when multiplicatively scaled. PSI data are significantly noisier, with 
potential variation in laser power or sample integrity over the course of the 
measurement; therefore, we have scaled PSI data to match the NSI data (Figure 
C.6). Signal averages for each timescale were: 5 ns (10,000); 50 ns (10,000); 2 μs 
(150); 2 μs (150); 100 μs (150); 10 ms (5). 
It is important to note that the scaled signal magnitude at time-zero (Figure C.6, 
magnitude of the red trace) is significantly larger than the maximum signal 
magnitude expected for this sample (~370 mOD vs. 270 mOD). Signal at very early 
timepoints (< 1 ns) may correspond to an excited state, associated with different 
absorptivities than the free FeII-CO. Until this magnitude discrepancy is resolved, 
it is not reliable to take the initial signal magnitude as the photolysis yield.  
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Figure C.6. Overlay of PSI and NSI data for CO rebinding kinetics in CYP119. 
PSI data (5 ns: red; 50 ns: green) is scaled by ~0.5 to overlay with NSI data (2 μs – 
10 ms: blue). 
Nonlinear least squares fitting of CO rebinding kinetics at various temperatures 
We have subjected picosecond-to-millisecond TA data (collected at temperatures 
10-70 °C) to a non-negative least squares fitting method (Figure C.7, see 
Appendix D for sample matlab script). The positive amplitudes at rate constants 
(log10(k)) greater than 10 are faster than the instrument response; these are an 
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Figure C.7. Rate constant amplitudes from nnls fitting of CO rebinding ps-to-ms 
TA data at various temperatures. Purple: 10 °C; Blue: 20 °C; Cyan: 30 °C; Green: 40 
°C; Yellow: 50 °C; Orange: 60 °C; Red: 70 °C. 
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C.4. Notes for Chapter 6 
Determination of ferrous/ferric ratio 
We have used a Matlab script (appendix D) to determine the ferrous/ferric ratio in 
each intermediate spectrum during potentiometric titration. An example is shown 
below: all ferrous is cyan, all ferric is green, the experimental data is blue, and the 
model, using 70% of the ferrous component, and 30% of the ferric component, is 
shown in red dashes. 
 
Figure C.8. Decomposition of a spectrum into ferric and ferrous components 
using the script: spectraldeconvoluter.m. 
Reproducibility 
The figure below shows potentiometric titrations for two batches of wild type P450 
BM3. The two protein samples were expressed and purified in separate labs (dark 
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green: Arnold group; light green: Gray group), measurements were performed 3 
months apart, using different electrodes (dark green: Pt mesh working, Pt wire 
counter, Ag/AgCl reference with vycor frit; light green: Au wire working, Pt wire 
counter, Ag/AgCl reference with salt bridge). The resulting potentials are within 
20 mV of one another. 
 
Figure C.9. Two separate potentiometric titrations of wild type P450 BM3. 
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D.1. Plotting x,y data: MEplotter 
The script MEplotter plots x and y data, including steady-state absorption spectra 
and single-wavelength transient absorption kinetics. 
MEplotter 
% TO PLOT WORKED-UP TRACES 
  
i=1; 
while i ~= 0 
% READ DATAFILE 
    [file,dirpath]=uigetfile('*.*'); 
    if isequal(file,0) || isequal(dirpath,0) 
        disp('no more') 
        i=0; 
        return 
    end 
    
    filet=[dirpath file]; 
    data=dlmread(filet); 
% EXTRACT X AND Y 
    xx=data(:,1);    
    yy=data(:,2); 
% PLOT 
    a=rand(3); 
    plot(xx,yy,'color',a(1:3)); 
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D.2. Time-resolved single-wavelength data workup 
Raw data collected on the ns1 (nanosecond pulsed, single-wavelength) system are 
saved into a “ *.ns1” file. This must first be converted to intensity vs. time 
(luminescence) or ΔOD vs. time (transient absorption) using the ns1_read.m 
script provided by Dr. Jay Winkler (available on the bilrc.caltech.edu website.) The 
ns1_read.m script saves the new, two column data as a .txt file, with time in the 
first column and intensity/ΔOD in the second. 
D.2.1. Time-zero adjustment 
The NSI instrumentation designates a “time-zero”. However, this designated time 
point is not always accurate, and can fluctuate by as much as 30 ns over the course 
of several months. All of the kinetics data in this Thesis are time-adjusted using 
xadjuster so that time-zero corresponds to the beginning of the rise in signal 
(within a few data points). 
xadjuster 
% xadjuster 
% To adjust x data to time=0 
  
i=1; 
while i ~= 0 
     
% READ DATAFILE 
    [file,dirpath]=uigetfile('*.*'); 
    if isequal(file,0) || isequal(dirpath,0) 
        disp('no more') 
        i=0; 
        return 
    end    
    filet=[dirpath file]; 
    data=dlmread(filet); 
     
%DETERMINE FILE PROPERTIES 
    data=dlmread(filet);                 %read raw file to var data 
    len=length(filet);                   %measure length of file name 
    file1=filet(1:len-4);                %remove the .dat 
    look=find(file1=='/');               %find all the / in the file 
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name 
    maxf=max(look)+1;                    %find the last / and index 1 
value past it (file name) 
    file2=file1(maxf:end);               %this was the file name 
    file3=double(file2);                 %file name converted to ascii 
     
% EXTRACT X AND Y 
    xx=data(:,1);    
    yy=data(:,2); 
% PLOT 
    a=rand(3); 
    plot(xx,yy,'b'); 
    hold 
  
% ASK FOR X-ADJUST 
    adjfactor=input('input the x offset (in seconds): '); 
    disp(adjfactor) 
    xnew=xx+adjfactor; 
    plot(xnew,yy,'r') 
    hold 
  
%WRITE DATA TO FILE 
        corcmp=[xnew yy]; 
        filecmp1=[file3, 100 46   116   120   116];   %Adds 'd.txt' to 
the end of the file name 
        filecmp2=char(filecmp1); 
        dlmwrite(filecmp2,corcmp,'precision',14);       %write a file 
of the adjusted xy data 
        disp(filecmp2);                                 %tell you the 
name of the new file 
  
end 
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D.2.2. Log-compression 
Data that would be subjected to (multi)exponential fitting protocols were log-
compressed, to avoid weighting of longer timepoints. The compress script was 
written to streamline this process. The function logtimej was modified from a 
script provided by Dr. Jay Winkler. In this case, compress sets the number of 
points per decade (ppd) to 600; the TA data in Chapters 2, 3, and most of Chapter 
5 used this compression. Picosecond TA data (ps1), and picosecond-to-
millisecond data overlays (Chapter 5 CO rebinding studies) were compressed to 
200 ppd. 
compress 
%COMPRESSES WORKED UP DATA, AND WRITES A NEW FILE 
clear 
  





    %READ DATAFILE 
        [file,dirpath]=uigetfile('/Users/Maraia/MATLAB/0Ahora/.dat');   
% -> CHANGE THIS TO YOUR DIRECTORY 
        if isequal(file,0) || isequal(dirpath,0)                        
% So it doesn't give an error if you press cancel 
            disp('cancelled!') 
            i=0; 
            return 
        end 
        %file=input('enter file path','s'); 
        filet=[dirpath file]; 
         
    %DETERMINE FILE PROPERTIES 
        data=dlmread(filet);                 %read raw file to var data 
        len=length(filet);                   %measure length of file 
name 
        file1=filet(1:len-4);                %remove the .dat 
        look=find(file1=='/');               %find all the / in the 
file name 
        maxf=max(look)+1;                    %find the last / and index 
1 value past it (file name) 
        file2=file1(maxf:end);               %this was the file name 
        file3=double(file2);                 %file name converted to 
ascii 
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    %EXTRACT X AND Y 
        t=data(:,1);                        %read the time data out to 
var xx 
        y=data(:,2);                        %read intensity out to yy 
        ppd=600;                            %points per decade 
         
        [tout,yout,wt] = logtimej(t,y,ppd); 
        tout=tout'; 
        yout=yout'; 
  
    %WRITE DATA TO FILE 
        corcmp=[tout yout]; 
        filecmp1=[file3, 99    46   116   120   116];   %Adds 'c.txt' 
to the end of the file name 
        filecmp2=char(filecmp1); 
        dlmwrite(filecmp2,corcmp,'precision',14);       %write a file 
of the adjusted xy data 
        disp(filecmp2);                                 %tell you the 
name of the new file 
end 
disp('compressed!'); 




%     function to convert y=f(t) data from linear in time 
%     to logarithmic in time 
% 
%     SYNTAX: 
%        [tout,yout,wt]=logtime(t,y,ppd) 
% 
%          t is the input time vector, linearly spaced 
%          y is the input y vector 
%          ppd is the number of points per decade for the output 
vectors 
%          tout is the new time vector space logarithmically 
%          yout is the new time vector space logarithmically 
%          wt is vector of weights giving the number of points averaged 
%                   to get the new yout value 
  
%Cut out time<0 data, which can't be plotted on a log scale 
ncount=1; 
while t(ncount)<=0 










if zt ~= zy 
   fprintf('ERROR: y and t vectors are different lengths') 
else 
  
   tmin=min(t); 
   tmax=max(t); 
% 
   ltmin=log10(tmin); 
   ltmax=log10(tmax); 
% 
   tt=ltmin:(1./(2.*ppd)):ltmax; 
   tt=10.^tt; 
   ztt=length(tt); 
% 
% 
   icount=1; 
   jcount=1; 
   for i=2:2:ztt 
      tout(jcount)=0; 
      yout(jcount)=0; 
      wt(jcount)=0; 
      while (icount < zt) & t(icount) < tt(i) 
        tout(jcount)=tout(jcount)+t(icount); 
        yout(jcount)=yout(jcount)+y(icount); 
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        wt(jcount)=wt(jcount)+1; 
        icount=icount+1; 
      end 
      if wt(jcount) ~= 0 
         tout(jcount)=tout(jcount)./wt(jcount); 
         yout(jcount)=yout(jcount)./wt(jcount); 
         jcount=jcount+1; 
      end 





	   285	  
D.3. Data-splicing 
In order to cover the (sub)nanosecond-to-second time range, log-compressed data 
taken at multiple timescales were spliced together to generate a complete trace. 
The script overlayer was used to import data for three timescales and 
multiplicatively scale at the users discretion. The function combine was used to 




%plots fastamp, slowamp, and no-stirring traces, and asks 
%for multiplyers to adjust the fast and no-stirring traces 
%so that they overlay better 
  
tscale=input('To splice 2us, 100us, and 10ms data, enter 1. \n To 
splice 100us, 10ms, 500ms data, enter 2. \n To splice 5ns, 50ns, and 
2us-500ms data, enter 3 ->'); 
  
% READ DATAFILES    
disp('select the fastest trace'); 
  
    [file,dirpath]=uigetfile('*.txt');  %opens a window to pick my file 
     if isequal(file,0) || isequal(dirpath,0) 
            disp('cancelled!') 
            hold 
            i=0; 
            return 
     end 
    filet=[dirpath file]; 
    data1=dlmread(filet); 
    
disp('select the corresponding middle trace-->'); 
  
    [file,dirpath]=uigetfile('*.txt');  %opens a window to pick my file 
    if isequal(file,0) || isequal(dirpath,0) 
            disp('cancelled!') 
            hold 
            i=0; 
            return 
    end 
    filet=[dirpath file]; 
    data2=dlmread(filet); 
     
disp('select the corresponding longest trace-->'); 
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    [file,dirpath]=uigetfile('*.txt');  %opens a window to pick my file 
    if isequal(file,0) || isequal(dirpath,0) 
            disp('cancelled!') 
            hold 
            i=0; 
            return 
    end 
    filet=[dirpath file]; 
    data3=dlmread(filet); 
     




















seguir=input('does it need adjustment? (y/n) ->', 's'); 
if seguir == 'n' 
    y1adj=y1; 
    y2adj=y2; 
    y3adj=y3; 
end 
  
while seguir == 'y'; 
    mult1=input('select a new first trace multiplier (default 1)->'); 
    if mult1 <= 0 
        mult1=1; 
        disp('defaulting multf=1'); 
    end 
    mult2=input('select a new second trace multiplier (default 1)->'); 
    if mult2 <= 0 
        mult2=1; 
        disp('defaulting mults=1'); 
    end 
    mult3=input('select a new third trace multiplier (default 1)->'); 
    if mult3 <= 0 
        mult3=1; 
        disp('defaulting multL=1'); 
    end 
     
    y1adj=mult1.*y1; 
    y2adj=mult2.*y2; 
    y3adj=mult3.*y3; 
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    semilogx(x1,y1adj,'r'); 
    hold 
    semilogx(x3,y3adj,'b'); 
    semilogx(x2,y2adj,'g'); 
    hold 
     












keep=input('do you want to keep this combined trace? (y/n)->', 's'); 
if keep == 'y'; 
    [Savefile,Savedirpath,Savefilter]=uiputfile([dirpath,'*.txt'],'Save 
overlayed traces',[dirpath,file]); 









%TO CREATE A SINGLE DATA SET COMBINING DATA FOR THREE TIMESCALES 
% INPUTS 
% vectors containing time (x) and delta OD (y) data 
% key:f,s & L are fast amp, slow amp, and no stirring.   
%   yf and yL are adjusted (hence yfadj, yLadj) by a multiplier to 
%   remove dicontinuities between the data from the three time ranges 
% 
% OUTPUTS 
% datac is a matrix with the combined time values in the first 
% column, and delta OD values in the second column 
  
%Timescales for different purposes 
if tscale == 1 
     
%For combining the 2us, 100us, 10ms data 
    time1l = 1e-9; 
    time1u = 1.5e-6; 
  
    time2l=1.5e-6;        
    time2u=0.5e-4;      %used to be 0.7e-4/0.4e-4 
  
    time3l=0.5e-4;     
     
elseif tscale == 2 
     
%For combining the 400us, 10ms, 500ms data 
    time1l = 1e-9; 
    time1u = 5e-5; 
  
    time2l=5e-5;        
    time2u=1e-3;   
  
    time3l=1e-3;  %USED to be 2.5e-3 
     
elseif tscale == 3 
     
%For combining the 5ns, 50ns, 2us-500ms data 
    time1l = 1e-12; 
    time1u = 3.5e-9; 
  
    time2l=3.5e-9;        
    time2u=35e-9;   
  
    time3l=35e-9;   
     
     
end 
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%ADJUSTING FIRST TRACE 
  
    %cycles to find indexes of the lower and upper bound times 
     
    xli=1; 
    while x1(xli) <= time1l 
        xli=xli+1; 
    end 
     
    xui=xli; 
    while x1(xui) <=time1u 
        xui=xui+1; 
    end 
     
    newx1=x1(1:xui); 
    newy1=y1adj(1:xui); 
    newx1=newx1'; 
    newy1=newy1'; 
     
% ADJUSTING SECOND TRACE 
     
    %cycles to find indexes of the lower and upper bound times 
    xli=1; 
    while x2(xli) <= time2l      
        xli=xli+1; 
    end 
     
    xui=xli; 
    while x2(xui) <=time2u 
        xui=xui+1; 
    end 
     
    newx2=x2(xli:xui); 
    newy2=y2adj(xli:xui); 
    newx2=newx2'; 
    newy2=newy2'; 
  
% ADJUSTING THIRD TRACE 
  
    %cycles to find indexes of the lower bound times 
    xli=1; 
    while x3(xli) <= time3l      
        xli=xli+1; 
    end 
     
    newx3=x3(xli:(end)); 
    newy3=y3adj(xli:(end)); 
    newx3=newx3'; 
    newy3=newy3'; 
     
%creates the combined trace 
combx=[newx1 newx2 newx3]; 
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hold 
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D.4. Singular Value Decomposition 
These scripts use truncated, generalized singular value decomposition (from 
Regularization Tools, Per Christian Hansen) to determine the number of kinetic 
components in single-wavelength transient absorption kinetics traces.  This can be 
done for a single kinetics trace using svder1, or accomplished and overlayed for six 








Adata=input('define the absorbance data vector  '); 
  
L=get_l(34,1); 
[UU sm XX]=cgsvd(Aspace,L); 
  
figure 
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svderMulti 
%svderMulti 








Adata=input('define the absorbance data MATRIX  '); 
  
L=get_l(34,1); 




trunc=input('enter the truncation value (<34) '); 
  
for icount = 1:6 
    X_L=tgsvd(UU,sm,XX,Adata(:,icount),trunc); 
















    barx(:,1)=X_LMat(ocount,:); 
    barx(:,2)=[1; 2; 3; 4; 5; 6;]; 
    barx(:,3)=abs(barx(:,1)); 
    barz=sortrows(barx,-3); 
    for incount=1:6; 
        ind=barz(incount,2); 
        bar(log10(kspace(ocount)),barz(incount,1),0.25,col(ind)); 
        %pause(1) 
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D.5. Multiexponential fitting 
A number of scripts are used to fit TA data to a sum of multiexponentials. 
nonlinear_fitter4 fits data to a sum of three and four exponentials, to compare 
fits. It uses the function autoresider to plot residuals and autocorrelation of 
residuals; these are used to determine whether deviations between data and fit are 
random or systematic (an additional exponent is indicated). MExpG_Fitter is 
used to globally fit data at multiple wavelengths to a sum of exponentials (defined 
by MExpG), using defined upper and lower bounds and initial guesses 
(MExpGvalues). 
nonlinear_fitter4 
%fitting kinetics data to a sum of exponentials 
  
%getting data 
xdata=input('define the x data:\n'); 




%defining fitting & parameters 
disp('we will be fitting to a sum of 3, 4 exponentials'); 
  
ft=fittype('a.*exp(-x.*2.2e7)+b.*exp(-x.*k2)+c.*exp(-x.*k3)+f'); 
%     a      b      c     f    k2    k3   
pu=[ 0.1,   0.3,    1,    1,  1e7,  5e6]; 
pl=[-0.1,  -0.4,   -1,   -1,  1e5,  5e2]; 











%used for all wavelengths 
ft2=fittype('a.*exp(-x.*2.2e7)+b.*exp(-x.*k2)+c.*exp(-x.*k3)+d.*exp(-
x.*k4)+f'); 
%     a      b      c     d    f     k2   k3    k4   
pu2=[ 0.1,     0.3,    1,   1,   1,   5e6,  5e5   1e4]; 
pl2=[-0.1,  -0.4,   -1,  -1,  -1,   5e5,  5e4   1e1]; 
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st2=[-0.02, -0.15, 0.1,   0,   0,   1e6,  1e5   1e3]; 
%pu=input('define upper bounds for a-e,k2-k5: 10 parameters\n'); 
%pl=input('define lower bounds for a-e,k2-k5: 10 parameters\n'); 






















%   Calculate and plot the autocorrelation of the residuals between 
ycalc and y 
% 

















    acorrin(1:len-aij,aij)=resid(aij+1:len); % 
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MExpGFitter 
%MultiExponential Global Fitter (fits to 6 wavelengths) 
%asking for data 
tvector=input('define the time vector -> '); 
dODdata=input('define the matrix of absorbance data -> '); 
  
x=tvector; 
%defining initial values and bounds 
[values,ubound,lbound] = MExpGvalues; 
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MExpG 
function [A]=MExpG(values,tvector) 
%UNTITLED Summary of this function goes here 
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MExpGvalues 
function [values,ubound,lbound] = MExpGvalues 
%UNTITLED2 Summary of this function goes here 
%   Detailed explanation goes here 
  
%defining initial values and bounds 
%'a' defines six pre-exponential terms corresponding to the first rate 
%constant, 'b' defines those pre-exponentials for the second rate 
constant, 
%and the same for 'c' 
a=[-0.2, -0.2, -0.2, -0.2, -0.2, -0.2]; 
b=[-0.15, -0.15, -0.15, -0.15, -0.15, -0.15]; 
c=[0.1, 0.1, 0.1, 0.1, 0.1, 0.1,]; 
f=[0.01, 0.01, 0.01, 0.01, 0.01, 0.01]; 
k=[2e7, 6e4, 1e3];              %these are the three exponential terms 
  
values=[a b c f k]; 
  
%upper bounds 
ua=[1, 1, 1, 1, 1, 1]; 
ub=[1, 1, 1, 1, 1, 1]; 
uc=[1, 1, 1, 1, 1, 1]; 
uf=[1, 1, 1, 1, 1, 1]; 
uk=[3e8,  5e6,  1e4]; 
  
ubound=[ua ub uc uf uk]; 
  
%lower bounds 
la=[-1, -1, -1, -1, -1, -1]; 
lb=[-1, -1, -1, -1, -1, -1]; 
lc=[-1, -1, -1, -1, -1, -1]; 
lf=[-1, -1, -1, -1, -1, -1]; 
lk=[1e6, 5e3, 5e0]; 
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D.6. Nonnegative least squares analysis 
Multiexponential kinetics data (with all positive magnitudes), such as fluorescence 
decays or CO rebinding in substrate-free P450 CYP119, can be examined using 
nonnegative least squares (nnls) fitting. This procedure requires that the data be 
log-compressed, and that the first time point be exactly zero. The nnls_prep script 
sets the initial time to zero and can be used to normalize data; the script 
nnls_grad_reg_r2_KT (written by Jay Winkler and modified by Kana Takematsu) 
does the fitting analysis. To further analyze the nnls outputs, the script Panalyzer 
and function Pmoments allow the user to define populations within the nnls 
histogram of rate constants and amplitude, and determine statistics (integrated 
amplitudes, first moment, and second and third centered moments) for each 
population. 
nnls_prep 
% nnls_prep  
% This script selects the maximum absorbance data point from x,y TA 
data, sets that time point to t=0, and 
% normalizes Y (absorbance) data 
  
i=1; 
while i ~= 0 
     
% READ DATAFILE 
    [file,dirpath]=uigetfile('*.*'); 
    if isequal(file,0) || isequal(dirpath,0) 
        disp('no more') 
        i=0; 
        return 
    end    
    filet=[dirpath file]; 
     
%DETERMINE FILE PROPERTIES 
    data=dlmread(filet);                 %read raw file to var data 
    len=length(filet);                   %measure length of file name 
    file1=filet(1:len-4);                %remove the .dat 
    look=find(file1=='/');               %find all the / in the file 
name 
    maxf=max(look)+1;                    %find the last / and index 1 
value past it (file name) 
    file2=file1(maxf:end);               %this was the file name 
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    file3=double(file2);                 %file name converted to ascii 
     
% EXTRACT X AND Y 
    xx=data(:,1);    
    yy=data(:,2); 
     
% DATA ADJUSTMENTS 
%    [myy,indmyy]=max(yy);                %find value and index of max 
Y-data point 
    indmyy=21; 
    xadj=xx(indmyy);                     %find time value of max Y-data 
point 
    xtrunc=xx(indmyy:end);               %truncating rise from X-data 
    ytrunc=yy(indmyy:end);               %truncating rise from Y-data 
    xnew=xtrunc-xadj;                    %setting first data point as 
time zero 
%    ynorm=ytrunc/myy;                    %normalizing Y-data to max Y-
data point   
     
% PLOT 
    plot(xx,yy,'r') 
    plot(xnew,ytrunc,'b'); 
  
  
%WRITE DATA TO FILE 
        corcmp=[xnew ytrunc]; 
        filecmp1=[file3, 95  116  48  110  46   116   120   116];     
%Adds '_t0n.txt' to the end of the file name 
        filecmp2=char(filecmp1); 
        dlmwrite(filecmp2,corcmp,'precision',14);       %write a file 
of the adjusted xy data 
        disp(filecmp2);                                 %tell you the 
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nnls_grad_reg_r2_KT 
%   Script to read [t,y] data from a file 
%   Fit using chisq and first derivative constraint 




















 %   return 
%elseif (a==2) 












%kana: add abs and define new wt 





while chk3 < 0 
chk=-1; 
prompt={'Enter the minimum value for \lambda', 
        'Enter the maximum value for \lambda', 
        'Enter the ratio of adjacent \lambda values', 
        'Enter the ratio of adjacent rate constants'}; 





helpstr1=['The program minimizes the sum of the squared deviations 
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between calculated and experimental intensities (chi-squared) AND the 
sum of the squared gradient of the P(k) function. The weighting factor 
between these two functions is lambda. Small \lambda values give more 
weight to chi-squared minimization. Large lambda values give more 
weight to P(k) gradient minimization. The program will scan from a 
minimum to a maximum value of lambda. The scanned lambda values are 
logarithmically spaced. This query asks for the maximum and minimum 
values of lambda as well as the ratio of adjacent lambda values.']; 
helpstr2=['The k-space vector is logarithmically spaced. This query 
asks for the raio of adjacent k values.]']; 
help1=' '; 
help2=' '; 
while chk < 0 
    
defanswer={num2str(lambda_min_def),num2str(lambda_max_def),num2str(lamb
da_inc_def),num2str(k_inc_def),}; 
    answer=inputdlg(prompt,dlg_title,numlines,defanswer,options); 
    ans1=cell2mat(answer(1)); 
    ans2=cell2mat(answer(2)); 
    ans3=cell2mat(answer(3)); 
    ans4=cell2mat(answer(4)); 
    % 
    chk=1; 
    hep1=0; 
    hep2=0; 
    if ishandle(help1)==1 
        close(help1); 
    end 
    if ishandle(help2)==1 
        close(help2); 
    end 
    % 
    if (isempty(ans1)) 
        chk=-1; 
    elseif ans1(1) == '?' 
        hep1=1; 
        chk=-1; 
    else 
        lambda_min=str2num(ans1); 
        if isempty(lambda_min) 
            chk=-1 
        else 
            lambda_min_def=lambda_min; 
        end        
    end 
    % 
    if (isempty(ans2)) 
        chk=-1; 
    elseif ans2(1) == '?' 
        hep1=1; 
        chk=-1; 
    else 
        lambda_max=str2num(ans2); 
        if isempty(lambda_max) 
            chk=-1 
        else 
            lambda_max_def=lambda_max; 
        end        
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    end 
    % 
    if (isempty(ans3)) 
        chk=-1; 
    elseif ans3(1) == '?' 
        hep1=1; 
        chk=-1; 
    else 
        lambda_inc=str2num(ans3); 
        if isempty(lambda_inc) 
            chk=-1 
        else 
            lambda_inc_def=lambda_inc; 
        end        
    end 
    % 
    if (isempty(ans4)) 
        chk=-1; 
    elseif ans4(1) == '?' 
        hep2=1; 
        chk=-1; 
    else 
        k_inc=str2num(ans4); 
        if isempty(k_inc) 
            chk=-1 
        else 
            k_inc_def=k_inc; 
        end 
    end 
    % 
    if (hep1 == 1) 
        help1=helpdlg(helpstr1,'Lambda Values') 
        hpos1=get(help1,'Position'); 
        set(help1,'Position',[hpos1(1)+0.5.*hpos1(3), 
hpos1(2)+0.5.*hpos1(4), hpos1(3), hpos1(4)]); 
    end 
    % 
    if (hep2 == 1) 
        help2=helpdlg(helpstr2,'k-ratio') 
        hpos2=get(help2,'Position'); 
        set(help2,'Position',[hpos2(1)+0.5.*hpos2(3), 
hpos2(2)+0.5.*hpos2(4), hpos2(3), hpos2(4)]); 
    end 
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chk=-1; 




helpstr3='If the data do not decay to zero, a slow rate constant can be 
added to the k-space vector to produce an offset in the data. This 
query asks if you want to include that offset rate constant.'; 
help3=' '; 
while chk < 0 
    % 
    choice=menu(menprompt,menopt1,menopt2,menopt3); 
    % 
    if ishandle(help3)==1 
        close(help3); 
    end 
    if choice == 1 
        Off_set=1; 
        chk=1; 
    elseif choice == 2 
        Off_set=0; 
        chk=1; 
    elseif choice ==3 
        help3=helpdlg(helpstr3,'Weighting'); 








menopt2='Weight y(i) values by 1/sqrt(yi)'; 
menopt3='Weight y(i) values by 1/yi'; 
menopt4='Help'; 
helpstr4='No weighting minimizes sum of {yi(exp)-yi(calc)}^2; higher 
intensity values carry more weight. The uncertainty in each yi(exp) 
value is approximately sqrt(yi(exp)). The sum of {[yi(exp)-
yi(calc)]/sqrt(yi(exp))}^2 is used to generate reduced chi-squared 
values. The optimum result is reduced chi-squared = 1. The sum of 
{[yi(exp)-yi(calc)]/yi(exp)}^2 minimizes the fractional deviations of 
experiment from calculated values.'; 
help4=' '; 
while chk < 0 
    % 
    choice=menu(menprompt,menopt1,menopt2,menopt3,menopt4); 
    % 
    if ishandle(help4)==1 
        close(help4); 
    end 
    % 
    if choice == 1 
        WT=eye(length(y)); 
        chk=1; 
    elseif choice == 2 
        WT=diag(wt); 
        chk=1; 
    elseif choice == 3 
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        WT=diag(wt); 
        WT=WT.^2; 
        chk=1; 
    elseif choice == 4 
        help4=helpdlg(helpstr4,'Weighting'); 








helpstr5='The two-point gradient for P(ki) is [P(k(i+1))-
P(k(i))]/delta. The three-point gradient for P(ki) is calculated by 
fitting the three points, [P(k(i-1)), P(k(i)), P(k(i+1))] to a second 




while chk < 0 
    % 
    choice=menu(menprompt,menopt1,menopt2,menopt3); 
    % 
    if ishandle(help5)==1 
        close(help5); 
    end 
    % 
    if choice == 1 
        grad=1; 
        chk=1; 
    elseif choice == 2 
        grad=2; 
        chk=1; 
    elseif choice == 3 
        help5=helpdlg(helpstr5,'Weighting'); 
    end 
    % 
end 
% 

















if (Off_set == 1) 
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if (grad == 1) 
    P_reg=2.*ones(lenk,1); 
    P_reg(1,1)=1; 
    P_reg(lenk,1)=1; 
    P_reg_3=zeros(lenk,1); 
    AA=diag(P_reg); 
    P_reg_2=-1.*ones(lenk-1,1); 
    AA1=diag(P_reg_2,1); 
    AA2=diag(P_reg_2,-1); 
else 
    P_reg=2.*ones(lenk,1); 
    P_reg(1,1)=1; 
    P_reg(lenk,1)=1; 
    P_reg_3=zeros(lenk,1); 
    AA=diag(P_reg); 
    P_reg_2=-1.*ones(lenk-2,1); 
    AA1=diag(P_reg_2,2); 







    % 
    AA_lam=lambda(ijk).*AA; 
    % 
    Aw=WT*A; 
    AAA=[Aw; AA_lam]; 
    yw=WT*y; 
    yy=[yw; P_reg_3]; 
    % 
    Pr=lsqnonneg(AAA,yy); 
    gradsq(ijk)=(AA*Pr)'*(AA*Pr); 
    % 
    chisq(ijk)=(yw-Aw*Pr)'*(yw-Aw*Pr); 
    chisq(ijk)=chisq(ijk)./(length(y)-length(Pr)-1); 
    %kana: deleted as necessary? 
    ycalc(:,ijk)=A*Pr; 
    resid(:,ijk)=y-ycalc(:,ijk); 
    resid(:,ijk)=resid(:,ijk).*wt; 
    %kana: wt is okay sometimes? the autocorrelation makes more sense 
if it 
    %is weighted? 
    % 
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    acorrin=zeros(len,jlen); 
    for aij=1:jlen 
        acorrin(1:len-aij,aij)=resid(aij+1:len,ijk); %",ijk" added 
4/27/2010 jrw 
    end 
    mvect=len-1:-1:len-jlen; 
    autoc(ijk,:)=(resid(:,ijk)'*acorrin)./mvect; 
    autoc(ijk,:)=autoc(ijk,:)./((resid(:,ijk)'*resid(:,ijk))./len); 
    % 
    Pok(:,ijk)=Pr; 
    % 
    subplot(3,2,1) 
    semilogx(x,y-ycalc(:,ijk),'r',[min(x) max(x)],[0 0],'k') 
    %semilogx(x,resid(:,ijk),'r',[min(x) max(x)],[0 0],'k') 
    %kana replace 
    A331=axis; 
    axis([min(x) max(x) A331(3) A331(4)]); 
    xlabel('time'); 
    ylabel('y_{obsd}-y_{calc}'); 
    title(['Residuals: {\chi}^2 = ',num2str(chisq(ijk),'%4g'),';  
(grad(P))^2 = ',num2str(gradsq(ijk),'%4g')]); 
    % 
    subplot(3,2,3) 
    [aa,bb]=size(autoc(ijk,:)); 
    plot([1:bb],autoc(ijk,:),'r',[1,bb],[0 0],'k') 
    xlabel('Correlation Channel'); 
    ylabel('Cr(j)'); 
    title('Autocorrelation of Residuals');  
    % 
    subplot(3,2,5) 
    semilogx([min(x) max(x)],[0 0],'k',x,y,'r',x,ycalc(:,ijk),'k') 
    xlabel('time'); 
    ylabel('Intensity'); 
    title(['{\lambda} = ',num2str(lambda(ijk),'%4g')]); 
    % 
    subplot(3,2,4) 
    HH=loglog(lambda(1:ijk),chisq(1:ijk),'ro-'); 
    xlabel('\lambda'); 
    ylabel('{\chi}^2'); 
    title('{\chi}^2 vs. \lambda'); 
    % 
    subplot(3,2,2) 
    bar(log10(k),Pr,'r') 
    axis([min(log10(k)), max(log10(k)), 0, 1.025.*max(Pr)]) 
    xlabel('log(k)'); 
    ylabel('P(k)'); 
    title(['{\lambda} = ',num2str(lambda(ijk),'%4g')]); 
    % 
    subplot(3,2,6) 
    loglog(chisq(1:ijk),gradsq(1:ijk),'ro-') 
    xlabel('{\chi}^2'); 
    ylabel('(grad(P))^2'); 
    title(['L-curve: {\lambda} = ',num2str(lambda(ijk),'%4g')]); 
    % 
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menprompt='Select an Option'; 
menopt1='Chose a different point'; 
menopt2='Refit the data'; 
menopt3='EXIT THE PROGRAM'; 
while chk2 < 0 
    [xtest,ytest, button]=ginput(1); 
    % 
    while (button == 1) 
    % 
        [lambdatest,ijktest]=min(abs(lambda-xtest));         
    % 
        subplot(3,2,1) 
        semilogx(x,y-ycalc(:,ijktest),'r',[min(x) max(x)],[0 0],'k') 
        %semilogx(x,resid(:,ijktest),'r',[min(x) max(x)],[0 0],'k') 
        %kana 
        A331=axis; 
        %axis([min(x) max(x) A331(3) A331(4)]); 
        axis([x(450) x(length(y)) -0.005 0.005]) 
        %kana: manually adjust0.1 to 0.005. 
        xlabel('time'); 
        ylabel('y_{obsd}-y_{calc}'); 
        title(['Residuals: {\chi}^2 = 
',num2str(chisq(ijktest),'%4g'),';  (grad(P))^2 = 
',num2str(gradsq(ijktest),'%4g')]); 
        % 
        subplot(3,2,3) 
        plot([1:bb],autoc(ijktest,:),'r',[1,bb],[0 0],'k') 
        %axis ([1 bb -0.1 0.1]) 
        %kana 
        xlabel('Correlation Channel'); 
        ylabel('Cr(j)'); 
        title('Autocorrelation of Residuals');  
    % 
        subplot(3,2,5) 
        semilogx([min(x) max(x)],[0 
0],'k',x,y,'r',x,ycalc(:,ijktest),'k') 
        xlabel('time'); 
        ylabel('Intensity'); 
        title(['{\lambda} = ',num2str(lambda(ijktest),'%4g')]); 
        % 
        subplot(3,2,4) 
        loglog(lambda(1:ijk),chisq(1:ijk),'ro-') 
        hold on 
        h1=loglog(lambda(ijktest),chisq(ijktest),'bo'); 
        set(h1,'MarkerFaceColor','b'); 
        hold off 
        xlabel('\lambda'); 
        ylabel('{\chi}^2'); 
        title('LEFT-CLICK on a point to see its fit, residual, and 
distribution; RIGHT-CLICK to 
proceed.','Fontsize',12,'Color','b','FontWeight','Bold'); 
        drawnow 
        % 
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        subplot(3,2,2) 
        bar(log10(k),Pok(:,ijktest),'r') 
        axis([min(log10(k)), max(log10(k)), 0, 
1.025.*max(Pok(:,ijktest))]) 
        xlabel('log(k)'); 
        ylabel('P(k)'); 
        title(['{\lambda} = ',num2str(lambda(ijktest),'%4g')]); 
        % 
        subplot(3,2,6) 
        loglog(chisq(1:ijk),gradsq(1:ijk),'ro-') 
        hold on 
        h2=loglog(chisq(ijktest),gradsq(ijktest),'bo'); 
        set(h2,'MarkerFaceColor','b'); 
        hold off 
        xlabel('{\chi}^2'); 
        ylabel('(grad(P))^2'); 
        title(['L-curve: {\lambda} = ',num2str(lambda(ijk),'%4g')]); 
        % 
        drawnow 
        % 
        [xtest,ytest, button]=ginput(1); 
        % 
        % 
    end 
% 
    choice=menu(menprompt,menopt1,menopt2,menopt3); 
    % 
    if choice == 1 
        chk2=-1; 
    elseif choice == 2 
        chk2=1; 
        chk3=-1; 
    elseif choice == 3 
        chk2=1; 
        chk3=1; 
    end 
%     close(H1); 
%     close(H2); 
%     close(H3); 




%kana: insert saving 
pause(3) 
[filename2,PathName2] = uiputfile('*.txt','choose directory','bozo'); 
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Panalyzer 
Written to determine population statistics, given a histogram (such as the 




% READ DATAFILE 
    [file,dirpath]=uigetfile('*.*'); 
    if isequal(file,0) || isequal(dirpath,0) 
        disp('no more') 
        i=0; 
        return 
    end 
    filet=[dirpath file]; 
    data=dlmread(filet); 
     
% EXTRACT X AND Y 
    ks=data(:,1);    
    Poks=data(:,2:end); 
     
% GET INDEX 
    %ind=17; 
    ind=input('what is the index for the desired P values? '); 
    desPoks=Poks(:,ind); 
     
% PLOT 
    %a=rand(3); 
    figure 
    bar(ks,desPoks,'r'); 
    hold 
    %semilogx(xx,yy,'color',a(1:3)); 
  
% SELECT POPULATIONS 
    klen=length(ks) 
    n=0; 
   
    seguir=input('would you like to analyze a population? (y/n): 
','s'); 
     
    col(1)='y'; 
    col(2)='g'; 
    col(3)='c'; 
    col(4)='b'; 
    col(5)='m'; 
    col(6)='k'; 
     
    while seguir=='y' 
        redo='y'; 
        n=n+1; 
        while redo=='y' 
	   311	  
            hold 
            bar(ks,desPoks,'r'); 
            hold 
            Plow(n)=input('enter the lower k(index) for the population: 
'); 
            Pup(n)=input('enter the upper k(index) for the population: 
'); 
            bar(ks(Plow(n):Pup(n)),desPoks(Plow(n):Pup(n)),col(n)) 
            redo=input('would you like to select a different region for 
this population? (y/n): ','s'); 
        end 
        seguir=input('would you like to select another population? 
(y/n): ','s'); 
    end 
     
    %DETERMINE STATISTICS (MOMENTS) 
    for m=1:n 
    
[tempint,tempcentro,tempcmoms]=Pmoments(desPoks(Plow(m):Pup(m)),ks(Plow
(m):Pup(m))); 
    Pint(m)=tempint; 
    Pcentro(m)=tempcentro; 
    Pcmoms(:,m)=tempcmoms; 
    end 
     
   Pint 
   Pcentro 
   Pcmoms 
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Pmoments 
function [P1int,centro,cmoms] = Pmoments(Ps,ks) 
%UNTITLED Summary of this function goes here 
%   Detailed explanation goes here 
  
%Ps are the populations 





P1int=trapz(Ps);            %Integrating the population distribution 
  
%uncentered moments 
% for n=1:4 
%     moms(n)=sum(Ps.*(ks.^n))./sum(Ps); 





    cmoms(n)=sum(Ps.*(centks.^n))./sum(Ps); 
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D.7. Hopping Maps 
The script MapMaker generates Hopping Maps using MapPlotter, MapValues, 
tauM, and tauETM. 
MapMaker 
%MapMaker - A GUI 
  
%MapMaker takes user input for various electron transfer parameters, 







%Acquiring Electron Transfer Parameters 
prompt1={'temperature (K)','A-I distance (A)','\beta step 1 
(1/A)','\lambda step 1 (eV)','I-B distance (A)','\beta step 2 
(1/A)','\lambda step 2 (eV)','A-B distance (A)','\beta single step 







%Acquiring the Hopping Map Range 
prompt2={'\Delta G(total) min  (eV)','\Delta G(total) max  
(eV)','\Delta G(1^s^t step) min  (eV)','\Delta G(1^s^t step) max  





%THE LOOP - repeats until the user presses 'cancel' 
while halt1~= 1 && halt2~=1 
     






%Making the HoppingMap 
[dGT,dG1,taoslog]=MapValues(convETparams,convmapRange);        
%generates map values 
MapPlotter(dGT,dG1,taoslog,convETparams,convmapRange);                   
%plots the map 
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   315	  
MapPlotter 
function MapPlotter(dGT,dG1,taoslog,convETparams,convmapRange) 
%Mapper3 Plots the hopping map 
%   Detailed explanation goes here 
  
etValues={'','\bfET Parameters','',['\rmT = 
',num2str(convETparams(1)),' K'],'',['r (A-I) = 
',num2str(convETparams(2)),' A'],['\beta (A-I) = 
',num2str(convETparams(3)),' A^-^1'],['\lambda (A-I) = 
',num2str(convETparams(4)),' eV'],'',['r (I-B) = 
',num2str(convETparams(5)),' A'],['\beta (I-B) = 
',num2str(convETparams(6)),' A^-^1'],['\lambda (I-B) = 
',num2str(convETparams(7)),' eV'],'',['r (A-B) = 
',num2str(convETparams(8)),' A'],['\beta (A-B) = 




loglines=(1:contourSpacing:15); %defines the position and spacing of 
contour lines 
  
scrsz = get(0,'ScreenSize'); 
figure1=figure('Position',[scrsz(3)/1.8 scrsz(4)/4 scrsz(3)/2.3 
scrsz(4)/2]); 













xlabel('\Delta G^0_T_o_t_a_l (eV)','FontSize',14); 
ylabel('\Delta G^0_1_s_t _s_t_e_p (eV)','FontSize',14); 
colorbar('peer',axes1); 
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Map Values 
function [dGT,dG1,taosNEWlog]=MapValues(ETparams,mapRange) 




























%The map resolution 
dGstep=mapRange(5); 
  






%GENERATING THE VALUES OF TAO: THE "Z" AXIS OF THE PLOT 
  
%Creates the matrix taos of dimensions lenx & leny which holds the "z" 
values for the Hopping Map, at 
%each (dG1,dGT) point 




    xcount=1; 
    dG1now=dG1(ycount); 
    while xcount<=lenx 
        dGTnow=dGT(xcount); 
        %this if statement defines the "sink" region 
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        if dG1now < dGTnow 
            taoVal=1e100; 
        else      
        
taoVal=tauM(dGTnow,dG1now,r1,r3,beta1,beta2,lamda1,lamda2,temp); 
        end 
         
        taos(ycount,xcount)=taoVal; 
        xcount=xcount+1; 




%Creates a vector taosET with length lenx holding values of taoET at  
%each dGT and dG1 




    dGTnow=dGT(tcount); 
    taoETVal=tauETM(dGTnow,rT,betaT,lamdaT,temp); 
    taosET(tcount)=taoETVal; 





%Where taoET/tao > 1, two step hopping is faster than single-step 
tunneling. 
%The values of a new matrix taoNEW are set to 1 if there is  





    ccount=1; 
    while ccount<=lenx 
        taoETC=taosET(ccount); 
        taoC=taos(rcount,ccount); 
        advantage=taoETC/taoC; 
        if advantage<1 
            taosNEW(rcount,ccount)=1;      %Only displays hopping areas 
        else 
            taosNEW(rcount,ccount)=taoC; 
        end 
        ccount=ccount+1; 
    end 
    rcount=rcount+1; 
end 
  






	   318	  
tauM 
function [tauVal] = tauM(dGT,dG1,r1,r3,B1,B3,lam1,lam3,T) 
%this function  
  
%Values for the constants 
h=4.13574*10^-15;   %planck's constant (eV*s) 
R=8.61733*10^-5;    %gas constant (eV/K) 
Habr02=0.0005323;   %Hab(r0)^2 (eV^2) 
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tauETM 
function [tauETVal] = tauETM(dGT,rT,BT,lamT,T) 
%Returns taoVal - the value of tao, for a given dG1 and dGT 
  
%Values for the constants 
h=4.13574*10^-15;   %planck's constant (eV*s) 
R=8.61733*10^-5;    %gas constant (eV/K) 
Habr02=0.0005323;   %Hab(r0)^2 (eV^2) 
r0=3;               %r0 (A) 
  
%values for recurring sets of constants 
c0=sqrt((4*pi^3)/((h^2)*lamT*R*T))*Habr02;    %the constants in front 
of the exponents in tao 
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D.8. Ferric/ferrous deconvolution 
The SpectralDeconvoluter script is used to deconvolute a two-component 
absorption spectrum and determine the percent of each parent component (e.g., 
ferric and ferrous components during potentiometric titration). Each spectrum 




%Ask for data 
xInt=input('Enter the wavelength data (must be the same for all 
spectra) '); 
yInt=input('Enter the intermediate spectrum to deconvolute '); 
yFe3=input('Enter the parent FeIII spectrum data '); 
yFe2=input('Enter the parent FeII spectrum data '); 
  
     























%iterate to find deconvolution 
while nInc > 0.001 && rebound < 20 
  
if errorTest_tot > lastError_tot 
    turn=-1*turn; 
    nInc=nInc/2; 
end 





if nNew < 0 
    nNew=0; 
    disp('lbounded!') 
    rebound=rebound+1; 
    turn=-1*turn; 
    nInc=nInc/2; 
end 
  
if nNew > 1 
    nNew=1; 
    disp('ubounded!') 
    rebound=rebound+1; 






















%plot final residuals 
plot(xInt,errorTest1,'k') 
plot(xInt,yInt,'b') 
plot(xInt,yTestNew,'r') 
hold 
figure 
plot(xvals,vals(1,:),'r') 
figure 
plot(xvals,vals(2,:),'b') 
figure 
plot(xvals,vals(3,:),'g') 
